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Introduction 
Chapter 1 
1.1 Tuberculosis & control 
 
Tuberculosis (TB) is an infectious disease that caused 9.2 million new 
cases and 1.7 million deaths in the world in 2006 (1). Over one-third of 
the world population is infected with Mycobacterium tuberculosis, the 
causative organism of TB. In the Netherlands, TB was the leading cause of 
death in the first decades of the last century, but improved socio-
economic circumstances, infection-control measures and the introduction 
of effective chemotherapy have reduced TB to a relatively uncommon 
disease. TB mortality rates in the Netherlands declined a thousand fold in 
one century and incidence was the lowest ever recorded in 2006 (2). 
Prospects are yet less good in other parts of the world. The human 
immunodeficiency virus (HIV) pandemic multiplied the TB caseload in 
many sub-Saharan countries and drug resistance is on the increase in 
several countries with high rates of multidrug-resistant (MDR) strains. 
Recently, extensively drug-resistance (XDR) was described and XDR-TB is 
an emerging public health probem in a number of countries (3). 
 
 
1.1.1 Infection and disease 
 
A person with infectious pulmonary TB expels aerosol droplets (0.5 to 5 
µm in diameter) containing M. tuberculosis bacteria by coughing, 
sneezing, singing or talking. People with prolonged and frequent contact 
have a high risk to inhale the bacteria and become infected. The 
asymptomatic stage, without clinical or radiological symptoms, is referred 
to as latent TB infection (LTBI). Persons with LTBI have approximately a 
10% lifetime risk to progress to TB. The risk of TB increases in HIV-
infected persons with low CD4 count, patients receiving immune-
suppressive therapy, and certain medical conditions, such as end-stage 
kidney disease and diabetes mellitus. Persons coinfected with M. 
tuberculosis and HIV, have an annual risk of 5-8% to develop TB (4, 5). 
The diagnosis of LTBI is by tuberculin skin test (TST), also called the 
Mantouxtest. Interferon-gamma release assays (IGRAs) have recently 
been introduced as another, or supplementary, diagnostic tool for LTBI. 
The incubation period of TB varies between some months to several 
decades, although most frequently infection progresses to disease within 
two years of infection. TB can affect almost any part of the human body, 
though the lungs are involved in two-third of cases. Symptoms related to 
pulmonary TB are productive and prolonged cough, haemoptoe, fever, 
night sweats, weight loss and fatigue. Other organs commonly involved 
are pleura, lymph nodes, urogenital system, nervous system, bones and 
joints. The diagnosis of TB depends on the organs involved. In pulmonary 
TB, a chest X-ray may show a typical radiographic picture with cavitation, 
although it can be normal as more frequently occurs in HIV-infected TB 
cases. Infectious pulmonary TB is highly suspected when acid fast bacilli 
are visible on direct microscopy of sputum by Ziehl-Neelsen or auramine-
rhodamine staining methods. Other forms of TB may need more specific 
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diagnostic procedures such as bronchoscopy and biopsy of affected 
organs. The diagnosis is confirmed by a positive culture of body material 
for M. tuberculosis complex. Strain typing, drug sensitivity testing and 
molecular analysis of isolates complete the microbiological steps of the 
diagnosis of TB (see chapter 1.2). 
In the Netherlands, LTBI is generally treated with six months 
isoniazid, which has an efficacy between 70 and 90% (6). LTBI can also 
be treated with four months rifampicin (7), e.g. if cases are infected with 
isoniazid-resistant strains, or if serious side effects of isoniazid complicate 
therapy. Treatment of TB requires daily administration of a combination of 
four drugs: isoniazid, rifampicin, pyrazinamide and ethambutol (8, 9). The 
World Health Organisation (WHO) policy is to directly observe the 
treatment (DOT) of TB. The six-month treatment regime of fully-sensitive 
TB has high cure rates with only 1-2% relapses. The treatment schedule 
can be adapted to the drug sensitivity of the strain. MDR strains are by 
definition resistant to isoniazid and rifampicin; XDR strains have additional 
resistance against quinolones and aminoglycosides. Treatment of MDR-TB 
and XDR-TB is less effective, complex and usually exceeds 18 months 
chemotherapy with five or more drugs. Large scale treatment results of 
XDR-TB are not yet available, although one case study reported 
devastating outcomes (3). 
 
 
1.1.2 Epidemiology 
 
TB incidence or incidence rate has been estimated by dividing the case 
notification per 100,000 persons in a year with the estimated proportion of 
cases detected (10). Thus, notified cases are the actual number of 
reported cases and incident cases the true number of new cases in a 
population in a specific time period. Estimated TB incidences vary 
considerably around the world from 363 per 100,000 population in the 
African region to 49 per 100,000 in the European region and 39 per 
100,000 in the Americas (Figure 1.1) (1). In 2006, the country with the 
highest estimated incidence was Swaziland, with 1,155 cases per 100,000 
population. India had the highest number of new cases in the world with 
an estimated 1.9 million cases (incidence 168 per 100,000). China had an 
estimated 1.3 million cases (incidence 99 per 100,000). In the United 
States incidence declined to 4.3 per 100,000 population. In the European 
Union (EU) incidence was highest in Romania (128 per 100,000) and 
Lithuania (62 per 100,000), and lowest in the Scandinavian countries (5-6 
per 100,000)1. Since 2000 incidence has declined in all EU states except 
the United Kingdom, the three Baltic states and Romania (1). 
1 Excluding incidences in some smaller EU countries such as Cyprus and Malta with even 
lower incidences.  
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Estimated TB incidence rate, 2006
Estimated new TB cases (all 
forms) per 100 000 population
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© WHO 2006. All rights reserved
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Figure 1.1. Estimated TB incidence by country in 2006 (1). 
 
 
In the Netherlands, TB disease notification started in 1951 and was based 
on hospital admissions. For countries with a good health care and 
information system, such as the Netherlands, incidence and notification 
are usually considered identical. In 1951, incidence was nearly 150 per 
100,000. In 1972, when mandatory notification of all cases to the Dutch 
Health Care Inspectorate started, incidence had already dropped to 18.4 
per 100,000 (Figure 1.2). Incidence continued to decline steadily until the 
mid-eighties when a high influx of immigrants caused an increase of TB 
incidence. In the last ten years, incidence in the Netherlands declined 
again and reached the lowest ever recorded rate of 6.2 per 100,000 in 
2006 (2). 
The Municipal Public Health Service (MPHS) Rotterdam-Rijnmond 
carries out the TB control activities for the municipality Rotterdam and 27 
surrounding municipalities. In figure 1.2, TB incidences in Rotterdam and 
these other municipalities are depicted. The Rotterdam TB incidence 
steadily increased from 1988 on, and doubled over a 15-year period to 
29.2 per 100,000 in 2003. In that year, the Rotterdam City Council 
requested the director of the MPHS Rotterdam-Rijnmond to investigate the 
causes of the high TB caseload in Rotterdam. 
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Figure 1.2. Tuberculosis incidence in the Netherlands, the municipality 
Rotterdam and 27 other municipalities of the Municipal Public Health 
Service Rotterdam-Rijnmond (2). 
 
 
Fifty-six percent of the catchment population of the Department of 
TB Control of the MPHS Rotterdam-Rijnmond lives in three very highly 
urbanised (>2500 addresses/km2) municipalities (Rotterdam, Schiedam 
and Vlaardingen). They form the metropolitan area in this thesis. 
The main characteristics of TB patients in the Netherlands is 
summarised in the annual surveillance reports that are compiled by KNCV 
Tuberculosis Foundation (2). In 2006, 1,021 cases were notified; 644 
(63%) were foreign-born, 66% had pulmonary TB, 7% had a previous 
episode of TB, 69% were culture-confirmed, 5.7% of isolates were 
isoniazid-resistant and 0.9% MDR-resistant, 4.0% of cases were HIV-
coinfected. Twenty-five percent of cases were actively traced and 82% of 
cases diagnosed in 2005 completed treatment; 7% of the cases died 
before or during treatment. 
 
 
1.1.3 Organisation of TB control in the Netherlands 
 
The basic principles of TB control are prompt TB diagnosis of symptomatic 
persons (passive case finding), completion of TB treatment (case holding) 
and identification of asymptomatic TB and LTBI cases (active case 
finding). Isolation of cases during the infectious stage of the disease is 
essential to reduce transmission. Mandatory isolation of patients 
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noncompliant with isolation procedures should have a legal basis. 
Institutional infection-control measures should be in place to prevent 
spread e.g. in health care facilities (11). Vaccination with bacille Calmette-
Guérin (BCG) protects young children from severe childhood TB, but does 
not prevent disease in adults. 
In the Netherlands, TB is a notifiable disease and should be reported 
to the MPHS within 24 hours after diagnosis according to the Infectious 
Diseases Act. Nurses of the Departments of TB Control guide patients 
throughout their treatment and sometimes supervise medication intake by 
applying DOT. TB and LTBI cases are actively searched for by contact 
tracing, and by risk and contact group screening. National guidelines have 
been developed for these interventions (12). Contact tracing is carried out 
according to the stone-in-the-pond approach (13). Risk groups have been 
classified as well-defined groups with a TB incidence of more than 50 per 
100,000 population. Immigrants, asylum seekers, prisoners, seamen are 
considered nationwide risk groups, while illicit drug users and homeless 
persons are locally defined risk groups depending on the epidemiological 
context. Professional contacts of risk groups are so-called contact groups, 
e.g. health care workers and social workers involved in care for homeless 
persons. Persons belonging to risk groups or contact groups are or may be 
periodically screened for TB or LTBI, either by chest X-ray or by TST. 
Municipalities are responsible for public health in the Netherlands 
and have formed Municipal Public Health Services (MPHS), as outlined in 
the Public Health Act. The Departments of TB Control of these MPHSs 
carry out the TB control activities. They receive the reports of new cases 
and report nowadays to the national Centre of Infectious Diseases. The 
Departments of TB Control have a low threshold for symptomatic clients, 
provide free care for TB cases, conduct contact investigations, screen risk 
and contact groups, are responsible for local surveillance and outbreak 
response, and implement selected BCG vaccination of high-risk children. 
The National Institute for Public Health and the Environment (RIVM) 
receives all M. tuberculosis isolates for strain typing, drug sensitivity 
testing and molecular analysis. The Committee for Practical TB Control, 
organised by KNCV Tuberculosis Foundation, is responsible for national 
policy and guideline development. KNCV Tuberculosis Foundation is also 
responsible for national surveillance and holds the Netherlands 
Tuberculosis Register (NTR). The low TB incidence in the Netherlands has 
made a reorganisation of TB Control necessary, which is now increasingly 
organised at a regional level. At this moment, the country is divided into 7 
regions with 8 back offices with the South-Holland region having two back 
offices, i.e. Rotterdam and The Hague. Furthermore, a strategic 
programme is currently being developed to move towards the elimination 
of TB, aiming to reduce the incidence to 1 case per million population 
(14). 
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1.2  DNA fingerprinting methods 
 
The complete genome of the M. tuberculosis laboratory strain H37Rv 
consisting of 4,411,529 base pairs (bp) was sequenced and published in 
1998 (15). Since then other M. tuberculosis strains and a strain of M. 
bovis have been fully sequenced (16). Although the M. tuberculosis 
genome is genetically highly conserved, insertion sequences, repetitive 
elements, genomic deletions and single nucleotide polymorphisms cause 
genetic polymorphisms which can be identified by various molecular DNA 
typing techniques, also called DNA fingerprinting (17). 
 
 
 
 
Figure 1.3. Chromosome of Mycobacterium tuberculosis hypothetical 
strain X and genotyping of M. bovis BCG, M. tuberculosis strain H37Rv, 
and strain X on the basis of IS6110 insertion sequences and mycobacterial 
interspersed repetitive units (MIRUs) (18). 
 
Reproduced with permission from Massachusetts Medical Society. 
Copyright © 2003 Massachusetts Medical Society. All rights reserved. 
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Figure 1.4. Physical map of the 1.35-kb M. tuberculosis insertion element 
IS6110. The cleavage sites of several restriction enzymes are depicted. 
PvuII cleaves the element at base pair 461 (19). 
 
Reproduced with permission from American Society for Microbiology. 
Copyright © 1993 American Society for Microbiology. All rights reserved. 
 
 
IS6110-based RFLP typing. The most widely applied genotyping method 
for M. tuberculosis is restriction fragment length polymorphism (RFLP) 
typing. The technique is based on identifying insertion sequences (IS) that 
are common in bacterial genomes. One of these elements, IS6110, was 
first reported by Thierry et al. (20). IS6110 occurs specifically in the 
genome of M. tuberculosis complex strains and is 1,355 bp in length 
(Figure 1.3). In 1993, van Embden et al. proposed a standardised method 
for strain identification using IS6110-based fingerprinting (19). Basically, 
a restriction endonuclease (PvuII) cuts the circular chromosome of M. 
tuberculosis at specific sites, including bp 461 in the IS6110 segment 
(Figure 1.4). The result is that the M. tuberculosis chromosome is divided 
into thousands of DNA fragments of varying size. These negatively 
charged DNA fragments are separated by algarose gel eletrophoresis and 
transferred to a nylon membrane (Southern blotting). The chemi-
luminiscence-labelled probe specific to the right side of IS6110 hybridises 
to the DNA fragments containing the right-hand part of IS6110. The 
banding pattern, visualised after chemiluminiscence, is detected on a 
light-sensitive film. Computer-assisted analysis using a dedicated software 
application facilitates storage and comparison of the DNA fingerprints. 
Standardised molecular weight markers, i.e. between 0.6-kb (kilo bp) and 
23.1-kb, enable comparison of DNA fingerprints within and between 
laboratories. Figure 1.5 shows a number of fingerprints of M. tuberculosis 
isolates. 
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Chapter 1 
RFLP typing has been the method of choice because of its high 
reproducibility, good discriminatory power and high specificity (28). 
However, apart from the limitations for low-copy strains, the RFLP typing 
procedure is also laborious, costly, and can only be performed on viable 
isolates. The turn-around time is long because the required amount of 
DNA (2 μg) is only reached after several weeks of culture (21). 
Furthermore, exchange of IS6110 data between laboratories is difficult 
because of the photographic type of result of RFLP typing. 
 
Other genotyping methods. Spacer oligonucleotide typing (spoligotyping) 
is a widely used polymerase chain reaction (PCR)-based technique to 
simultaneously detect and type M. tuberculosis. The M. tuberculosis 
genome usually contains a distinct chromosomal region, the so-called 
direct repeat (DR) region. This region consists of 36-bp DRs separated by 
spacer DNA sequences of 37 to 41 bp. Forty-three known spacer 
sequences are identified by spoligotyping. The result of this typing method 
is binary data derived from the presence or absence of these spacer 
sequences. Another relatively new DNA typing method is the 
mycobacterial interspersed repetitive unit (MIRU) or variable-number 
tandem repeats (VNTR) genotyping. This method determines the number 
of repeats in various independent repeat loci in the genome. Similarly to 
spoligotyping, this technique has the advantage of being PCR-based, and 
thus does not require extended cultivation of the M. tuberculosis strains 
before typing. The results from VNTR typing can also be represented 
numerically, allowing easy storage, comparison and exchange of data. 
Recently, a standardised VNTR typing method was proposed to include 15 
VNTR loci for routine epidemiological studies and 24 for phylogenetic 
studies (29). The discriminatory power of the 15-loci VNTR typing was 
found to be equal to that of IS6110 RFLP typing for an international 
collection of M. tuberculosis strains. At the RIVM in the Netherlands, 
where RFLP typing has been applied on a routine basis since 1993, all M. 
tuberculosis isolates of 2004 to 2008 have been retyped with VNTR typing 
(personal communication Kristin Kremer), and since 1 January 2009 VNTR 
typing replaced IS6110-based RFLP typing  
18
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1.3 Molecular epidemiology of tuberculosis 
 
Molecular epidemiology can be defined as “the science that focuses on the 
contribution of potential genetic and environmental risk factors, identified 
at the molecular level, to the etiology, distribution and prevention of 
disease within families and across populations” 
(http://www.pitt.edu/~kkr/molepi.html). This chapter discusses the 
relevance of genotyping for understanding TB transmission and its use for 
control activities. 
 
The European Concerted Action on Molecular Epidemiology and Control of 
Tuberculosis outlined factors that should be considered by those 
conducting and interpreting studies of M. tuberculosis in populations (30). 
They stated that these studies should be conducted in conjunction with 
conventional epidemiological investigations of contacts, should involve a 
high proportion of all cases in a population and should provide specific 
information on population and patients. A number of review articles 
described current insights and applications of DNA fingerprinting in TB 
control (16-18, 31, 32). 
 
 
1.3.1 Contribution of molecular epidemiology to understand TB 
transmission 
 
Two population-based studies from San Francisco and New York, both 
published in 1994, combined for the first time molecular and conventional 
epidemiological methods to investigate TB transmission in a large number 
of patients (33, 34). The assumption that 90% of incident cases in the 
United States resulted from reactivation of latent, remote TB infection 
(35) was challenged in these studies, because they found that about one-
third of urban cases had clustered strains and were presumably recently 
infected. Both studies were considered landmark for the application of 
DNA fingerprinting (22). Since that time, many other studies confirmed 
that a considerable proportion of disease in low-prevalence countries was 
caused by recent transmission, in particular in urban areas. High 
clustering rates in rural areas without documented outbreaks may 
however result from infections that occurred many years or decades 
before by strains circulating at that time and having survived without 
molecular change (23). Non-matching, i.e. unique fingerprints, suggest 
that these patients are not involved in recent chains of transmission in the 
area under study and result from an infection that was acquired several 
years in the past (reactivation) or outside the area under study 
(importation). 
Molecular epidemiological studies identified risk factors for 
clustering, which varied according to the specific epidemiological situation 
(33, 34, 36, 37). Common risk factors in these studies were sex, younger 
age, nonimmigrants, AIDS patients or HIV-coinfection, alcohol abuse, 
injection drug use and homelessness (31). Also, certain subpopulations or 
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ethnic groups had a higher risk of clustering such as Hispanics and the 
black population in a number of American studies and black Caribbean 
ethnicity in London (33, 34, 38). High rates of clustering among persons 
and risk groups reflect primarily the risk of infection, although e.g. HIV-
infected persons also have a higher probability for disease development. 
Some studies showed that drug resistance was a risk factor for clustering 
indicating transmission of these strains in communities (33). However, 
van Soolingen et al. found that drug-resistant strains were less 
transmissible (39). The clustering proportion usually reaches a plateau 
after 3-4 years of universal genotyping (30). 
Molecular epidemiological studies have confirmed high-risk sites for 
TB transmission. Cronin et al. defined traditional settings for TB 
transmission as households or contacts with close relatives and friends, 
and all other settings as non-traditional (40). Homelessness is an 
independent risk factor for clustering in almost all molecular population-
based studies, and thus transmission most likely occurs in places common 
to these persons, such as shelters (41). Other non-traditional settings, 
such as the workplace, hospitals, bars, schools, prisons and churches have 
been described in outbreak reports (42-44). 
A number of genotyping studies focused on the concept of recurrent 
TB, i.e. disease reoccurring after a first episode (45-49). A second episode 
can either be caused by the same strain (endogenous reactivation or 
relapse) or result from an infection with a new strain. Relapse TB due to 
reactivation or to reinfection are clinically indistinguishable. Genotyping 
has shown the ability to differentiate the different pathogenesis of 
recurrent TB. In low-incidence countries, the proportion of recurrent TB 
caused by reinfection was much higher than previously believed. In high-
endemic countries, reinfection rates are markedly high due to the high 
risk of infection in these communities (48, 49). 
Prospective population-based studies using genotyping showed that 
some epidemiological links of clustered cases could only be established 
after meticulously interviewing clustered patients (50, 51). A considerable 
proportion of TB transmission thus occurs during casual contact, e.g. in 
local shops and public transport, with few opportunities to target these 
contacts for enhanced contact tracing (16, 18, 39, 40, 44, 50). Clustered 
cases that are not epidemiologically linked may also result from remote 
transmission or transmission in the country of origin of immigrants (51, 
52). Van Deutekom et al. reinvestigated a subset of seven RFLP clusters 
without epidemiological links and found that five were subdivided by 
MIRU-VNTR typing, indicating false clustering of TB patients by IS6110 
typing (53). 
 
 
1.3.2 Applications of molecular epidemiology for TB control 
 
Molecular typing has been used to identify and confirm outbreaks, as 
described in many studies (42, 54-59). Common in these studies is that 
they report on a single strain or a limited number of strains causing the 
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outbreak, often in a high-risk group. In the beginning of the 1990s, DNA 
fingerprinting revealed that nosocomial transmission in hospitals with 
drug-resistant strains contributed to the resurgence of TB in the United 
States which affected HIV-infected persons and health care workers (60, 
61). This alerted public health officials and revived the national TB 
programme (56). 
Molecular epidemiology also showed that recently infected cases 
were mostly not identified by conventional contact tracing (18). In the 
Netherlands, genotyping results only led to the extension of 1% of contact 
investigations, and relatively few additional persons with TB or LTBI were 
diagnosed (51). The use of DNA fingerprinting in conventional contact 
tracing activities is further limited because of the long latency period of TB 
and the slow turn-around time of RFLP results. 
Population-based molecular epidemiological studies investigated 
transmission dynamics and clustering rates in several cities, states and 
countries, most of them in low-incidence countries. In a recent meta-
analysis including 36 studies in 17 countries the TB clustering proportion 
varied greatly between 7.0 and 72.3% (31). Clustering proportions are 
usually higher in urban areas. Table 1.1 provides an overview of clustering 
rates in selected cities of low-endemic countries. 
Transmission dynamics between immigrants and nonimmigrants in 
low-incidence countries has been researched in a number of studies (62-
64). DNA fingerprinting also can help local public health authorities to 
identify high-risk populations and TB transmission sites (18, 41). 
Fingerprinting has been used as a tool to monitor trends, evaluate 
interventions and programmes (37). In San Francisco, the clustering rate 
declined from 51.2 to 29.8 per 100.000 population after TB control 
activities were intensified (65). In Denver, the proportion of clustering 
strains among homeless persons decreased from 49 to 14 after 4 years of 
screening for LTBI and TB (66). The overall decline of TB incidence in the 
Netherlands and in Arkansas was caused by a decrease of nonclustered 
case rates among persons aged 65 years or more, which is mainly the 
result of a cohort effect (67, 68). In Texas, genotyping was combined with 
geographical information systems to identify high-risk groups for targeted 
TB testing programmes (69). 
Genotyping also highlighted the occurence and significance of 
laboratory cross-contamination (70). In general, contamination is 
suspected when identical fingerprints are cultured from different patients 
in the same laboratory within a seven days period (21, 71). In the 
Netherlands, laboratory cross-contamination was approximately 3 percent 
and reduced after quality enhancing procedures, such as sending multiple 
samples and critically comparing laboratory results with clinical findings, 
were installed (26). 
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1.4 Aim of the thesis and research questions 
 
The aim of this thesis is to investigate the role of DNA fingerprinting for TB 
control. Based on current knowledge of the use of DNA fingerprinting in 
other cities and countries, the following specific research questions have 
been formulated: 
 
1) What has been the added value of DNA fingerprinting for TB control in 
a metropolitan area?  
 
2) What are the causes of the high TB incidence in a metropolitan area, as 
revealed by DNA fingerprinting? 
 
3) What do our studies add to the knowledge of TB transmission? 
 
 
1.5 Outline of the thesis 
 
The first research question is addressed in the chapters 2 and 3. Chapter 
2 describes a transmission classification model to determine place and 
time of infection of all TB cases. The extent of misclassification was 
assessed for cases with a DNA fingerprint if genotyping was not combined 
with epidemiological information. In Chapter 3 an illustrative cluster is 
presented graphically to show epidemiological links between cases and 
transmission places. The specific cluster findings are used to discuss 
relevant issues in TB control. 
The second research question is addressed by describing several 
applications of DNA fingerprinting in a metropolitan area. In Chapter 4 
demographic and disease-related factors of tuberculosis cases in a highly 
urbanised area are compared with cases of less-urbanised municipalities. 
In Chapter 5 an extensive contact investigation among illicit drug users 
and homeless persons in Rotterdam is described. This investigation was 
carried out in 2001 and initiated a screening programme among illicit drug 
users and homeless persons. In Chapter 6 the results from an evaluation 
of this screening programme, using DNA fingerprinting, are discussed. 
Results from the methodological studies in chapters 2 and 3, and 
the different studies on metropolitan tuberculosis in chapters 4, 5 and 6 
also address the third research question, as well as the study described in 
Chapter 7, concerning the use of DNA fingerprinting to determine which 
health care workers were nosocomially infected in the Netherlands in the 
period 1995 to 1999. The general discussion (Chapter 8) reviews the 
research questions and the results of the studies in the context of the 
literature, it discusses the implications for future TB control in the 
Netherlands, and lists the conclusions and recommendations. 
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Chapter 2 
 
Abstract 
 
We conducted a population-based study in the Rotterdam region of The 
Netherlands to determine the place and time of infection of tuberculosis 
(TB) cases using conventional epidemiological and genotyping 
information. In particular, we focused on the extent of misclassification if 
genotyping was not combined with epidemiological information. 
Cases were divided into those with a unique mycobacterial DNA 
fingerprint, a clustering fingerprint, and an unknown fingerprint. We 
developed transmission classification trees for each category to determine 
whether patients were infected in a foreign country or recently (<2 years) 
or remotely (>2 years) infected in The Netherlands. 
Of all TB cases during the 12-year study period, 38% were infected 
in a foreign country, 36% resulted from recent transmission in The 
Netherlands, and 18% resulted from remote infection in The Netherlands, 
while in the remaining cases (9%) either the time or place of infection 
could not be determined. The conventional epidemiological data suggested 
that at least 29% of clustered cases were not part of recent chains of 
transmission. Cases with unknown fingerprints, almost all culture 
negative, relatively frequently had confirmed epidemiological links with a 
recent pulmonary TB case in The Netherlands and were more often 
identified by contact tracing. 
Our findings highlight the idea that genotyping should be combined 
with conventional epidemiological investigation to establish the place and 
time of infection of TB cases as accurately as possible. A standardized way 
of classifying TB into recently, remotely, and foreign-acquired disease 
provides indicators for surveillance and TB control programme perfor-
mance that can be used to decide on interventions and allocation of 
resources. 
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Introduction 
 
The steady decline of tuberculosis (TB) incidence, especially since the 
introduction of chemotherapy in the 1950s, was reversed in the late 1980s 
in many developed countries due to immigration, concurrent human 
immunodeficiency virus (HIV) infections, and inadequate TB control 
practices (1). In the last 10 years, however, the general downward trend 
has resumed in many of these countries, necessitating review of current 
TB control strategies. Several countries where the incidence of TB is low 
are currently developing TB elimination plans in order to reach the goal of 
less than 1 case per million population per year (2, 3). 
For TB control, it is relevant to know where and when patients were 
infected, because recently infected patients represent ongoing 
transmission, those with remotely acquired infection are a result of TB 
transmission in the past, and patients infected in a foreign country are an 
expression of the particular TB situation in that country. The absolute TB 
incidence and the relative contributions of recently, remotely, and foreign-
acquired disease influence the choice of TB control strategies (4-6). The 
proportion of recent transmission is also an important indicator for 
surveillance and TB control programme performance (7, 8). 
DNA fingerprinting of Mycobacterium tuberculosis isolates provides a 
tool to disentangle the different transmission pathways (6, 9, 10). The 
percentage of clustered cases in an area indicates the amount of recent 
transmission in a community, but clustering is not identical with recent 
transmission (11-13). Furthermore, fingerprinting studies alone ignore 
culturenegative cases, although their contribution to the TB caseload and 
to recent transmission may be substantial. Thus, a combined use of 
conventional epidemiological and genotyping data will ascertain more 
accurately where and when patients were infected (7, 8, 14). A 
standardized way of classifying transmission will help to monitor and 
compare TB control programmes. 
We developed and applied a transmission classification model to 
determine the place and time of infection of all TB cases in a highly 
urbanized area by using information from conventional epidemiological 
investigation and molecular typing. In addition, we assessed the extent of 
misclassification for cases with a DNA fingerprint if genotyping was not 
combined with epidemiological information. 
 
 
Materials and Methods 
 
Study area and study population. The study was conducted in a highly 
urbanized area with 1.9 million inhabitants in the southern part of the 
province of South-Holland, The Netherlands. Reported cases diagnosed 
between 1 January 1995 and 31 December 2006 were included in the 
study, excluding 41 sailors with a residential address outside The 
Netherlands and 12 inmates of a deportation centre for illegal immigrants 
transferred from other regions of the country. M. tuberculosis complex 
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strains were identified by using an Accuprobe culture confirmation test 
(Genprobe, Inc., San Diego, CA) or, since January 2004, with a GenoType 
MTBC assay (Hain Lifescience GmbH, Nehren, Germany). Species within 
the M. tuberculosis complex were distinguished by a combination of 
biochemical tests and DNA fingerprint methods, as described in detail by 
van Klingeren et al. (15). Mycobacterium africanum isolates were not 
distinguished from M. tuberculosis and are therefore included among the 
isolates identified as M. tuberculosis. All 34 patients infected with 
Mycobacterium bovis, the 2 patients with Mycobacterium canettii strains, 
and the single patient with Mycobacterium bovis bacillus Calmette-Guérin 
were excluded from our study. In culture-negative cases, diagnosis was 
based upon clinical, radiographic, histopathological, and/or epidemio-
logical grounds. 
The national TB disease register provided data for reported cases 
after approval by its data protection committee. Cases that resulted from 
laboratory cross-contamination had been withdrawn from the register. The 
data were completed and validated using local registers, patient records, 
and the DNA fingerprinting register of the National Mycobacteria 
Reference Laboratory. The Medical Ethics Committee of Erasmus MC, 
University Medical Center Rotterdam, Rotterdam, approved the study 
protocol. 
Recurrent TB was defined as disease reoccurring more than 1 year 
after the start of a previous episode. Twenty-five patients had two 
episodes during the study period, all with a culture-confirmed first 
episode. Of these recurrent cases, 14 were considered relapses, because 6 
were not bacteriologically confirmed in the second episode, 7 had the 
same fingerprint as the first episode and their clusters had no pulmonary 
case since the first episode, and in 1 case, the M. tuberculosis isolate was 
erroneously not forwarded for restriction fragment length polymorphism 
(RFLP) typing. These 14 second-episode cases were excluded from the 
study. The other 11 recurrent cases were considered reinfections and both 
episodes were included in the study. Five of these cases had different 
fingerprints in both episodes, and 6 had identical fingerprints, but these 
cases shared epidemiological features with 1 or more pulmonary TB cases 
that were added to the cluster since the first episode. 
 
DNA fingerprints. Since 1 January 1993, all M. tuberculosis isolates in The 
Netherlands have been subject to standardized IS6110-based RFLP 
typing, also called DNA fingerprinting (16). Clusters are defined as groups 
of patients having isolates with fully identical RFLP patterns or, if 
mycobacterial strains harbour fewer than 5 IS6110 copies, isolates with 
identical subtyping in assays using the polymorphic GC-rich sequence 
(PGRS) probe (17). The first case in each cluster was classified as unique. 
In one cluster, the first and second positions were changed because a 4-
month-old child was the first case in the cluster but she was 
unquestionably infected by her mother, who was diagnosed with 
urogenital TB 2 months later (18). 
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Transmission classification model. Cases were grouped into three main 
categories: (i) cases with a unique fingerprint, (ii) cases with a clustering 
fingerprint, and (iii) cases with an unknown DNA fingerprint. The category 
with unique fingerprints was subdivided into cases in immigrant and 
nonimmigrant patients. Transmission classification trees were developed 
for each category (see Table 2.1 and the supplemental material 2.1 to 
2.5) and discussed during three consensus meetings with TB public health 
specialists. 
The outcome of the classification process was, first of all, a 
likelihood scale of place of transmission, i.e., confirmed infected in a 
foreign country, probably infected in a foreign country, indeterminate, 
probably infected in The Netherlands, and confirmed infected in The 
Netherlands. The questions leading to this outcome were related to the 
date and time period of residence in The Netherlands for cases in 
immigrants; documented contact with a pulmonary TB case; documented 
history of frequent travel to countries where TB is endemic, i.e., more 
than 3 months cumulative during the 5 years prior to diagnosis; and the 
time difference with the last preceding pulmonary case in the cluster for 
clustered cases. In addition, the results of entrance screening were used 
to determine the most likely place of infection in immigrant patients 
without a DNA-fingerprinted isolate. 
For patients infected in The Netherlands, the time of infection was 
classified as recently infected (≤2 years), remotely infected (>2 years), 
and unknown time of infection. Decisions were based on information 
routinely collected by TB public health nurses on the relationship between 
clustered cases and their assessment of whether an epidemiological link 
was confirmed, i.e., the patient knew a person in the cluster by name or 
was at the same place at the same time with a clustered pulmonary case, 
or the link was possible, i.e., the patient shared behavioural patterns 
(such as homelessness, illicit drug use, and pub visiting) with other 
patients in the cluster (7, 19). For confirmed epidemiologically linked 
clustered cases, the time difference between the dates of sample 
collection determined whether a secondary case had a recent or remote 
infection. Clustered cases without a confirmed epidemiological link were 
considered infected by the last preceding pulmonary case in the cluster. In 
cases without a fingerprint, decisions on the time of infection were based 
on a documented contact with a pulmonary TB case and a history of 
previous TB. 
 
Results 
 
Table 2.1 shows selected demographic and disease characteristics of the 
2,636 cases included in the analysis. Of the 2,027 cases (77%) with a 
known DNA fingerprint, 919 (45%) were unique, of which 135 were the 
first case in a national cluster and 1,108 (55%) were clustered cases 
which were not the first case. Of the 609 cases (23%) with an unknown 
DNA fingerprint, 13 were culture confirmed but not RFLP typed and 596 
were culture negative. 
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Table 2.1. Selected demographic and disease-related factors of 2,636 TB 
cases in the Rotterdam region, 1995 to 2006. 
 
 No. or % of TB cases with indicated type 
of fingerprint 
Patient characteristics Unique  Clustering  Unknown 
 No. %  No. %  No. % 
 
Total no. 
 
919   
 
1,108   
 
609  
Male 485 52.8  738 66.6  322 52.9 
Age (yr)         
   0-14 15 1.6  32 2.9  109 17.9 
   15-29 258 28.1  386 34.8  145 23.8 
   30-44 276 30.0  400 36.1  157 25.8 
   45-64 164 17.8  229 20.7  121 19.9 
   ≥ 65 206 22.4  61 5.5  77 12.6 
Born in the Netherlands 219 23.8  338 30.5  273 44.8 
Previous history of TB 68 7.4  58 5.2  35 5.7 
HIV infection 51 5.5  50 4.5  13 2.1 
Illicit drug user or homeless 
person 
25 2.7  157 14.2  19 3.1 
Pulmonary TB 576 62.7  811 73.2  271 44.5 
Active case found by contact  
     investigation 
11 1.2  107 9.7  121 19.9 
Active case found by screening 
 
99 10.8  108 9.7  57 9.4 
 
 
Patients older than 64 years more often had an infection with a 
unique fingerprint rather than a clustering or unknown fingerprint, 
patients between 15 and 44 years old more frequently had an infection 
with a clustering fingerprint rather than a unique or unknown fingerprint, 
and patients less than 15 years old more often had an infection with an 
unknown fingerprint rather than a known fingerprint. Patients with 
clustered cases were more often male, illicit drug users, or homeless than 
patients with infections with a unique fingerprint. Patients with isolates 
with a known fingerprint had pulmonary TB or an HIV coinfection more 
frequently than patients with isolates with an unknown fingerprint, while 
patients with isolates with an unknown fingerprint were more frequently 
born in The Netherlands or were identified in a contact investigation. 
 
Classification of place of transmission. Epidemiological information 
suggested in 19 of 700 (3%) cases in immigrants with an isolate with a 
unique fingerprint that they were probably infected in The Netherlands 
(Table 2.2). Travel history suggested in 32 of 219 (15%) cases in 
nonimmigrants with an isolate with a unique fingerprint that they were 
probably infected in a foreign country. Sixty-two clustered cases were not 
38
Transmission Classification Model 
preceded by a pulmonary case in the cluster (52 were the second, 8 the 
third, 1 the sixth, and 1 the seventh case in a cluster) and followed the 
classification tree for unique fingerprints. Altogether, 114 (10%) clustered 
cases were classified as infected in a foreign country, while the remaining 
994 (90%) were probably or confirmed infected in The Netherlands. Of the 
cases with an unknown fingerprint, 318 (52%) were classified as probably 
or confirmed infected in The Netherlands and 221 (36%) as probably or 
confirmed infected in a foreign country, and for the remaining 70 (12%), 
no decision could be made on possible place of infection. 
 
Classification of time of transmission for patients infected in The 
Netherlands. All cases with a unique fingerprint with a probable or 
confirmed infection in The Netherlands were classified as remotely 
infected in The Netherlands, with the exception of two patients who had a 
documented contact with a visiting person diagnosed with pulmonary TB 
shortly after leaving The Netherlands (Table 2.2). Figure 2.1 shows the 
classification of time of infection for clustered cases infected in The 
Netherlands, indicated in Table 2.2 by boldface. Of these 994 cases, 369 
patients (2 + 256 + 111) (37%) were confirmed to be recently infected, 
414 (42%) were possibly recently infected, and 211 (10 + 160 + 41) 
(21%) were confirmed remotely infected. Of all cases with an unknown 
fingerprint, 154 (25%) were recently infected in The Netherlands. The 
majority of these cases (121 of 154) were identified by tracing contacts, 
while 33 cases had a documented contact with a recent pulmonary TB 
case in The Netherlands. 
 
Epidemiological links. An epidemiological link was confirmed in 260 (23%) 
clustered cases, with 197 patients being recently infected and 63 remotely 
infected. In 190 (17%) clustered cases an epidemiological link was likely, 
because these patients shared the same behavioural characteristics. The 
other cases did not fulfil our criteria for a confirmed or possible epidemio-
logical link, although patients often had a similar ethnic background and 
lived in the same geographical area. Epidemiological links were 
significantly more frequently confirmed in RFLP clusters with at least 5 
bands (254 of 1,031; 25%) than in low-copy-number RFLP clusters which 
required additional PGRS typing (6 of 77; 8%) (P value of <0.01). Cases 
with an unknown fingerprint (154 of 609; 25%) had a confirmed recent 
epidemiological link more often than cases with a clustering strain (197 of 
1,108; 18%) (P value of <0.01). 
Table 2.2 summarizes data showing that of all culture-confirmed and 
culture-negative TB cases, 38% were probably or confirmed infected in a 
foreign country, 36% were probably or confirmed recently infected in The 
Netherlands, and 18% were probably or confirmed remotely infected in 
The Netherlands. In 4% of all cases, a decision on the time of infection in 
The Netherlands could not be reached, while in 5% of all cases, both the 
place and time of infection remained indeterminate in the classification 
process. 
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982 clustered cases 
probably or confirmed 
infected in the 
Netherlands 
n = 256
(84 with a confirmed 
EPI link )
n = 566
n = 160 
(22 with a confirmed 
EPI link)
YES
YES NO
n = 414
n = 41n = 111
Recently infected
n = 781
Remotely infected
n = 201
NO
n = 152
YESNO
YES
NO
Was the first PTB in the 
cluster within 2 years? 
Was the preceding PTB in 
the cluster within 2 years?
Was there a confirmed EPI link 
with another clustered case?
EPI link within 2 years?
12 clustered cases without 
a preceding PTB
(2 had a recent infecton 
with a confirmed link; 10 
had a remote infection)
(see table 2)
 
 
Figure 2.1. Classification of time of infection for clustered cases from the 
Rotterdam area that were probably or confirmed infected in The 
Netherlands, 1995 to 2006 (n=994). PTB, pulmonary tuberculosis; EPI 
link, epidemiological link. 
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Cluster size. The 1,243 clustering bacteria strains, including 135 cases 
which were the first case in a national cluster, were part of 452 national 
clusters. The cases in the study contributed with 1 case to 263 national 
clusters, with 2 cases to 98 clusters, with 3 to 10 cases to 74 clusters, and 
with more than 10 cases to 17 clusters. The largest cluster in The 
Netherlands, with 160 cases nationwide, contained 132 cases from the 
study area. The proportion of clustered cases recently infected in The 
Netherlands increased with the sequential number in a cluster (Table 2.3). 
Thirty-eight percent of cases that had the second rank in a cluster were 
recently infected in The Netherlands, while this proportion increased to 
more than 75% when the person was more than the 10th case in a 
cluster. 
 
 
Table 2.3. Contribution of to cluster size in The Netherlands of clustered 
cases from the Rotterdam region that were not the first in the cluster and 
their classification of transmission, 1995 to 2006. 
 
 
No. (%) of patient that were: 
 
Patient’s 
sequential 
no. in 
national 
clusters 
 
Total  
no. of  
regional  
cases 
Infected in a 
foreign 
country 
Recently 
infected in  
The 
Netherlands 
Remotely 
infected in  
The 
Netherlands 
2 184 55 (29.9) 70  (38.0) 59 (32.1) 
3 98 18 (18.4) 49 (50.0) 31 (31.6) 
4-5 121 10  (8.3) 76 (62.8) 35 (28.9) 
6-10 195 18  (9.2) 144 (73.8) 33 (16.9) 
11-20 168 8   (4.8) 130 (77.4) 30 (17.9) 
21-50 197 4   (2.0) 178 (90.4) 15 (7.6) 
≥ 51 145 1  (0.7) 135 (93.8) 8 (5.5) 
Total 
 
1,108 114  (10.3) 783 (70.7) 211 (19.0) 
 
 
Discussion 
 
We used classification trees and combined molecular and conventional 
epidemiological data to ascertain the place and time of infection of all TB 
cases in our study population. Although most studies divide transmission 
into recent and remote infections, we added a separate category of 
infections acquired in a foreign country and limited the recent and remote 
categories to those infections acquired in The Netherlands. Of all TB cases 
during the 12-year study period, 38% were infected in a foreign country, 
36% resulted from recent transmission in The Netherlands, and 18% 
resulted from remote infections in The Netherlands, while in the remaining 
cases (9%), either the time or place of infection could not be determined. 
The conventional epidemiological data suggested that at least 29% of 
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clustered cases were not recently infected in The Netherlands. Cases with 
unknown fingerprints, almost all culture negative, relatively frequently had 
confirmed epidemiological links with a pulmonary TB case and were more 
often identified by contact tracing and, therefore, presumably were 
recently infected in The Netherlands. 
Molecular studies often use the n – 1 method, in which the first case 
in a cluster is considered unique (12, 20). The proportion of clustering, 
however, strongly depends on the time period of the study, the 
geographical area, and the proportion of cases included in a fingerprinting 
programme (12, 14). In The Netherlands, genotyping has been performed 
for nearly all M. tuberculosis isolates for 14 years and clustering is 
confined to the national borders. If we had restricted the n – 1 method to 
the Rotterdam study region, 452 instead of 135 cases that were the first 
in a cluster would be considered unique and the clustering proportion 
would decrease from 55 to 39%, which underscores the influence of the 
geographical area on clustering. 
In most studies, recently transmitted TB is defined as disease 
occurring within 2 years of infection (4, 21-23), although some studies 
have limited the latency period to 1 year (6, 24, 25) or extended it to 5 
years after infection (26). There is a need to decide on the latency period 
of recent disease development so that outcomes, such as programme 
performances, can be compared. We propose to use the 2-year latency 
period, as applied in our study. 
Cases with unique strains are rarely the result of recent 
transmission in a country if universal genotyping has been applied for 
more than 2 years. There are some rare exceptions that we also 
encountered, such as transmission by a visiting person who is diagnosed 
with TB after leaving the country. Recently transmitted bacteria may also 
be reported as unique strains if the M. tuberculosis genotype has changed 
over time (8). The half-life of RFLP genotypes is unclear but has been 
estimated to vary between 3 and 10 years in certain situations (27, 28). 
In our study, five initially unique fingerprints of epidemiologically linked 
cases were reinvestigated by the National Mycobacteria Reference 
Laboratory and showed a 1-band difference with the expected clusters, 
and these strains were therefore placed in the respective RFLP clusters. 
We recommend that fingerprinting programmes should assess 
epidemiological links if RFLP patterns differ by 1 band, to identify these 
molecular changes. 
In our study, 71% (783 of 1,108) of clustered cases were confirmed 
or possibly recently infected in The Netherlands, 211 (19%) were 
remotely infected in The Netherlands, and 114 (10%) were infected in a 
foreign country. The proportion of clustered cases due to recent 
transmission in our study is an overestimation because all cases without 
known epidemiological links and with a preceding pulmonary case in the 
cluster within 2 years were classified as recently infected in The 
Netherlands. In particular in circumstances of high transmission with large 
clusters, it is more difficult to ascertain the source case and time of 
infection (29). 
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The results of our study also showed that patients with low rank 
numbers in their clusters were frequently infected in a foreign country or 
remotely infected in The Netherlands. There are basically three 
explanations for clustered cases not representing recent transmission (9, 
11, 30). Immigrant patients may have been infected in their countries of 
origin with a genetically homogenous strain also present in the national 
fingerprinting database. Nonimmigrant patients may have been infected 
several years or decades before with a strain circulating at that time in the 
country under study. And last, RFLP typing may be unable to differentiate 
two nonidentical strains. We recommend that additional genotyping, such 
as direct repeat sequence or mycobacterial interspersed repetitive units 
and variable-number tandem repeat analysis, is considered if epidemio-
logical links are not confirmed in small-sized clusters, as was done in 
other studies (31, 32). Cases in PGRS clusters with low-copy-number RFLP 
strains had a relatively low percentage of confirmed epidemiological links 
in our study, confirming the lack of discriminatory power of additional 
PGRS typing (33, 34). 
In most developed countries, the diagnosis of TB is confirmed by 
culture in 80% of all cases at the most (35, 36). Thus, transmission 
studies that rely exclusively on genotyping overlook the contribution of 
culture-negative cases to recent transmission. In our study, cases without 
a fingerprint had a confirmed recent epidemiological link significantly more 
often than cases with a clustering strain, indicating the importance of 
culture-negative TB as a result of recent transmission. 
In our classification model, we used a number of questions leading 
to decisions of place and time of infection with a certain probability. 
Positive answers to questions about recent residence in The Netherlands 
in cases with a unique fingerprint and documented contact with a 
pulmonary TB case clearly provide stronger evidence for the outcome 
than, e.g., questions about frequent travel to countries where TB is 
endemic. We applied the questions stepwise, and in this way, we believe 
that we have made optimal use of relevant and available information. In 
the future, with improved interviewing skills of TB public health nurses 
and the use of a more-systematic approach to investigate and confirm 
links between cases, classification can become more accurate. 
Furthermore, the model should be evaluated in other transmission 
settings to assess its application in these circumstances. 
Our findings underline the consensus that clustering should not be 
considered identical with recent transmission and that genotyping should 
be combined with conventional epidemiological investigation. A standard-
dized way of classifying TB into recently, remotely, and foreign-acquired 
disease provides indicators for surveillance and programme performance 
that can be used to decide on interventions and allocate resources. 
Programmes with predominately recent transmission may focus on a 
package of targeted activities for active case finding, while those with a 
high proportion of imported strains should consider screening for TB and 
latent TB infection in immigrants and those with mainly reactivated cases 
can shift attention to the elimination of TB. 
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Supplement 2.1. Classification of recurrent TB cases that also had a first 
episode during study period. 
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Supplement 2.2. Classification tree for cases with a unique fingerprint 
(immigrant cases). 
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0 852 10
Transmission Classification Model
Culture: Mycobacterium tuberculosis
RFLP: unique or first case in a cluster
Country of birth: The Netherlands
FREQUENT TRAVEL HISTORY TO 
TB ENDEMIC COUNTRIES
YES
KNOWN CONTACT OF PTB 
PATIENT IN THE NETHERLANDS 
BEFORE 1/1/1993 ? 
NO
YES NO
Probability scale of place of infection. 0 = confirmed infected in a foreign country; 2 = probably infected in 
a foreign country; 5 = indeterminate; 8 = probably infected in the Netherlands and 10 = confirmed 
infected in the Netherlands
 
 
Supplement 2.3. Classification tree for cases with a unique fingerprint 
(nonimmigrant cases). 
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Supplement 2.4. Classification tree for cases with a clustering fingerprint. 
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Transmission Classification Model
TB with an unknown DNA fingerprint
KNOWN CONTACT OF 
PTB PATIENT ABROAD?
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BORN IN THE NETHERLANDS
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PTB PATIENT IN THE 
NETHERLANDS
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CHEST X-RAY ABNORMALITIES 
AT ENTRANCE SCREENING OR 
POSITIVE TST?
NO
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FREQUENT TRAVEL HISTORY TO 
TB ENDEMIC COUNTRIES
YES
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YEARS RESIDENCE IN THE 
NETHERLANDS LESS THAN YEARS 
IN A FOREIGN COUNTRY?
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Probability scale of place of infection. 0 = confirmed infected in a foreign country; 2 = probably infected in 
a foreign country; 5 = indeterminate; 8 = probably infected in the Netherlands and 10 = confirmed 
infected in the Netherlands
 
 
Supplement 2.5. Classification tree for cases with an unknown 
fingerprint. 
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Abstract 
 
DNA fingerprinting of Mycobacterium tuberculosis isolates offers better 
opportunities to study links between tuberculosis (TB) cases and can 
highlight relevant issues in urban TB control in low-endemic countries.  
An outbreak with 28 cases with identical DNA fingerprints and 4 
epidemiologically linked culture-negative cases was used for the 
development of a visual presentation of epidemiologic links between 
cases. 
Of 32 cases, 17 (53%) were linked to the index case, and 11 (34%) 
to a secondary case. The remaining four (13%) could not be linked and 
were classified as possibly caused by the index patient. Of the 21 cases 
related to the index case, TB developed within one year of the index 
diagnosis in 11 patients (52%), within one to two years in four patients 
(19%), and within two to five years in six patients (29%).  
Cluster analysis underscored several issues for TB control in an 
urban setting, such as the recognition of the outbreak, the importance of 
reinfections, the impact of delayed diagnosis, the contribution of pub-
related transmissions and its value for decision-making to extend contact 
investigations. Visualising cases in a cluster diagram was particularly 
useful in finding transmission locations and the similarities and links 
between patients. 
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Introduction 
In descriptive epidemiology, the distribution and transmission of infectious 
diseases is usually described in terms of place, person, and time. This 
approach is appropriate for diseases with a short incubation period but far 
less so for chronic diseases such as tuberculosis (TB), which progresses 
from latent infection to active disease over a period ranging from months 
to many years. In TB epidemiology, graphic presentation is often limited 
to trend description over years in a defined region, with sociodemographic 
characteristics of the patients (1, 2). However, in outbreak management, 
one would like to know which secondary cases are caused by an index 
patient. Presentation in a time line may help to detect epidemics, plan 
interventions, and evaluate these efforts. 
DNA fingerprinting of Mycobacterium tuberculosis isolates has 
improved the understanding of TB transmission and helped to identify 
outbreaks, high-risk groups, and laboratory cross-contaminations (3, 4). 
To allow adequate interpretation and comparison, these molecular studies 
should involve a high proportion of cases in a population, be combined 
with conventional epidemiological investigations, and specify patient 
characteristics and study length (4, 5). In the Netherlands, the proportion 
of culture-confirmed cases is high (1); nearly all M. tuberculosis isolates 
have been genotyped for more than 14 years, and results are available at 
Municipal Public Health Services (MPHS) (6, 7). 
We describe a cluster of cases in the Rotterdam area, introducing a 
novel cluster diagram that shows epidemiologic links between cases. The 
cluster analysis is used to discuss relevant issues in urban TB control in 
low-endemic countries. 
 
 
Methods 
Since 1993, all M. tuberculosis isolates in the Netherlands are subject to 
standardised insertion sequence (IS)6110-based restriction fragment 
length polymorphism (RFLP) genotyping, referred to as DNA fingerprinting 
(8). Clusters are defined as groups of patients having isolates with fully 
identical RFLP patterns or, if strains have fewer than five IS6110 copies, 
with identical sub-typing determined by the Polymorphic GC-Rich 
Sequence probe (9). TB control nurses of MPHSs explore possible links 
between clustered cases during visits to patients. 
The MPHS Rotterdam-Rijnmond covers the municipality Rotterdam 
(about 600,000 inhabitants) and 27 other municipalities, serving a total 
population of 1.3 million. Between 1993 and 2006, 2,562 TB cases were 
reported, resulting in an average annual incidence rate of 23.3 per 
100,000 for Rotterdam municipality and 6.6 per 100,000 for other 
municipalities. Of the 2,562 cases, M. tuberculosis was cultured in 1,969 
(76.9%), of which 1,939 (98.5%) were RFLP-typed. Of these, 881 
(45.4%) were unique or initially unique first cases in a cluster, and 1,058 
(54.6%) were non-first cases in a cluster. Of the RFLP-clustered cases, 
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497 (47.0%) were the 1-5th case in a national cluster, 325 (30.7%) the 6-
50th case, while 236 cases (22.3%) were 51st or subsequent case in three 
large national, predominantly Rotterdam, clusters. 
A medium-sized molecular cluster of 28 cases with considerable 
transmission in and around Rotterdam was used to develop a cluster 
diagram with Microsoft Visio® software including a time-period bar, zones 
suggesting locations of transmission, and symbols representing the ethnic 
background, disease site, and infectious status of patients, and arrows 
representing documented epidemiological links between cases. The 
causative M. tuberculosis strain was susceptible to all first-line TB drugs. 
Four culture-negative epidemiological linked cases were included in the 
cluster diagram.  
Contact investigation was executed according to Dutch guidelines, 
i.e. close contacts of smear-positive TB patients are examined in two 
rounds with a tuberculin skin test (TST) performed immediately after 
diagnosis of the index patient and two months after their last contact. 
Cases identified with a latent TB infection are generally treated with six 
months isoniazid. Contacts ineligible for TST (born before 1 January 1945, 
vaccinated with bacille Calmette-Guérin (BCG), or having positive TST or 
TB in the past) are examined twice with a chest radiograph: immediately 
after diagnosis of the index and three months after the last contact with 
the index. An investigation is extended from close to casual contacts on 
finding high rates of recent TB infections or TB cases. All those investi-
gated are linked to the index patient in the client information system of 
the Dept of Tuberculosis Control. Using this data, we analyzed the results 
of TSTs and radiographs of contacts linked to patients in our cluster. 
The Medical Ethics Committee of Erasmus MC, University Medical 
Center Rotterdam, Rotterdam approved the study protocol. 
 
Results 
 
Description of the outbreak. The first strain identified in our cluster (Figure 
3.1) was from a Surinamese person with pleural TB (case 1). One month 
later, pulmonary TB was diagnosed in a Bosnian woman (case 2), who 
four months earlier had reported to the Dept of Tuberculosis Control that 
a Bosnian man was her houseguest for several weeks and had subse-
quently entered a German hospital with smear-positive pulmonary TB 
(case X). Due to prior BCG vaccination, the woman had a chest X-ray at 
presentation and three months after her last contact with patient X. Her 
second radiograph showed discrete upper lobe infiltrative lesions. One 
month later, her sputum culture became positive for M. tuberculosis; at 
her next consultation, radiographic changes were more pronounced and 
sputum smears were positive. 
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Within a few months after clustering of cases 1 and 2, another eight 
cases were diagnosed with TB caused by a mycobacterial strain having an 
identical fingerprint. Almost all these patients frequented a certain pub in 
Rotterdam, and the TB control nurses found that patient X had been ill for 
several months and also visited this pub. Case 8 was a five-year-old child 
who had a positive TST and hilar lymphadenopathy on the chest X-ray. TB 
was diagnosed by positive culture for M. tuberculosis of the gastric lavage 
fluids. His brother (case A) likewise had a positive TST and hilar 
lymphadenopathy, and started TB treatment without further diagnostic 
investigation. Both children often accompanied their grandfather to the 
above-mentioned pub, which was owned by relatives. 
Several months after case 10, smear-positive pulmonary TB was 
diagnosed in an 18-year old student of a vocational training school (case 
11). He had been coughing for five months and visited his general 
practitioner several times. Contact tracing revealed latent TB infections 
(LTBI) in all his seven family members, in classmates, and persons at his 
vocational training site, including five persons with TST conversions. After 
two months, a second student from the school was diagnosed with smear-
positive pulmonary TB (case 13). He did not share ethnic background or 
classes with case 11. His family, friends, and classmates were examined, 
but extension of the contact investigation was actually decided on the 
basis of DNA fingerprint results. When they confirmed clustering, the 
entire school was examined and yielded one case of pleural TB (case 15) – 
confirmed by culture of a pleural biopsy – and 40 LTBI cases. Disease 
developed in a brother of case 11 (case 16) despite treatment with 
isoniazid; he later admitted taking only three weeks of medication despite 
attending all medical check-ups. The disease developed in another relative 
of case 11 (case 21), who had been treated for TB twenty years earlier.  
Five other patients (cases 14, 22-24, and D) had a link with the pub 
and were most likely infected by patient X. Patient D, one of the pub 
owners, had a chest X-ray in a general hospital four months before her TB 
diagnosis; it showed bilateral opacities and she was treated for 
pneumonia. Despite repeated visits to her general practitioner, smear-
positive pulmonary TB was diagnosed only when she travelled to her 
native country. In the interim, she had stayed with her disabled child 
several months in a hospital, and had infected a nurse (case 27) who 
seven years earlier had completed LTBI treatment after converting the 
TST. 
 
Patient characteristics. The 32 patients in this outbreak (excluding case X) 
were aged 5 to 67 years (average 33 years); 81% were male; 25 (78%) 
had pulmonary TB, of which 14 were smear-positive. None were found 
coinfected with HIV. All 32 patients completed TB treatment. Of the 32 
patients, 21 lived in Rotterdam, seven in two nearby towns, and one (case 
22) resided in a village 50 km from Rotterdam. After genotyping, this last 
patient was reinterviewed and revealed regular visits to the Rotterdam 
pub up to one year before diagnosis. The remaining three (cases 4, 18 
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and 27) lived outside the Rotterdam area but had links to the city or to 
other patients in the cluster. 
 
 
Table 3.1. Parameters (time, person and place) by which cases in the 
outbreak were linked.  
 
Tuberculosis case  
in cluster 
Linked to  
source patient 
Time Person Place 
2, 3 Case X Yes Yes Yes 
1, 4, 11 Case X Yes No No 
5, 6, 7, 8, 9, 10, A Case X Yes No Yes 
14, 22, 23 Case X No No Yes 
24, D Case X No Yes Yes 
12, 13, 15 Case 11 Yes No Yes 
16, 21 Case 11 Yes Yes Yes 
B, 17 Case 14 Yes Yes Yes 
C Case 18 Yes Yes Yes 
26, 27 Case D Yes No Yes 
28 Case 23 No Yes Yes 
18, 19, 20, 25 No link established No No No 
 
Cases with a number are culture-confirmed; cases with a letter are culture-negative 
cases epidemiologically linked to the cluster. 
 
 
Second and third generation cases in the outbreak. Of 32 cases, 17 (53%) 
were epidemiologically linked to case X (i.e. secondary cases) based on 
time intervals, personal contacts, or meeting places (Table 3.1), and 11 
cases (34%) were certainly or possibly linked to a secondary case (i.e. 
tertiary cases). The remaining four clustered patients (13%) could not be 
linked and were classified as possibly infected by case X (i.e. secondary 
cases).  
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Figure 3.2 shows the interval between the month of case X diagnosis 
and the month specimens were collected from the 21 persons who were 
certainly or possibly infected by him. Of these, TB developed within a year 
of the index diagnosis in 11 (52%), within one to two years in four (19%), 
and within two to five years in six patients (29%).  
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Figure 3.2. Curve of the time between tuberculosis infection and 
development of disease in 21 secondary cases. * The date of development 
of disease was assumed as the date of specimen collection and latest time 
of infection was defined as the diagnosis date of the index patient. 
 
 
Contact investigation. Contact tracing was mainly limited to close contacts 
of pulmonary TB cases (Table 3.2). Three investigations were extended to 
many casual contacts after DNA fingerprinting confirmed that transmission 
had occurred, respectively, in the above-mentioned pub, vocational school 
and hospital. Only a few pub visitors outside the known contacts could be 
tested due to non-cooperation of the primary pub owner. 
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Table 3.2. Contact tracing results of smear-positive pulmonary and other 
tuberculosis patients of the cluster. 
  
  
Number 
of 
contacts 
examined 
 
Number of 
contacts 
examined 
with TST 
 
Number of 
tuberculosis 
infections 
Proportion of 
tuberculosis 
infections 
among those 
tested 
 
Tuberculosis 
cases 
Mr. X 3 1 1 100 Case 2 
Case 2 23 14 1 7 Case 3 
Case 4 0 0 0 0  
Case 9 24 5 0 0  
Case 10 50 41 1 2  
Case 11 194 154 24 16 (Case 16) 
Case 13 45 33 0 0  
School 1,730 964 40 4 Case 15 
Case 14 1 0 0 0 Case B 
Case 18 11 4 0 0 Case C 
Case 22 31 15 1 7  
Case 23 4 4 1 25  
Case D 3 3 3 100  
Case 25 10 2 0 0  
Hospital 100 92 1 0  
Case 28 32 8 3 38  
Other 67 32 3 9 Case A 
Total 2,328 1,372 79 5.8 6 
 
Cases with a number are culture-confirmed; cases with a letter are culture-negative 
cases epidemiologically linked to the cluster. 
Discussion 
 
In retrospect, the index patient of the cluster was highly infectious, 
causing 11 secondary TB cases within one year after exposure. Contact 
investigation after detailed interviewing of an infectious patient normally 
identifies contacts for screening and preventive treatment. In this case, 
however, the index patient was initially unknown and the natural history 
of the disease was unimpeded. Five years after the index diagnosis, 28 
culture-confirmed cases with identical fingerprints had been identified, 
forming a new molecular cluster. The cluster diagram highlighted several 
issues relevant to urban TB control in low-incidence countries. 
 
Natural history of tuberculosis. The classification of patients in the cluster 
allowed us to draw a curve of secondary cases. Of these cases, TB 
developed within one year of infection in 11 (52%), within two years in 15 
(71%), and between two to five years in six patients (29%). The curve 
recalls results of previous tuberculin conversion studies, which estimated 
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that TB develops within five years in 14% of adults infected, with 60% of 
cases presenting within one year, 85% within two years, and 15% within 
two to five years (10). Some of our late-secondary cases may have been 
misclassified as caused by the index patient, raising the proportion of 
secondary cases that occurred within two years. 
The number of secondary cases reported in the first year allows one 
to estimate the total number of persons infected by the index patient and 
to predict the number to be expected in the next few years. As illustrated 
by our cluster, secondary cases can generate tertiary cases, and together 
with late-secondary cases they can protract an TB outbreak over many 
years (3, 11-14). 
Our study included four culture-negative TB cases and 75 LTBI 
cases, indicating that conventional epidemiological investigation and 
molecular typing should be combined (5). Studies using only genotyping 
data exclude such cases and may thus underestimate the true extent of 
an outbreak and the value of active case finding. 
 
Reinfection. Cluster analysis and conventional epidemiological 
investigation revealed two reinfections (cases 21 and 27). Molecular 
studies have demonstrated that the extent of exogenous reinfection in 
recurrent TB depends largely on the epidemiological context (4, 15). In 
populations at low risk, most recurrence results from reactivation, 
although the proportion due to reinfection in some low-endemic countries 
may exceed expectations, ranging between 16% and 44% (16-18). Our 
two reinfection cases illustrate that a contact investigation must also look 
carefully at previously infected persons. 
 
Geographical clustering and urban spread. The outbreak was mainly 
limited to the Rotterdam area; patients outside the area were 
epidemiologically linked with a clustered case. Our experience with DNA 
cluster analysis is that most clustered patients in the Netherlands are 
residents of the same geographical region. 
Genotyping can be used to monitor the magnitude of the problem of 
TB transmission. Several studies have demonstrated that the proportion of 
clustered cases in urban areas comprise 20 to more than 50 percent of all 
local TB cases, indicating recent transmission (3, 4, 19-23). A recent 
outbreak of an isoniazid-resistant M. tuberculosis strain with more than 
132 cases in London and a molecular cluster of 150 in the Netherlands (of 
which 85% are in Rotterdam), underscore the need in large cities for 
interventions tailored to specific risk groups (12, 13, 24). 
 
Tuberculosis among foreign-born persons. Typically, foreign-born 
residents account for more than 50% of TB cases reported in low-endemic 
countries (2). Although most are probably infected in their native 
countries (25), recent transmission in the country of residence can 
contribute significantly to high incidence in the foreign-born. In our 
cluster, the index patient directly and indirectly caused disease in 32 
persons, of whom 10 (31%) shared his ethnic background and 22 (69%) 
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did not. In general, transmission between foreign nationalities and to the 
indigenous nationality varies widely in low-endemic countries, probably 
reflecting different social mixing patterns (25-28). 
 
Transmission in high-risk settings. Our cluster diagram shows that half of 
the cases were infected in the same pub. Bars are known for high 
transmission rates due to crowding and poor ventilation (11, 29, 30). 
Smoking may also increase the risk of M. tuberculosis infection (31). 
Contact investigation is often hampered by pub owners’ reluctance to 
assist in informing the clientele, difficulties in finding contacts, and 
unwillingness of infected persons to start a potentially hepatotoxic 
preventive treatment that precludes the use of alcohol (11). 
Our cluster analysis also confirmed TB transmission at a school and 
in a hospital. The increased risk for health care workers is well-
documented and is usually related to delayed diagnosis of TB patients (32, 
33). In our study, a patient’s relative was the source case of TB 
transmission to a health care worker, so the nosocomial setting was 
incidental. 
 
Promoting early case detection and maintaining clinical expertise. Delays 
in seeking medical attention or receiving diagnosis facilitate TB 
transmission (4). Our index patient severely delayed seeking care despite 
the urging of his friends. On the other hand, two secondary patients 
repeatedly visited their general practitioners before being diagnosed with 
TB, and one of these was diagnosed abroad. Delays in these three cases 
led to several LTBIs and TB cases. In many low-incidence countries, TB 
expertise is declining in general practitioners, clinical specialists, and 
public health professionals, but resulting delays in diagnosis can be 
reduced by continuing education (34). Delays in seeking care can be 
reduced by public health education and low-threshold access to TB 
diagnostic and therapeutic services. 
 
Outbreak management and contact investigation. In our outbreak, 6 TB 
cases and 75 persons with LTBI were traced. Most LTBI cases were 
diagnosed in the school investigation, and treatment controlled the 
situation because no more cases were identified in three years of follow-
up. The importance of preventive therapy was highlighted by a 
noncompliant patient with LTBI who subsequently developed TB. 
 Failure to identify and examine eligible contacts, as occurred in the 
pub investigation, is a major reason for disease development (14). Our 
diagram shows that even detailed interviewing failed to disclose all links 
between patients and potential locations of transmission, a problem also 
encountered by others (3, 4, 7, 11, 14, 35). However, our study clearly 
demonstrates that clustering of cases in time and place, with similar 
sociodemographic patterns, resulted from recent transmission in the 
Netherlands. 
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Conclusions 
In an urban area in a low-endemic country with ongoing TB transmission, 
cluster analysis was a useful complement to conventional epidemiological 
investigation. It revealed that foreign-born patients were infected in this 
low-endemic country and not their native countries, as might have been 
assumed. Visualising cases in a cluster diagram was particularly useful in 
finding transmission locations and the similarities and links between 
patients. It also helped to monitor the cluster and outbreak over time and 
to estimate the number and timing of future cases. 
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Abstract 
 
Rationale: The overall decline of tuberculosis (TB) incidence in most 
developed countries has made differences between urban and rural 
communities more prominent. 
Objectives: To clarify the causes of the high TB case rate in a metropolitan 
area. 
Methods: Comparing characteristics of patients and mycobacteria in urban 
and suburban municipalities of the Rotterdam region in the Netherlands 
between 1995 and 2006. 
Main Results: The TB case rate in the urban municipalities was 3.8 times 
higher than in suburban municipalities. After stratification for country of 
birth, case rates were 1.7 times higher for immigrants and 2.8 times 
higher for nonimmigrants in the urban municipalities. At least 47% of 
urban immigrant TB cases had foreign-acquired disease against 62% of 
immigrant cases in the suburban municipalities. Recent transmission 
caused 40% of the case rate in the urban and 28% in suburban 
municipalities, translating into a 5.5 times higher recent transmission case 
rate in urban municipalities. Illicit drug users and homeless persons 
accounted for 10.3% of all urban cases. 
Conclusions: The high urban TB case rate was related to the high 
proportion of urban immigrants who frequently reactivate a foreign-
acquired infection. Besides that, recent transmission caused a substantial 
part of the TB caseload in urban municipalities, both among urban 
immigrants and nonimmigrants. Illicit drug users and homeless persons in 
urban municipalities were particularly at risk for TB due to recent 
infection. Metropolitan TB control should address these different causes of 
the high urban TB case rates by a package of targeted and tailored 
interventions. 
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Introduction 
 
Over the past century tuberculosis (TB) incidence in developed countries 
gradually declined, especially after effective chemotherapeutic treatment 
regimens were introduced since the 1950s. An upsurge of TB occurred in 
the 1980s in many low-incidence countries due to increased immigration, 
concurrent human immunodeficiency virus (HIV) infections and 
inadequate TB control practices (1), but the general downward trend has 
resumed in many of these countries (2). In the Netherlands, the TB 
incidence of 2006 was the lowest ever recorded with 6.2 cases per 
100,000 persons (3). 
The overall decline has made differences of TB incidences in urban 
and rural areas more prominent (4, 5). In France, 43% of all cases lived 
in the Paris region, which contained 19% of the French population (5). In 
England and Wales, 41% of cases lived in London, although only 14% of 
the population resided in this city. The incidence in London increased to 
44.8 per 100,000 in 2006 (personal communication Jonathan Croft). In 
2006, the average TB incidence in the four largest cities in the 
Netherlands (Amsterdam, Rotterdam, The Hague and Utrecht) was 21.7 
per 100,000 population (3). They notified 34% of all TB cases in the 
Netherlands, although only 13% of the Dutch population lived in these 
four cities. TB case rates in urbanized and rural areas probably reflect 
different dynamics. It is thought that in rural areas TB more often results 
from reactivation of remote infections, while in urban areas imported 
disease and ongoing transmission, more specifically among certain urban 
risk groups such as illicit drug users and homeless persons, account for 
higher cases rates (6). 
DNA fingerprinting of Mycobacterium tuberculosis isolates provides a 
tool to disentangle the different transmission pathways (7, 8). Although 
the percentage of clustered cases in an area indicates the amount of 
recent transmission in a community, clustering is not identical with recent 
transmission (9-11). Combined use of conventional epidemiological and 
genotyping data, using standardized algorithms, ascertains more 
accurately recently and remotely infected cases (12-15).  
 The objective of this study is to clarify the causes of the high TB 
case rate in a very highly urbanized area by comparing the characteristics 
of patients and mycobacteria in these areas with those in less-urbanized 
municipalities. Based on the findings, we propose a package of targeted 
and tailored active case finding and case holding activities for metropolitan 
TB control. 
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Methods 
Study area. The study was conducted in the city of Rotterdam (about 
600,000 inhabitants) and 54 neighboring municipalities (about 1,300,000 
inhabitants) located in the southern part of the province of South-Holland, 
the Netherlands. Population characteristics by municipality, age group and 
country of birth were obtained from the Office for National Statistic, 
Statistics Netherlands (http://www.cbs.nl). Statistics Netherlands divides 
every municipality in the Netherlands into one of the following five Area 
Address Density (AAD) categories: (i) very highly urbanized (>2500 
addresses/km2); (ii) highly urbanized (1500–2500 addresses/km2); (iii) 
moderately urbanized (1000–1500 addresses/km2); (iv) low urbanized 
(500–1000 addresses/km2); and (v) rural (<500 addresses/km2). We 
compared AAD1 with AAD2-5 municipalities, because of the expected high 
TB case rate in the very highly urbanized areas and our specific interest in 
its causes. In this study, we refer to AAD1 as urban and AAD2-5 as 
suburban; foreign-born persons are defined as immigrants and people 
born in the Netherlands as nonimmigrants. The Medical Ethics Committee 
of Erasmus MC, University Medical Center Rotterdam, Rotterdam approved 
the study protocol. 
 
Study cases. The Netherlands TB register provided data of notified cases 
in the Rotterdam region after approval by its data protection committee. 
These data were completed and validated with local registers, patient 
records and the DNA fingerprinting register of the National Mycobacteria 
Reference Laboratory. Notified TB cases diagnosed between January 1, 
1995 and December 31, 2006, were included in the study, excluding 41 
sailors with a residential address outside the Netherlands, 12 inmates of a 
deportation center for illegal immigrants transferred from other regions of 
the country, 65 cases staying in asylum seekers centers, 14 recurrent 
cases with a relapse during the study period, 34 cases infected with 
Mycobacterium bovis, two cases infected with Mycobacterium canetti and 
one case infected with Mycobacterium bovis bacille Calmette-Guérin 
(BCG). Cases that resulted from laboratory cross-contamination were 
already withdrawn from the Netherlands TB register. 
 
Mycobacteria and DNA fingerprints. Since 1993, all M. tuberculosis isolates 
in the Netherlands are subject to standardized insertion sequence 
(IS)6110-based restriction fragment length polymorphism (RFLP) typing, 
also called DNA fingerprinting (16). Clusters are defined as groups of 
patients having isolates with fully identical RFLP patterns and, if strains 
harbor less than 5 IS6110 copies, with identical sub-typing by use of the 
Polymorphic GC-Rich Sequence probe (17). 
 
Classification of transmission. We used a transmission classification model, 
combining conventional epidemiological information with DNA 
fingerprinting data, to classify cases into recently (≤2 years) or remotely 
(≥2 years) infected in the Netherlands or infected in a foreign country, as 
previously described (15). Briefly, clustered cases with a documented 
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contact with a pulmonary TB case within two years before diagnosis were 
classified as recently infected, and if the link was more than two years as 
remotely infected. Clustered cases without an epidemiological link were 
classified according to the last preceding pulmonary case in the cluster, 
i.e. recently if less than two years and remotely if more than two years. 
Cases with a unique fingerprint were classified as remotely infected in the 
Netherlands or infected in a foreign country depending on the time of 
residence in the Netherlands and travel history to countries where TB is 
endemic. Cases with unknown fingerprints, almost all culture-negative, 
were classified according to a documented contact with a pulmonary TB 
case, time of residence in the Netherlands, travel history to countries 
where TB is endemic, and for immigrant cases relevant findings at 
entrance screening. 
 
Statistical Methods. We used univariate logistic regression to assess the 
importance of demographic and disease-related variables for TB cases. 
The dependent variable was residence in urban or suburban munici-
palities. All independent variables with a significance level of ≤0.05 were 
included in a multivariate logistic regression model. Data were analyzed 
by SPSS version 15 (SPSS, Inc., Chicago, IL). 
 
Results 
 
Demographic and disease characteristics of patients. Table 4.1 compares 
demographic and disease-related characteristics of all 1,817 TB cases in 
the three urban municipalities (Rotterdam, Schiedam and Vlaardingen) 
and all 755 cases in 52 suburban municipalities. After adjustment, cases 
in the urban municipalities were more often male, foreign-born, illicit drug 
user or homeless. Cases in suburban municipalities were more often older 
than 64 years. The M. tuberculosis strains of cases in urban municipalities 
clustered more frequently than strains from cases in suburban munici-
palities. Table 4.2 provides absolute number and proportion of cases by 
classification of transmission in both areas. Recent transmission caused 
40% of the urban and 27% of the suburban TB caseload (p<0.001). 
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Chapter 4
Case rate by municipality. For the 12-year study period, average TB case 
rates for each municipality are shown in Figure 4.1. Case rates were 3.8 
times higher in urban municipalities (20.4 per 100,000 population) than in 
suburban municipalities combined (5.4 per 100,000 population). Case 
rates decreased with declining urbanization grade (AAD1: 20.4, AAD2: 
6.7, AAD3: 5.0, AAD4: 4.0 and AAD5: 3.1 per 100,000 population; χ2 test 
for trend, p<0.001). Case rates also differed considerably between postal 
code areas within the Rotterdam municipality, with rates above 40 per 
100,000 population in two inner boroughs of the city, both with an 
address density of more than 5,000 per km2. 
 
 
Figure 4.1. Average tuberculosis case rate (per 100,000 population) A) for 
Rotterdam and 54 surrounding municipalities (above) and B) for Rotterdam 
divided by postal code areas (below), 1995-2006. 
1 (Rotterdam), 2 (Schiedam) and 3 (Vlaardingen) are very highly urbanized municipalities 
with an area address density of more than >2500 addresses/km2). 
 
A) 
B) 
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Case rates by age group, country of birth and RFLP typing. All age-specific 
case rates (per 100,000 population) for immigrants and nonimmigrants 
were higher in urban municipalities than in suburban municipalities (Table 
4.3). Immigrants in urban municipalities had a 1.7 times higher case rate 
than immigrants in suburban municipalities (65.2 versus 39.5; p<0.001). 
The highest case rates were found in immigrants between 15 and 29 
years, both in urban and suburban municipalities (78.2 and 67.2, 
respectively) with no significant difference between these rates (p = 0.1). 
Case rates in immigrant age groups between 30 and 44 years and 
between 45 and 64 years differed significantly between urban and 
suburban municipalities (p<0.001 for both). Nonimmigrants in urban 
municipalities had a 2.8 times higher case rate than nonimmigrants in 
suburban municipalities (7.2 versus 2.6; p<0.001). The difference was 
consistent for all nonimmigrant age groups, except for the group older 
than 64 years, in which the rate ratio was nonsignificant. 
Case rates related to a unique RFLP in urban municipalities were 1.3 
times higher than those in suburban municipalities for immigrants (23.6 
versus 18.5; p=0.004) and 2.1 times higher for nonimmigrants (1.7 
versus 0.8; p<0.001). The clustered case rate for immigrants in urban 
municipalities was 2.2 times higher than in suburban municipalities (29.8 
versus 13.7; p<0.001). For nonimmigrants, the clustered case rate was 
4.4 times higher in urban municipalities compared to suburban 
municipalities (3.4 versus 0.8; p<0.001). 
 
Case rate by classification of transmission. The recent transmission case 
rate for all inhabitants of urban municipalities was 5.5 times higher than 
for those in suburban municipalities (8.2 versus 1.5; p<0.001) [Data not 
shown]. Stratified for country of birth (Table 4.4), the recent transmission 
case rate for immigrants in urban municipalities was 2.6 times higher than 
in suburban municipalities (23.1 versus 8.8; p<0.001) and for all 
nonimmigrants 4.6 times higher in urban municipalities (3.8 versus 0.8; 
p<0.001). Further stratification by age group showed that for immigrants, 
these recent transmission case rates were 1.7 times higher in age group 
15 to 29 years (p=0.002), 2.4 times higher in age group 30 to 44 years 
(p<0.001) and 5.0 times higher in age group 45 to 64 years (p<0.001). 
The rate ratios of these case rates increased significantly by age groups 
(χ2 test for trend, p<0.001). In nonimmigrants, these rate ratios were 4.4 
for the age group between 0 and 14 years (p<0.001); 5.7 in the 15 to 29 
years age group (p<0.001); 5.0 in the 30 to 44 years age group 
(p<0.001); and 6.0 in the age group 45 and 64 years (p<0.001). 
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Figure 4.2 shows case rates for immigrants and nonimmigrants in 
urban and suburban areas by recent or remote infection in the 
Netherlands, foreign-acquired infection and unknown place or time of 
infection. Case rates due to recent transmission were higher for urban 
immigrants than for urban nonimmigrants (23.1 versus 3.8; p<0.001) and 
higher for suburban immigrants than suburban nonimmigrants (8.8 versus 
0.8; p<0.001). TB caused by foreign-acquired infections contributed with 
30.9 cases per 100,000 population (47%) to the TB case rate of urban 
immigrants and with 24.4 per 100,000 population (62%) to TB among 
suburban immigrants. 
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Figure 4.2. Case rate by classification of transmission for immigrants, 
nonimmigrants and total population in urban and suburban municipalities, 
1995-2006.  
Discussion 
 
In our study, the TB case rate in three urban municipalities was 3.8 times 
higher than in 52 suburban municipalities. The case rate increased 
significantly with the level of urbanization. In the multivariate analysis, 
cases in urban municipalities were more often male, younger than 65 
years, immigrant, illicit drug user or homeless, and had more frequently a 
clustering M. tuberculosis strain. After stratification for country of birth, 
case rates were 1.7 times higher for immigrants and 2.8 times higher for 
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nonimmigrants in the urban municipalities than in suburban municipalities. 
At least 47% of urban immigrant TB cases had foreign-acquired disease 
against 62% of immigrant cases in the suburban areas. Immigrants in the 
urban municipalities had a 2.6 times higher recent transmission case rate 
than those in suburban municipalities; for nonimmigrants the case rate 
was 4.6 times higher. 
In low-prevalence countries, TB case rates in urban and suburban 
areas show wide disparities and can even differ considerably between 
boroughs within large cities (5, 18). In our study, stratification for country 
of birth generated smaller differences of case rates in urban and suburban 
municipalities. Thus, the higher overall case rate in the urban 
municipalities was partly due to the larger proportion of immigrants in 
these areas, which is a characteristic of almost all metropolitan cities in 
low-prevalence countries (19, 20). DNA fingerprinting confirmed that TB 
among immigrants resulted most frequently from foreign-acquired 
infections. The highest case rate was among immigrants between 15 and 
29 years, with similar rates in urban and suburban municipalities, also 
indicating that most of these infections were acquired before residence in 
the Netherlands. 
Several studies demonstrated that the proportion of clustered cases 
in urban areas comprised 20 to more than 50 percent of RFLP-genotyped 
TB cases (19, 21-24). The clustering proportion of urban cases (59%) in 
our study was comparably high. Clustering, however, is not identical with 
recent transmission, and genotyping data should be analyzed together 
with conventional epidemiological information. Our finding that 40% of all 
urban cases were recently infected confirmed that recent transmission 
contributed substantially to the high TB caseload in the urban munici-
palities. Comparison of TB case rates of urban and suburban municipalities 
also showed that ongoing transmission was particularly an urban 
phenomenon. Recent transmission was more common among the urban 
immigrant population in our study, and is most likely related to the total 
high TB case rate among immigrants and possibly influenced by factors 
such as housing conditions, risk group behavior and delays in diagnosis. 
Ineffective contact investigation procedures may also have contributed to 
the high proportion of recent transmission among immigrants in urban 
municipalities. According to the Dutch TB guidelines, BCG-vaccinated 
contacts of smear-positive TB patients were not eligible for tuberculin skin 
testing (TST) during most of the study period and were examined only by 
radiograph. In our study population, 72% of urban cases were immi-
grants. Most of their close contacts were either BCG-vaccinated in their 
native country or vaccinated in the Netherlands as part of a targeted BCG-
vaccination programme. Contact investigation with chest radiography 
failed to diagnose LTBI in these contacts. 
Certain groups, such as illicit drug users and homeless persons, are 
at high risk for TB and are typically found in large cities (20, 25). In our 
study, 10.3% of urban TB cases were homeless or used illicit drugs. In a 
previous study, we calculated that the TB case rate among these risk 
groups varied between 250 and 500 per 100,000 and that 83% had a 
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clustering strain (26). Thus, ongoing transmission accounted for the high 
TB case rate among and illicit drug users and homeless persons in the 
urban municipalities and influenced the recent transmission case rate in 
the general urban population. We therefore calculated and compared 
recent transmission case rates of age groups and country of birth of urban 
and suburban inhabitants without these risk profiles and all significant rate 
ratios described in the results remained the same (data not shown). Thus, 
recent transmission was not only common among illicit drug users and 
homeless persons, but also among the other urban immigrant and 
nonimmigrant population. 
One of the features of large cities is that many people travel 
together or gather for work, education and leisure, often in congested 
places (22). A substantial part of TB transmission occurs unrecognized 
and cannot be traced through contact investigation, as has been revealed 
by other genotyping studies (27). Pubs e.g. are well-known places for high 
TB transmission due to crowding and poor ventilation (28). Several of the 
molecular clusters in our study expanded due to pub-related outbreaks in 
the urban municipalities, which protracted over many years. 
 For nonimmigrants between 15 and 64 years, the case rate related 
to a unique fingerprint was several times higher in urban municipalities 
than in suburban areas, although the contribution to the overall case rate 
was low. Different risk and behavioral patterns such as visits of children of 
immigrants to their parents’ native countries and international travel of 
young urban persons, such as students, may explain this unexpected 
finding and needs further study. 
Our study showed that the high TB case rate in the urban 
municipalities was driven by ongoing transmission among certain 
identified risk groups, such as illicit drug users and homeless persons, but 
also among other immigrants and nonimmigrants in these cities. 
Furthermore, we showed that the high TB case rate was related to the 
high proportion of immigrants who frequently reactivate a foreign-
acquired infections. Thus, metropolitan TB control should focus on a 
package of targeted interventions (18). These interventions should be 
aimed at hard-to-reach, marginalized urban risk groups, such as illicit 
drug users and homeless persons. For active case finding, radiographic 
screening can be very useful to identify asymptomatic cases in these 
populations (26, 29, 30). Case holding activities are key in TB control, and 
directly observed therapy is elementary to complete treatment in specific 
TB patients, to prevent defaulting and the possible development of 
resistant strains. TST examination of contacts of pulmonary TB patients is 
one of the cornerstones of TB control in low-incidence countries. The 
recent introduction of interferon-gamma release assays in TB control 
provides better opportunities to correctly identify latent infections among 
BCG-vaccinated contacts and to offer preventive treatment (31). Since the 
majority of cases are diagnosed once symptomatic, education should be 
directed at the health care providers who see these patients first, such as 
general practitioners in inner-cities, and social workers involved with the 
care of urban risk groups. Low-threshold services, such as public health 
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TB clinics, are needed for symptomatic persons without health insurance 
or otherwise marginalized in the society. In addition, screening immi-
grants for TB and LTBI are important interventions to reduce the burden 
of disease and prevent transmission in the host country (20, 32). 
Genotyping can identify groups of persons at high risk and offer 
opportunities to develop targeted interventions to actively screen for TB or 
LTBI, as has been described by others (26, 33). The lessons learned from 
TB control in metropolitan areas are almost universal and sharing of 
experience and interventions should be facilitated, e.g. in international 
working groups. 
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Abstract 
 
In early 2001 there were indications that tuberculosis (TB) was 
increasingly becoming a problem among drug addicts and homeless 
persons in Rotterdam, after a periodical screening was discontinued in 
1997. A contact investigation around a homeless drug addicted man in 
Rotterdam with infectious pulmonary TB is described. 
Contact investigation: A total of 507 drug addicts, homeless persons, and 
staff of facilities for these risk groups were examined with tuberculin skin 
testing (TST) and chest radiography. DNA fingerprinting of mycobacterio-
logical cultures through Restricted Fragment Length Polymorphism 
methodology and molecular epidemiology investigation through cluster 
analysis were performed. 
Outcome: TST showed an infection prevalence of 29%, especially among 
staff of services for drug addicts and homeless persons. Six persons with 
active intrathoracic TB were identified. Cluster analysis demonstrated no 
relation with the initial case but showed intense transmission of TB among 
drug addicts and homeless persons in Rotterdam by multiple sources. As a 
consequence of the findings, a proposal to the Council of the City of 
Rotterdam resulted in the re-introduction of a comprehensive TB 
screening programme among these risk groups with mobile digital X-ray 
units (MXUs). 
Conclusion: This contact investigation gradually obtained the 
characteristics of a screening of drug addicts and homeless persons. Novel 
technologies, such as MXUs, facilitate appropriate and efficient outreach 
approaches to TB control among difficult-to-reach groups. This method 
and knowledge of individual fingerprints and clusters of TB patients are 
indispensable for underpinning proposals for change of local TB control 
strategies and convincing local authorities of the rationale. 
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Introduction 
 
In the mid-1990s the number of hard drug addicts in Rotterdam 
(population 600 000) was estimated at ~3700 through the capture-
recapture method (1). The hard core of homeless persons was estimated 
~1100 persons, many of them also hard drug or alcohol addicted (2). On 
average 10 drug addicts or homeless persons were diagnosed with 
tuberculosis (TB) annually. Although a fraction of drug addicts and 
homeless persons were periodically screened for TB until 1996, still the 
majority of TB cases were found passively with symptoms. In 1997 
screening was stopped because of limited financial and human resources 
and the Department of TB Control of the Rotterdam Municipal Health 
Service adopted a reactive strategy, i.e. an institution for drug addicts or 
homeless persons was examined only after an infectious case of TB was 
detected (contact investigation). 
In early 2001 there were indications that TB was increasingly 
becoming a problem among drug addicts and homeless persons in 
Rotterdam. In 1999, TB was diagnosed in 13 drug addicts or homeless 
persons (8.8% of the total number of TB cases in Rotterdam), and in 2000 
there were 17 cases (12.6%). DNA fingerprinting of the Mycobacterium 
tuberculosis isolates showed that a specific cluster had developed in 
Rotterdam with a substantial number of patients being drug addicted or 
homeless. According to the quarterly reports of the National Institute of 
Public Health and the Environment (RIVM), this was the fastest growing 
and largest TB cluster in the Netherlands. 
We describe a contact investigation among drug addicts and 
homeless persons in Rotterdam turning into a screening exercise, and how 
DNA fingerprint cluster analysis contributed to the re-introduction of a 
comprehensive programme of periodic active case finding among these 
risk groups. 
 
Initial case. A homeless, schizophrenic, drug addicted 50-year-old male 
came to the Department of TB Control in 2001 with a persistent cough 
that had worsened since 2 months. The chest X-ray (CXR) showed 
extensive infiltrative lesions with small cavities, compatible with infectious 
pulmonary TB (Figure 5.1). It appeared that the man had been referred 
by his general practitioner twice before but had never reported himself. 
This time he was accompanied by a social worker. After the CXR was 
made the man left immediately but the social worker managed to bring a 
sputum sample from the patient the next day. Microscopical examination 
of the sputum after Ziehl-Neelsen staining showed many alcohol and acid 
fast bacteria. The patient could be traced the same day and was admitted 
to a general hospital for isolation and treatment. 
Considering the duration of his complaints and the extent of the 
abnormalities on the CXR, it was assumed that the patient had been 
infectious for a long time. Besides, the infectiousness was regarded high, 
considering the quantitative count of alcohol and acid fast bacteria in the 
sputum. Furthermore, the patient had a very social lifestyle, chatting with 
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many people every day, while his cough hygiene was minimal. In the 
months preceding the diagnosis, the man had stayed in three different 
shelters for homeless persons. He visited the regional institution for 
ambulatory mental health care, daily, for supervised intake of 
antipsychotic drugs. 
 
 
 
 
Figure 5.1. Chest X-ray of the initial patient. 
 
 
Outline of the contact investigation. The Department of TB Control 
planned an extensive contact investigation that was initially aimed at the 
staff and visitors of the three homeless shelters, as well as the staff of the 
regional institution for ambulatory mental health care. According to the 
national guidelines for contact investigation, contacts with a previous 
history of TB, latent tuberculosis infection (LTBI) or BCG vaccination, and 
persons born before January 1, 1945 are excluded from tuberculin skin 
testing (TST) and are examined by CXR. Among persons examined with 
TST in the first round 20% had a LTBI. These results lead to an extension 
of the second round of the contact investigation to a larger group of 
residents of various shelters for homeless persons, as they often stay at 
different locations. The outlines of the contact investigation were, 
therefore, deliberately obscured and it obtained more the characteristics 
of a screening. 
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In the second round, contacts were checked at the Department of 
TB Control with TST or CXR. In addition, 312 residents of shelters for 
homeless persons were examined for TB on location. A mobile digital X-
ray unit (MXU) was used, allowing one of the TB physicians to read the 
CXR immediately in the van (Figure 2). In this way evident abnormalities 
could be detected instantly and follow-up examination could be initiated at 
once. All CXRs were later reviewed at the Department of TB Control. In 
this group TST was not performed because of expected poor compliance 
with preventive treatment. 
 
 
 
 
Figure 5.2. TB screening at a hostel for homeless persons in Rotterdam 
with a mobile digital X-ray unit. 
 
 
Outcome of the contact investigation. In the contact investigation a total 
of 507 persons were examined. For 127 persons the examination 
consisted of one or more TSTs (Table 5.1). In 28 persons – 18 staff 
members and 10 residents – LTBI was found, resulting in an infection 
prevalence of 29% (only persons in whom the TST examination could be 
completed were counted in the denominator). The CXR of one shelter 
resident with a positive TST in the first round of the contact investigation 
was suspicious for pulmonary TB. The sputum culture for M. tuberculosis 
became positive after several months. In two larger shelters for homeless 
persons the infection prevalence among staff members was high with 26% 
(6 out of 23 persons) and 27% (4 out of 15 persons). Preventive treat-
ment with isoniazid during 6 months was started for 17 persons while for 
the remaining 10 individuals it was decided to follow them up with CXRs 
every 6 months during 2 years. 
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Table 5.1. Results of tuberculin skin testing. 
 
Conclusion Number of persons tested 
No LTBIa 67 
Recent LTBIb 28 
(23 persons had a positive TST in the first 
round (including one resident in whom 
active TB was diagnosed later); 1 person 
with a positive TST in the second round; 4 
persons with a TST conversion) 
Infection with mycobacterium 
other than TB 
2 
Examination not completedc 30 
Total number of persons 
examined with TST 
 
127 
 
LTBI: latent tuberculosis infection; TB: tuberculosis; TST: tuberculin skin test 
a: TST negative in first and second round, or TST negative when only the second round 
was performed 
b: TST positive in the first round, or TST positive when only the second round was 
performed, or TST negative in the first 
round but positive in the second round (conversion) 
c: No TST performed in the second round, or TST in the second round not read 
 
 
Table 5.2. Results of chest radiography examinations. 
 
Conclusion Number of persons examined 
No indication of active 
intrathoracic TB 
375 
Active intrathoracic TB 5 
Second round: 2 persons with smear-
positive pulmonary TB; 2 persons with 
culture-positive pulmonary TB and 1 person 
with tuberculous pleurisy 
Total number of persons 
examined with a CXR 
 
380 
 
TB: tuberculosis; CXR: chest X-ray 
 
 
The other 380 persons were examined for active TB by means of a CXR 
(Table 5.2). Individuals examined with a CXR as a result of a positive TST 
are excluded from this number. As a result of the TB examination on 
location with the MXU, active intrathoracic TB was diagnosed in five 
persons: two persons with smearpositive pulmonary TB, two persons with 
culture-positive pulmonary TB, and one person with a tuberculous 
pleurisy. The results of this contact investigation translate into a 
prevalence rate of 1183 TB cases per 100 000 persons examined. All six 
patients with active TB completed 6 months of therapy under Directly 
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Observed Therapy. Remarkably, two of these patients, one of them 
smear-positive, stayed in a shelter of which the initial case had been a 
resident for 3 months, which until then was unknown. During follow-up, 
LTBI was found in several staff members of this shelter and in one staff 
member culture-positive TB was diagnosed. These results are not 
presented in the tables since it is considered a new contact investigation.  
 
DNA fingerprint results. When M. tuberculosis is cultured from sputum or 
other patients’ material in the Netherlands, the microbiology laboratory 
sends the isolate to the national mycobacteriological reference laboratory 
at the RIVM for DNA fingerprinting through Restricted Fragment Length 
Polymorphism (RFLP) methodology (3). When a RFLP pattern matches 
that of the mycobacterial DNA from at least one other patient, they belong 
to a so-called cluster. This often indicates transmission of TB between 
these persons or infection by a common source or sources. 
The mycobacterial RFLP pattern of the initial case was unique, i.e. 
not previously found in the Netherlands. None of the six other TB cases 
found had the same DNA fingerprint as the initial patient. The DNA 
fingerprint of four out of these six TB cases – as well as the fingerprint of 
the staff member mentioned above-belonged to the largest TB cluster in 
the Netherlands, almost entirely consisting of patients from Rotterdam. 
One fingerprint belonged to another major cluster related to homelessness 
in Rotterdam and one fingerprint was unique. 
 
 
Discussion 
 
In this contact investigation, which gradually obtained the characteristics 
of a screening, many cases of LTBI and six patients with active TB were 
found. RFLP pattern analysis showed that none of the secondary TB cases 
were related to the initial patient but reflected intense transmission of TB 
in the group of drug addicts and homeless persons in Rotterdam by 
multiple sources. 
Under Dutch public health laws the Local Authorities are responsible 
for infectious disease control, implemented by Municipal Health Services. 
Metropolitan areas harbour a disproportionate number of inhabitants 
belonging to various risk groups for TB, such as recent immigrants from 
TB high-endemic countries, hard drug users, or homeless persons. High 
rates of TB among homeless persons in large cities are well documented 
almost universally (4-9). Outbreaks of TB in homeless shelters have been 
reported (10, 11). Molecular epidemiology investigation through RFLP 
cluster analysis has contributed to the understanding of the significance 
and spread of TB in a community and demonstrated the importance of 
(recent) transmission of TB, e.g. among homeless persons (12-15). 
Transmission of TB among homeless persons can also affect shelter 
personnel and other staff of medical and social services contacted by 
homeless persons (16, 17). The many cases of LTBI we found among staff 
members of institutions that dealt with homeless persons were probably 
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the result of intense exposure to TB during several years. Active case 
finding has been reported to decrease TB transmission and overall case 
rate among urban homeless persons (17, 18). However, the yield of some 
TB screening programmes of homeless persons may be low due to poor 
health care system uptake and poor treatment completion rates (5, 19-
23). Among risk groups such as homeless persons, conventional methods 
of contact investigation are not feasible for various reasons (8, 9). 
Outreach interventions, bringing active case finding and case holding 
services closer to certain risk groups, with incentives to maximize 
compliance, and in co-ordinated co-operation with hospitals, social 
services and the community, have been described (17, 22, 24). Among 
some groups of careless care-avoiders strong persuasion or even 
mandatory screening may be necessary and has resulted in a drastic 
reduction of TB incidence (17, 18). Novel technologies, such as MXUs with 
digital X-ray equipment facilitate appropriate and efficient approaches of 
targeted TB control among difficult-to-reach groups. A TB physician can 
read the CXR immediately and follow-up examination can be initiated 
instantly, such as a short medical history, spot sputum collection, or 
referral to a clinic accompanied by a TB nurse or social worker. In this 
way, the failure of many individuals in attending the medical services as a 
result of their care-avoiding behaviour can be prevented. Also, the bond 
created in the first encounter with health care providers will positively 
influence the trust of the patient and contribute to better compliance. 
Many homeless persons are also alcohol or hard drug addicted. High 
rates of TB among hard drug users are also reported (25-27). Digital 
MXUs can also be employed in co-operation with needle exchange posts, 
methadone substitution programmes, or day-care facilities for hard drugs 
users. In the Netherlands MXUs have been used effectively for TB control 
among prisoners and in centres for asylum seekers (28). This has 
facilitated its use in case of an outbreak of TB or screening of other risk 
groups on location. 
Considering the outcome of the DNA fingerprint analysis, this 
‘contact investigation’ should be regarded as a screening, revealing 
several undetected TB cases among hard drug users and homeless 
persons in Rotterdam. As a consequence of these findings, a proposal to 
re-introduce TB screening for hard drug users, methadone users, and 
homeless persons in Rotterdam gained momentum from the Municipal 
Health Service and the institutions providing social services to these risk 
groups. It contributed to making TB screening among drug users, 
methadone users, and homeless persons one of the priority issues in the 
Council Programme 2003-6 of the Council of the City of Rotterdam. This 
resulted in the re-introduction of a comprehensive TB screening 
programme among these risk groups, aimed at semi-annual radiological 
examination, with a digital MXU already used for screening prisoners and 
asylum seekers. Also, arrangements were made with the institutions for 
social services for drug users, methadone users, and homeless persons for 
periodic examination of their staff members. 
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Conclusions 
 
Contact investigation has not been effective among hard drug users and 
homeless persons in Rotterdam. The use of MXUs with digital X-ray 
equipment facilitates TB control among certain difficult-to-reach TB risk 
groups. Molecular technologies in TB control such as mycobacterial strain 
identification with DNA fingerprinting can recognize local epidemiological 
patterns previously undetectable. The knowledge of individual fingerprints 
and clusters of TB patients not only contributes to better risk group 
identification but is also indispensable for underpinning proposals for 
change of local TB control strategies and convincing local authorities of 
the rationale behind appeals for support, in this case for a screening 
programme. 
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Abstract 
 
Rationale: In 2002, a mobile radiographic screening programme was 
started in Rotterdam to respond to high rates of tuberculosis (TB) among 
illicit drug users and homeless persons. 
Objectives: We studied trends and characteristics of TB among these risk 
groups and assessed the impact of the screening programme on 
transmission, using molecular typing. 
Methods: Description of trends, and of demographic and disease-related 
characteristics of tuberculosis cases among these risk groups between 
1993 and 2005. TB was considered to result from recent transmission if 
the mycobacterial DNA fingerprints of cases were identical to those of 
other cases in the risk groups in the previous 2 years. 
Measurements and Main Results: During the study period, 206 individuals 
with TB among illicit drug users and homeless persons were notified, 
representing 11.4% of the total case load of 1,811 in Rotterdam. The 
annual number of tuberculosis cases declined from 24 at the start of the 
screening programme to 11 cases in 2005. The screening programme 
identified 28 cases (a prevalence rate of 327 per 100,000 radiographs), of 
which 12 were smear positive. In 1997–2002, more than 80% of the illicit 
drug users or homeless persons with TB were infected with one of the 
Mycobacterium tuberculosis strains prevalent among these risk groups. 
After nearly 4 years of systematic radiographic screening this proportion 
declined to 45% in 2005. 
Conclusions: DNA fingerprinting can be a useful tool to evaluate the 
impact of a TB screening programme. We advocate that screening of illicit 
drug users and homeless persons should be continued to prevent a 
resurgence of TB. 
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Introduction 
 
In low-prevalence countries, tuberculosis (TB) is becoming a problem 
especially affecting large cities, where high rates can be found among 
certain risk groups such as (recent) immigrants, asylum seekers, 
prisoners, illicit drug users, and homeless persons (1-3). These risk 
groups need targeted interventions for (early) case detection and 
adequate treatment supervision (4). In the Netherlands, immigrants and 
asylum seekers from TB high-endemic countries are screened twice per 
year by chest X-ray for 2 years, and new inmates are radiographically 
screened after entering a correctional facility (5). Mobile digital X-ray units 
(MDXUs) visit the asylum seeker centres and prisons on a weekly basis. 
In the city of Rotterdam (about 600,000 inhabitants), a screening 
programme among clients of a limited number of facilities for illicit drug 
users and homeless persons was discontinued in 1996 (6). The number of 
TB cases among illicit drug users and homeless persons gradually doubled 
over an 8-year period to 23 in 2001, which translated into an annual 
notification rate of 511 per 100,000 persons, more than 50 times the TB 
notification rate of 9.0 per 100,000 persons in the Netherlands in that 
year (5). DNA fingerprinting of the Mycobacterium tuberculosis isolates 
revealed that a fast-growing cluster developed in the Netherlands with a 
substantial number of patients from Rotterdam being illicit drug users or 
homeless. A large contact investigation among these risk groups in 2001 
identified multiple asymptomatic infectious TB cases, whereas cluster 
analysis of all six culture-positive secondary cases demonstrated that 
none of them was linked to the initial case (6). As a consequence of these 
findings, a comprehensive targeted TB screening programme with an 
MDXU was introduced in May 2002, aiming to detect cases early and to 
control the epidemic. 
The objectives of this study were to describe the trends and 
characteristics of disease among illicit drug users and homeless persons 
with TB, to evaluate nearly 4 years of systematic screening, and to 
determine the effect of screening on transmission, using information from 
molecular typing. 
 
 
Methods 
 
Case Definition. An illicit drug user was defined as a person who, at the 
time of diagnosis, regularly used heroin or cocaine, or was receiving 
methadone replacement therapy. A homeless person was defined as a 
person who frequently used day-care, night-care, residential, or other 
facilities for homeless persons. 
All notified TB cases among illicit drug users with a registered 
address in Rotterdam and homeless persons residing in Rotterdam who 
were diagnosed between January 1, 1993, and December 31, 2005, were 
included in the study. To compare demographic and disease-related 
characteristics, all TB cases not belonging to these risk groups, and 
99
Chapter 6 
notified in the same period, were also studied. Information about the 
patients was extracted from the TB register of the Department of 
Tuberculosis Control and from individual patient records. 
 
Screening. A targeted mobile TB screening programme among illicit drug 
users and homeless persons in Rotterdam was reintroduced in May 2002, 
visiting an incomplete number of services and facilities in that year. Since 
January 1, 2003, all known facilities – that is, four methadone-dispensing 
centres, six day- or night-care facilities (some of them also having safe 
drug consumption rooms), three residential homes, and the street 
prostitution zone – were visited twice per year with an MDXU. The 
screening of the 14 facilities was performed during 12 working days per 
half-year, with an average of 102 persons per day, ranging between 36 
and 319. The screening results were obtained from the Client Information 
System of the Department of Tuberculosis Control. The yield of the 
screening was cross-checked with individual patient records. 
 
Mycobacteria and DNA Fingerprints. Since 1993, all M. tuberculosis 
isolates in the Netherlands have been subject to standardized insertion 
sequence (IS)6110-based restriction fragment length polymorphism 
(RFLP) typing, so-called DNA fingerprinting (7). Clusters are defined as 
groups of patients having isolates with fully identical RFLP patterns or, if 
strains harbour fewer than five IS6110 copies, with identical subtyping by 
use of the polymorphic GC-rich sequence probe (8). The mycobacterial 
DNA fingerprints of TB cases among illicit drug users and homeless 
persons were compared with those of other cases with the same risk 
profile in previous years. If the mycobacterial DNA clustered with a 
preceding case within a 2-year period, the disease was considered to be 
due to recent transmission related to illicit drug use or homelessness (9). 
Because of this 2-year time lag, only cases in the period 1995 to 2005 
were included in the analysis of recent transmission. 
 
Statistical Methods. We analyzed data with SPSS version 12 (SPSS, Inc., 
Chicago, IL). We calculated χ2 trends for the proportion of TB cases 
among illicit drug users and homeless persons of the total caseload and 
the proportion of recently infected TB cases in these risk groups for three 
periods, that is, a first period from calendar years 1993 through 1996 and 
1995 through 1996, respectively, with mobile screening, a second period 
from calendar years 1997 through 2001 without screening, and a third 
period from calendar years 2002 through 2005 with the MDXU screening 
programme. For comparison of the proportion of smear-positive TB cases 
and cases found through active case finding among illicit drug users and 
homeless persons, the third period started in May 2002. We calculated the 
odds ratio of demographic and disease-related characteristics of TB cases 
among illicit drug users and homeless persons. Multivariate logistic 
regression was performed, considering factors significant in univariate 
analysis. 
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Results 
 
Trends of Disease. During the 13 years of study, 90 TB cases were notified 
as illicit drug users, 37 were homeless persons, and 79 were both illicit 
drugs user and homeless. These 206 cases represented 11.4% of the total 
TB caseload of 1,811 in Rotterdam (Table 6.1). The annual number of TB 
cases among illicit drug users and homeless persons doubled from an 
average of 12 in the years 1993 until 1998 to 23 in 2001. After the 
introduction of the mobile screening programme the annual number and 
the proportion fell between 2002 and 2005 from 24 to 11 and 16.4 to 
8.5% (p <0.05), respectively. The annual notification rate decreased from 
533 per 100,000 persons in 2002 to 244 per 100,000 persons in 2005, 
based on an estimated number of 4,500 illicit drug users and homeless 
persons in Rotterdam. 
 
 
Table 6.1. Tuberculosis (TB) cases among illicit drug users or homeless 
persons compared to the total number of cases of the city of Rotterdam 
1993-2005. 
 
Illicit Drug Users or 
Homeless Persons 
with TB 
 
Year 
Number of 
TB cases n % 
 
χ2 Test for Trend for 
Proportions 
 
1993 125 16 12.8  
1994 137 10 7.3  
1995 107 8 7.5  
1996 125 13 10.4 Years 1993-1996: p=0.58 
1997 138 12 8.7  
1998 129 12 9.3  
1999 148 20 13.5  
2000 135 14 10.4  
2001 156 23 14.7 Years 1997-2001: p=0.11 
   
 
2002 146 24 16.4  
2003 171 25 14.6  
2004 164 18 11.0  
2005 130 11 8.5 Years 2002-2005: p=0.03 
Total 1,811 206 11.4  
   
 
The horizontal line demarcates the start of the screening programme in May 2002. In 
that year 7 cases were notified before and 17 cases after the screening programme was 
started.  
 
 
Characteristics of Disease. Table 6.2 compares demographic and disease-
related characteristics of illicit drug users and homeless persons with TB 
and cases without this risk profile in Rotterdam between 1993 and 2005. 
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In the multivariate analysis illicit drug users and homeless persons with 
TB were more often in the age group between 40 and 59 years, born in 
the Netherlands, and coinfected with human immunodeficiency virus 
(HIV). They more often had pulmonary disease with positive sputum or 
bronchoalveolar fluid smears for acid-fast bacilli. The proportion of smear-
positive TB cases among illicit drug users and homeless persons was 
55.3% (26 of 47), 58.0% (51 of 88), and 47.9% (34 of 71) during the 
three periods. The proportion of smear positivity during the MDXU 
screening programme decreased compared with the nonscreening years, 
although the decrease was not statistically significant (p = 0.11). The M. 
tuberculosis strains of illicit drug users and homeless persons clustered 
more frequently. TB cases among illicit drug users and homeless persons 
were more often identified through active case finding, such as contact 
investigation and screening. 
 
 
Table 6.3. Number of persons screened, chest X-rays taken, tuberculosis 
cases and incidence rate of mobile radiographic screening programme 
among illicit drug users and homeless persons in Rotterdam. 
 
 
Number of 
Persons 
Screened 
Number of 
Chest X-rays 
Number of 
Tuberculosis 
cases 
Smear-positive 
Tuberculosis 
Cases 
Prevalence Rate 
(per 100,000 
chest X-rays) 
2002 (from 
May on) 1,229 1,484 11 
 
4 741 
2003 1,824 2,605 10 4 384 
2004 1,712 2,431 1* 0 41 
2005 1,507 2,039 6 4 294 
Total 3,248 8,559 28 12 327 
      
 
* Two persons had a suspected chest X-ray but could not be followed up. One person 
reported to a hospital with complaints one week after the chest X-ray was taken and the 
other person could not be traced, but reported two months later with symptoms to the 
Department of Tuberculosis Control of the Municipal Public Health Service. Both of them 
had TB. 
 
 
Targeted Mobile Digital X-ray Screening and Other Active Case-finding 
Activities. During the 3 years and 8 months of the MDXU screening 
programme, 8,559 chest X-rays were taken of 3,248 individuals (Table 
6.3). The total yield of the screening was 28 TB cases, of which 12 cases 
were smear positive and 27 cases were culture confirmed. This translated 
into a prevalence rate of 327 cases per 100,000 radiographs. In the same 
period, another 7 TB cases among illicit drug users or homeless persons 
were identified through contact investigation and 7 via the TB screening 
programme in prisons, resulting in 42 of a total of 71 TB cases (59.2%) 
among these risk groups found through active case finding during the time 
of the MDXU screening programme. In the first 4 years of the study 
period, 15 of a total of 47 TB cases (31.9%) were found through active 
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case finding, of which 9 cases were found via mobile screening of these 
risk groups, 2 cases through contact tracing, and 4 cases via the TB 
screening programme in prisons. During the nonscreening period, 26 of a 
total of 88 cases (29.5%) were actively traced, of which 17 cases were 
found through contact investigation and 9 via the TB screening 
programme in prisons. The difference in the proportion of cases identified 
through active case finding during the MDXU screening programme and 
during the nonscreening years was highly significant (p < 0.001). 
 
Case-holding Activities. During the study period 1993–2005, initial 
hospitalization was required for two-thirds of the TB cases among illicit 
drug users and homeless persons, because of the high proportion of 
infectious cases. Fourteen patients (6.8%) were detained in a designated 
hospital for a mean period of 10 weeks (3–26 wk), because they did not 
comply with isolation procedures during the infectious period. Other 
aspects of case holding are addressed in the discussion. TB cases among 
illicit drug users and homeless persons had a significant lower treatment 
completion rate than did cases without the risk profile (79.1 vs. 86.8%, 
unadjusted odds ratio, 0.6 [95% confidence interval, 0.4–0.8]; p <0.05). 
However, 25 of the 28 cases (89.2%) identified through the mobile 
radiographic screening programme completed treatment. 
 
Molecular Epidemiology. Table 6.4 gives cluster information of the 
mycobacterial strains of the culture-confirmed TB cases among illicit drug 
users or homeless persons in Rotterdam over the period 1993–2005. In 
31 cases TB was caused by mycobacteria with an unique DNA pattern in 
the Netherlands, of which 9 were the first case of a cluster; 3 of these 
clusters (clusters 13, 19, and 30) also included other illicit drug users or 
homeless persons with TB in Rotterdam. In the remaining 156 TB cases 
(83.4%) the mycobacteria belonged to 27 different clusters. Four 
mycobacterial strains (clusters 1, 13, 17, and 19) were the causative 
microorganism in 62.8% (117 of 187) of the culture-confirmed cases with 
an RFLP. 
In 1997–2002, more than 80% of the illicit drug users or homeless 
persons with TB were infected with one of the M. tuberculosis strains 
prevalent among these risk groups within 2 years before diagnosis (Figure 
6.1). The proportion of prevalent strains declined from 82% in 2002 at the 
start of the screening programme to 45% in 2005 (p <0.05). 
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Figure 6.1. Annual proportion of tuberculosis cases among illicit drug 
users and homeless persons in Rotterdam with identical restriction 
fragment length polymorphism with cases in these risk groups 2 years 
before diagnosis. Fisher exact test for trend first (screening) period 
(1995–1996): p = 0.22; χ2 test for trend second (nonscreening) period 
(1997–2001): p = 0.77; χ2 test for trend third (MDXU screening) period 
(2002–2005): p = 0.03. 
 
 
Figure 6.2 shows details of cluster 17, the largest TB cluster in the 
Netherlands with 150 cases in December 31, 2005. Initially it contained 
only TB cases with the same ethnic background and all residing in 
Rotterdam (13 cases in 1996–1997). One of them was an illicit drug user 
who was diagnosed at the end of 1996 with extensive disease. In the 
years 1998–2001 another 76 cases were added to this cluster, among 
them 34 cases from Rotterdam with a drug addiction or homeless status 
(46%) and also documented secondary cases among family members, and 
medical and social staff involved in the care for these persons. The 
number of cases among illicit drug users and homeless persons in this 
cluster declined during the screening years 2002–2005, with only one 
case during the last 2 years. The growth of cluster 17 continued in 2004 
and 2005 due to pub-related transmission among migrants with the same 
ethnic background as the initial cases of the cluster. 
 
 
Start screening 
program 
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Figure 6.2. Epidemic curve of tuberculosis cases in cluster 17 in the 
Netherlands by year, residential area, and risk factors. Column patterns: 
solid, illicit drug user or homeless person in Rotterdam; hatched, resident 
of Rotterdam, not an illicit drug user or homeless; open, patient residing 
elsewhere in the Netherlands. 
 
 
Discussion 
 
As a response to a doubling of TB cases among illicit drug users and 
homeless persons a comprehensive targeted screening programme was 
introduced in May 2002 in Rotterdam. 
 Three years and 8 months after this introduction of periodic 
radiographic screening the annual number of TB cases among illicit drug 
users and homeless persons, and their proportion of the total number of 
TB cases, had declined by approximately 50% and reached preoutbreak 
incidence levels. Molecular genotyping showed a decrease of prevalent 
strains among these risk groups as well as a reduction in the number of 
incident TB cases among illicit drug users and homeless persons in 
relevant clusters, providing further evidence that transmission was 
reduced during the intervention. 
 
TB among Homeless Persons and Illicit Drug Users. Outbreak reports of TB 
among residents of homeless shelters in large cities in Europe and the 
United States have cited high TB incidence rates ranging from 250 to 
more than 1,000 per 100,000 persons (9-14). In one review homeless TB 
cases represented between 6.1 and 6.7% of all cases between 1994 and 
2003 in the United States (15). At the height of the outbreak in 
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Rotterdam, one of six TB cases (16.4%) used illicit drugs or was homeless 
at the time of diagnosis. We have combined these two risk factors 
because they were strongly interrelated, although illicit drug use was 
more dominant. 
Homelessness and drug addiction are important risk factors for TB 
because transmission is facilitated by late presentation, common to 
marginalized care avoiders, crowding, and poor ventilation of shelters or 
safe drug consumption rooms. In addition, interrelated factors such as 
HIV-infection, malnutrition, and alcohol and drug abuse increase the risk 
of progression to active disease once infected (16-20). In our study 
cohort, HIV coinfection was three times more common among illicit drug 
users and homeless persons with TB than among cases without these risk 
factors. 
 
Demographic and Disease Characteristics. Illicit drug users or homeless 
persons with TB in Rotterdam were more often born in the Netherlands 
than were cases without these risk factors, and DNA fingerprinting showed 
that the majority of cases among these risk groups clustered. This 
underpins the notion that the increase in the number of illicit drug users 
and homeless persons with TB was due to intensive and prolonged 
transmission in Rotterdam. 
Illicit drug users or homeless persons with TB more often had 
disease located in the lungs, which more frequently had reached an 
infectious stage with positive sputum or bronchoalveolar lavage fluid 
smears after direct microscopy. They represented 19.3% (111 of 576) of 
all infectious cases in Rotterdam during the study period. DNA 
fingerprinting analysis, including all cases from the general population, 
showed that apart from other illicit drug users or homeless persons, also 
workers in close contact with the risk groups, such as shelter staff, social 
and health care workers and volunteers, as well as family members, had 
developed TB caused by M. tuberculosis strains prevalent among these 
risk groups. 
 
Screening, Case-finding, and Case-holding Activities. Systematic chest 
radiographic screening for TB, especially with M(D)XUs, has been reported 
in a limited number of outbreaks of TB among homeless persons (21-23). 
In the Netherlands, MDXUs were already used for several other screening 
activities, so they could be easily used for the screening of illicit drug 
users and homeless persons. We considered screening with an MDXU the 
most appropriate intervention for active case finding because of the 
urgent public health situation and previous findings that asymptomatic 
infectious cases may persist undiagnosed for a long time in the targeted 
community (6). In addition, symptomatic cases may report late because 
of limited access to care and to patient delay (24). Alternative 
interventions to control TB among homeless persons, such as symptom 
screening, spot sputum screening, treatment of latent TB infections in 
HIV-infected populations, and environmental control activities have been 
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applied (9, 10, 25, 26), although the success of these approaches has 
been questioned (20). 
The screening resulted in a prevalence rate of 741 per 100,000 
radiographs in the first year, but declined after some years of systematic 
screening, suggesting that the epidemic was being controlled. The total 
yield was 327 TB cases per 100,000 radiographs, which is high compared 
with the outcomes of other TB screening programmes in the Netherlands, 
such as entry screening of immigrants (111 per 100,000 radiographs) or 
prisoners (72 per 100,000 radiographs) (5). Our findings were similar to 
the result of radiographic screening of opiate users in Amsterdam in the 
1990s of the last century (400 per 100,000 radiographs) (11). Radio-
graphic screening detects only active intrathoracic TB cases. Additional 
interventions, such as screening for latent TB infections, might be of use 
in a phase of a controlled epidemic to identify cases at risk and select 
candidates for preventive treatment, although low completion rates have 
been reported among homeless persons (27). 
Apart from active case-finding activities, completion of treatment is 
essential to control TB and prevent new cases (28). High completion rates 
can be achieved by directly observed therapy, in which patients take their 
medication under supervision (28, 29). In Rotterdam, all illicit drug users 
and homeless persons with TB have a directly observed therapy 
indication, and as a result of the screening programme additional human 
and other resources were needed to maximize case holding. Incentives 
such as public transport tickets, priority accommodation in shelters, 
voluntary admission to specialized TB hospitals, or assistance in applying 
for temporary residence permits also contributed to the high treatment 
completion rate. The use of detention as a last resort to isolate 
noncompliant infectious patients and complete treatment has been 
successfully applied in other programmes to control tuberculosis (30). 
 
DNA Fingerprint Analysis. DNA fingerprint studies, most of them based on 
RFLP, combined with conventional epidemiologic information, have 
increased our knowledge of TB transmission (10, 31-34). Community 
studies demonstrated unidentified outbreaks of TB and underlined the 
importance of ongoing transmission, also in low-prevalence countries (33, 
34). Molecular studies have pointed out the limitations of standard 
contact-tracing procedures to identify or prevent new cases and have 
showed the contribution of DNA fingerprinting to surveillance and the 
evaluation of TB control programs (33-35). For adequate interpretation 
and comparison, molecular studies should ideally involve a high proportion 
of cases in a population, be conducted in conjunction with conventional 
epidemiologic investigations, provide information about patient character-
ristics, and report the time period of the study (36). In the Netherlands, a 
comprehensive database of DNA fingerprints of nearly all culture-
confirmed TB cases over more than 10 years is available (37-39). 
Together with detailed epidemiologic information from the patient records 
the present study fulfils the above-cited criteria. 
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DNA fingerprinting has been used to document clonal relationships 
in shelter-associated outbreaks over long time periods (9, 40, 41). In our 
study, the four most prevalent mycobacterial strains continued to reoccur 
in the illicit drug–using or homeless population for 8 to 13 years. It is 
unlikely that these cases were due to a single point source, because 54% 
(data not shown) of the illicit drug–using or homeless cases in these 
clusters were infectious. Ongoing transmission from multiple sources 
among illicit drug users or homeless persons sustained the outbreak for 
many years. The growth of one of these clusters clearly illustrated the 
epidemic spread both inside and outside these risk groups. DNA 
fingerprint analysis also revealed that isoniazid-resistant strains were 
introduced in the homeless community in Rotterdam, leading to a 
secondary case and creating the potential for new and more complicated 
outbreaks, as documented elsewhere (42). 
The proportions of TB cases among illicit drug users and homeless 
persons with prevalent strains varied between 80 and 90% at the height 
of the epidemic in Rotterdam and were higher than the reported 
proportions in Denver (49%), Los Angeles (53%), San Francisco (60%), 
New York (60%), or Budapest (70%) (9, 10, 13, 31, 43). One of these 
studies also measured the effect of an intervention on the proportion of 
prevalent strains, and showed a decrease from 49 to 14% after a 
mandatory screening programme using symptom screening and tuberculin 
skin testing was implemented (9). During the mobile radiographic 
screening programme in Rotterdam, which was not mandatory but used 
an opting-out strategy and strong persuasion of clients to comply with 
screening, the proportion of TB cases among illicit drug users and 
homeless persons with prevalent strains declined from 82% in 2002 to 
45% in 2005. 
 
 
Conclusions 
 
After the introduction of systematic and targeted TB screening among 
illicit drug users and homeless persons with mobile digital X-ray units in 
Rotterdam, the annual number of notified TB cases among these risk 
groups decreased and transmission fell. This study demonstrates that DNA 
fingerprinting can be a useful tool to evaluate the impact of a TB 
screening programme. Although the yield declined after some years of 
systematic screening, we advocate that screening of illicit drug users and 
homeless persons in Rotterdam should be continued to prevent a 
resurgence of TB as was experienced after discontinuing a screening 
programme at the end of the last century. 
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Abstract 
 
The risk for healthcare workers (HCWs) of tuberculosis (TB) attributable to 
occupational exposure is difficult to determine, as are the conditions 
contributing to this risk. The objective of the present study was to 
determine which TB cases among HCWs in the Netherlands were infected 
during work and to analyse factors which contributed to infection and 
subsequent disease. 
The total study population consisted of 101 cases over a 5-yr period. 
In 67 (66%) subjects the route of infection could be determined by 
epidemiological and microbiological information. Of these cases, 28 out of 
67 (42%) were due to infection at work, 19 (28%) were community 
acquired, and 20 (30%) were infected abroad. 
The 28 cases infected at work were subject to an in-depth analysis. 
Delayed diagnosis of the index case, especially in the elderly patient, was 
the main cause of patient-to-HCW transmission. In some circumstances, 
inadequate infection-control measures also contributed to transmission. 
In conclusion, a high suspicion of tuberculosis by the clinician, 
adequate infection-control measures by hospital authorities, and early 
identification of latent tuberculosis infection by occupational and public-
health specialists are necessary to prevent tuberculosis among healthcare 
workers. 
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Introduction 
 
Healthcare workers (HCWs) are at risk of nosocomial infection with 
Mycobacterium tuberculosis (1). This risk was high in the pre-
chemotherapy era, but declined rapidly after the introduction of effective 
treatment, which reduced the infectious period of tuberculosis (TB) 
patients, as well as the absolute number of TB patients in many countries 
(2). Along with the declining risk, the attention for infection-control 
practices in hospitals has lessened (2). Recognition of nosocomial 
transmission as a public-health issue was renewed when extensive HIV-
related transmission of multidrug-resistant TB occurred in New York City 
hospitals (NY, USA), which also affected HCWs, some with fatal outcomes 
(3-5). 
Several research methods, such as cohort studies and case–control 
studies, have been applied to study and estimate the extent of work-
related TB among HCWs (2, 6-8). These studies have methodological 
limitations in determining the excess risk for HCWs and the importance of 
conditions of exposure leading to this risk (7, 8). Cohort studies and case–
control studies are often unable to differentiate between occupational and 
nonoccupational risk, while outbreak reports may describe extraordinary 
situations with a high number of infecting inocula, particular virulent 
strains or HIV comorbidity, making it difficult to extrapolate such results 
to nonoutbreak conditions (4, 6, 7, 9). 
In the Netherlands, all TB cases are reported to the Netherlands 
Tuberculosis Register (NTR), which also includes information on risk-group 
status (10). One of the variables within the register is ‘‘working in the 
healthcare/social welfare sector’’. Every year, on average 20–30 HCWs out 
of 1,500 cases are reported with TB. The objective of the present study 
was to determine which cases were really infected during healthcare work 
in the Netherlands and to analyse factors which contributed to infection 
and subsequent disease. 
 
 
Methods 
 
The current study cohort comprised of all consecutive TB patients 
registered in the Netherlands during the period of January 1, 1995 to 
December 31, 1999, who were classified as ‘‘working in the 
healthcare/social-welfare sector’’. After approval by the ethical committee 
of the NTR, all 37 Depts of Tuberculosis Control of the Municipal Health 
Services (MHSs) responsible for notification of the cases were identified 
and asked for their collaboration. This essentially meant that nurses who 
were involved in patient management and contact investigations related 
to these patients were interviewed to answer three basic questions as 
follows. 1) Was the patient really a HCW before or at the time of 
diagnosis? 2) What kind of work was the HCW involved in at the time of 
diagnosis or before diagnosis? 3) Does epidemiological or molecular 
information exist to prove or exclude infection during work in the 
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Netherlands? Cases were excluded if the patient was not a HCW or the 
diagnosis of TB was withdrawn after notification. 
Since 1993, all M. tuberculosis isolates in the Netherlands are 
subject to standardised insertion sequence (IS) 6110-based restriction 
fragment length polymorphism (RFLP) typing, socalled DNA fingerprinting 
(11). Clusters are defined as groups of patients having isolates with fully 
identical RFLP patterns or, if strains harbour less than five IS6110 copies, 
with identical sub-typing by use of the polymorphic GC-rich sequence 
probe (12). The fingerprints of all culture-confirmed cases in the cohort 
were cross-checked with the National DNA fingerprint database. 
With the information from the interviews, the NTR and DNA 
fingerprints, patients were classified into four categories as follows. 
Category 1: HCW infected during healthcare work in the Netherlands. 
Cases were included if an epidemiological nosocomial link was confirmed 
by matching DNA fingerprints, or TB was diagnosed during a contact 
investigation carried out at the workplace, or a well-documented epide-
miological link was present without bacteriological confirmation of the 
diagnosis in the HCW. Category 2: HCW infected in the community. These 
cases had either matching DNA fingerprints with a close contact in the 
community or, if culture negative, were considered infected in the 
community based on convincing epidemiological evidence, such as contact 
investigation among household contacts and friends. Category 3: HCW 
infected abroad. This category includes Dutch HCWs who worked for a 
long period in a hospital within a TB endemic country, as well as foreign-
born HCWs. Classification was also based on tuberculin skin test (TST) 
conversion after leaving the Netherlands and on DNA fingerprints (e.g. a 
unique fingerprint). Category 4: HCW place of infection unknown, 
including the remaining cases which could not be classified into one of the 
above categories. 
Cases belonging to category one were investigated in more detail by 
contacting the TB departments of the MHSs and other health institutions 
involved. Patient and disease characteristics of both the HCW and the 
index case were obtained from patient records. In addition, information 
was collected about the circumstances under which transmission occurred. 
The results were discussed with involved professionals working in these 
settings. The study design did not allow for collection of standardised 
information about the airflow (ventilation) in relevant rooms. 
 
 
Results 
 
In the 5-yr study period, 123 patients were recorded as working in the 
healthcare/social welfare sector. Eight cases were misclassified as having 
TB, seven had a latent TB infection and one case had disease caused by 
M. avium. Another 21 cases were workers/volunteers involved in the 
social services in asylum seekers centres, penitentiary institutions and 
homeless centres that did not have a HCW status. In total, these 29 
(24%) cases were excluded from the analysis, leaving a total of 94 eligible 
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HCWs with active TB. However, during the field research, seven additional 
cases were identified, which were not (yet) included in the present study. 
The box on the registration form was either not ticked or information was 
wrongly copied into the national TB register. These cases were included in 
the current study, giving a total study population of 101 HCWs. 
The incidence of TB among HCWs was calculated for hospital 
workers involved in patient care, since they are at greatest risk for 
nosocomial infection and their denominator can be more accurately 
determined. In 1997, 126,500 persons were involved in patient care in 
Dutch hospitals (13). During the 5-yr study period, 50 cases were 
hospital-employed HCWs involved in patient care, resulting in a TB 
incidence of 7.9 per 100,000 per annum. The other 51 cases were 
employed in nursing homes, home-care organisations or were general 
practitioners, physiotherapists, student doctors or not employed in the 
healthcare setting at the time of diagnosis. 
Table 7.1 shows the classification of the cases in the four categories. 
Of the 47 cases infected in the Netherlands, 28 were work-related 
(category one) and 19 community acquired (category two). The 
attributable risk (AR) of healthcare work in the Netherlands can be derived 
directly by dividing the number of cases in category one by all cases 
infected in the Netherlands (categories one and two) and is 0.6 (28 out of 
47). The relative risk (RR) for healthcare work in the Netherlands can be 
calculated by AR (1–1/RR) and is 2.47. 
Of the 11 HCWs infected abroad (category three) and born in the 
Netherlands, all but one case was involved in patient care in developing 
countries, often for many years. One Dutch HCW had a negative TST 
when leaving the Netherlands to work in a refugee camp in Kenya and on 
returning the TST was 6 mm. No treatment for latent TB infection was 
prescribed in accordance with Dutch guidelines. The patient developed 
pleural TB within 1 yr of returning, with a M. tuberculosis strain identical 
to a strain prevalent among Somalian TB patients in the Netherlands. 
In-depth investigation focused on the 28 cases infected during work 
in the Netherlands. Among them, 16 cases were classified based on both 
an epidemiological link and a matching DNA fingerprint, two cases had an 
epidemiological link and a unique fingerprint which could be explained 
(see below), eight cases had culture-negative TB diagnosed in a contact 
investigation at work, and two HCWs with culture-negative TB had a well-
documented contact in the hospital, but were diagnosed after they 
reported with symptoms. However, five cases were excluded from analysis 
below since they had no identified patient contact: two HCWs were 
infected by a regular visitor of the hospital; two HCWs by another HCW; 
and one laboratory assistant developed cutaneous TB with a unique 
fingerprint after injuring herself with a needle in a laboratory. 
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Characteristics of HCWs and index patients. The median (range) age of 
the HCWs was 28 (21–65) yrs with the majority being female (18 out of 
23). The following professions were involved: nurses (n=14); doctors 
(n=4); ward assistants (n=2); bronchoscopy assistants (n=2); and an 
assistant of an outpatient department (n=1). In total, 21 were infected in 
the hospital and two outside the hospital. The hospital workers were 
deployed at the following departments: a pulmonology ward (n=9); an 
internal medicine (including AIDS) department (n=5); a bronchoscopy 
unit (n=2); an outpatient department (n=2); and at other wards (n=3). 
In total, 10 cases had pulmonary TB (among them two cases were smear 
positive), 12 had pleural TB and one had TB of the skin. None of the cases 
reported a previous history of TB. There were no HCWs with HIV co-
infection. However, as the HCWs were not systematically tested for HIV, 
this information is incomplete. All isolates were drug susceptible and all 23 
HCWs completed treatment. 
In 21 out of the 23 patients, the infection could be attributed to a 
specific index case, while in two cases only incomplete information of the 
presumed index patient could be obtained. Of the known sources, 16 
index patients each caused one secondary case among HCWs, one index 
case was the source of two secondary cases and one index case caused 
three secondary cases among HCWs. Almost all index patients had smear-
positive pulmonary TB, except for two cases: one with disseminated TB 
with chest radiography abnormalities, a negative sputum culture and a 
positive stool culture for M. tuberculosis; and one case with a TB abscess 
of the knee joint that was surgically managed and drained. The median 
(range) age of the index patients was 45 (25–87) yrs, with 44% of the 
index patients (eight out of 18) aged >60 yrs. Two index cases were HIV 
infected. 
 
Interval between infection and diagnosis of TB in HCW. The date of 
infection was determined as the date of admission of the index case to the 
hospital or, for nonhospitalised patients, the date of first contact with the 
HCW. The date of TB diagnosis of the HCW was the date of admission to 
the hospital, or for nonhospitalised HCWs, the date of specimen collection 
for TB examination or the first date of presenting with symptoms at a 
health post. For two HCWs, both infected by the same index patient, the 
interval could not be determined because the index patient was 
undiagnosed for a long time, probably >1 yr. One of these HCWs even 
developed pleural TB 4 months before the index patient was diagnosed. 
The interval between infection and disease of TB cases among HCWs 
is presented in Figure 7.1. The median interval was 32 weeks for all 21 
secondary cases and 34 weeks for the 13 culture-confirmed secondary 
cases. The factors that contributed to infection are summarised in Table 
7.2. In 10 index cases, mostly elderly patients with comorbidity, TB was 
initially not suspected and, thus, adequate isolation was delayed. This 
diagnostic delay was the main cause of patient-to-HCW transmission, 
while in some circumstances inadequate isolation measures contributed to 
infection. 
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Figure 7.1. Interval between contact and diagnosis of 19 tuberculosis 
(TB) cases among healthcare workers. Pulmonary TB was diagnosed after 
10, 12, 18, 23, 29, 31, 32, 75, 78 weeks and 4 yrs (last case not shown). 
In six cases, TB was confirmed by a positive culture. Pleural TB was 
diagnosed after 17, 23, 24, 26, 31, 32, 33, 45, 65, 85 weeks and 9 yrs 
(last case not shown). In seven of these cases, TB was confirmed by a 
positive culture. Two cases (pleural TB and TB of the skin) had an 
undetermined interval due to a long delay in diagnosis of the index patient 
(both infected by the same source case). 
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Table 7.2. Underlying factors for patient-to-healthcare worker (HCW) 
transmission of tuberculosis (TB). 
 
 HCW with TB 
 
Failure to identify and isolate index case 
   For some days after admission 
   For 3 weeks 
   During out-patient consultation 
   During irrigation of an abscess at home for several months 
 
 
4 
4# 
3 
1 
Total delay in diagnosis 12 
 
Inadequate infection-control 
   Surgical masks used during isolation period  
   Adequate protective masks used, but not all the time  
 
 
3 
2 
Total Inadequate infection-control practices 5 
High-risk procedures¶ 2 
No underlying factors identified 2 
Incomplete information of the index patient† 2 
 
Data are presented as n.  
#: One 80-yr-old index patient, with chronic obstructive pulmonary disease, was 
diagnosed with smear-positive pulmonary TB 2 months after a previous hospital 
admission of 3 weeks and caused three secondary cases among HCWs: two among other 
elderly hospitalised patients (one died) and one in a visitor. The four bacteriologically 
confirmed cases had identical DNA fingerprints as the index case.  
¶: i.e. bronchoscopies.  
†: one HCW developed pleural TB 15 months after being diagnosed and treated for a 
latent TB infection (LTBI) after exposure in a hospital. The other HCW had pleural TB with 
a unique fingerprint. She was treated for LTBI 9 yrs previously after exposure to a highly 
infectious case, before DNA fingerprinting was carried out in the Netherlands. This case 
was included in the study population because no other risk factors were identified. 
 
Screening for TB or latent TB infection. Eight HCWs were diagnosed with 
TB in a contact investigation or pre-employment screening. Three HCWs 
developed TB despite treatment for latent TB infection (LTBI) with 6 
months isoniazid (one was diagnosed later in a pre-employment 
screening). In three HCWs, LTBI was missed due to a false-negative TST. 
Results are shown in Table 7.3.  
Seven HCWs with TB were not enrolled in a contact investigation or 
periodical screening. Two of them should have been included in a 
periodical screening, both employed at a pulmonology ward. Another two 
should have been included in a contact investigation, but in one situation 
the index patient refused to mention contacts with health professionals. In 
the remaining three cases, contact investigation or periodical screening for 
TB was not indicated and the link with the index patient was only 
determined by matching DNA fingerprints retrospectively. 
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Table 7.3. Enrolment of healthcare workers (HCWs) with tuberculosis 
(TB) in active case finding activities. 
 
In a contact investigation (n=10) 
   TB diagnosed six times 
   LTBI missed twice, TST false negative# 
   Two HCWs developed TB despite treatment with 6 months isoniazid for 
        a latent TB infection.  
In a pre-employment screening (n=2) 
   TB diagnosed twice¶ 
In periodical screening (n=4) 
   LTBI missed once, TST false negative#  
   Two HCWs were infected and developed TB within the screening 
        interval 
   One BCG-vaccinated HCW was screened by periodical chest 
        radiography, no TB found 
Not enrolled in a contact investigation or periodical screening 
(n=7)  
 
LTBI: latent TB infection; TST: tuberculin skin test; BCG: bacille Calmette–Guérin.  
#: two HCWs had a negative TST in a contact investigation and one in a periodical 
screening, but later developed pleural TB with the same strain as the presumed index 
cases. Retrospectively, TSTs were false negative 7, 8 and 10 weeks after contact with the 
index patient, while they were 10 mm, 19 mm and ‘‘strongly positive’’ at the time of 
diagnosis, 31, 32 and 24 weeks after infection.  
¶: One was diagnosed with LTBI before contact investigation at work. The HCW 
completed 6 months isoniazid preventive treatment, but had chest radiography 
abnormalities 4 yrs later at pre-employment screening. TB was confirmed by a positive 
culture of material obtained by video-assisted thoracoscopy and the restriction fragment 
length polymorphism pattern matched with the index patient.  
 
 
Discussion 
 
In the present study, a case series of HCWs with TB, information from a 
comprehensive national DNA fingerprinting database and detailed 
epidemiological information from TB departments was used to distinguish 
nosocomial and non-nosocomial routes of transmission. In 67 out of 101 
(66%) HCWs with TB, the route of infection could be determined. Among 
them, 28 out of 67 (42%) were infected during work in the Netherlands, 
19 (28%) were community acquired and 20 (30%) were infected abroad. 
In 34% of cases, the route of transmission could not be determined, 
mainly due to lack of bacteriological confirmation. 
The TB incidence rate for hospital-employed HCWs with patient 
contacts (7.9 per 100,000) was approximately two times higher than the 
incidence rate for Dutch citizens during the study period (average 4.4 per 
100,000), but still lower than the rates for all citizens in the Netherlands 
(average 9.8 per 100,000 with immigrants accounting for >50% of all 
cases) (10). The present authors also calculated the relative risk for 
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healthcare work in the Netherlands by classifying cases into categories. 
The RR of 2.47 compares with findings in England and Wales where TB 
rates in HCWs were two to three times higher than those in similar 
occupational groups (14). The fact that in one third of cases the route of 
transmission could not be determined (category four) probably does not 
influence the distribution of cases among the three categories and the RR 
in a significant manner. 
Only 20% of all HCWs with TB were foreign born. This differs from 
studies in low-incidence countries with high percentages of foreign-born 
HCWs with TB (14-17). Almost all HCWs with work-related TB in the 
present study developed early manifestations of TB, such as primary 
pulmonary TB, pleural TB or TB of the skin. Although active-case finding 
activities such as pre-employment screening and contact investigation 
detect TB in an early stage, often without bacteriological confirmation, the 
current authors also found a relatively short interval between infection 
and disease for HCWs who presented with symptoms. In these cases, 
awareness of the HCW and a high suspicion of the physician might have 
limited diagnostic delay, as has been observed elsewhere (14), although 
in one other study the health-seeking behaviour was similar for HCWs and 
controls (17). 
The reported TB cases among HCWs are the tip of the iceberg of 
nosocomial transmission of M. tuberculosis bacteria. After all, only 10% of 
TB infections will eventually lead to active TB (18), so many more 
infections have occurred. Furthermore, through pre-employment 
screening, contact investigation and periodical screening of HCWs, a 
number of latent TB infections are identified (250 annually in the 
Netherlands) and treated in the majority of cases (10). However, as the 
present data show, a significant proportion of these infections have been 
acquired outside the hospital, as has been observed in other studies (19-
21). Furthermore, other patients (and visitors) might be at even greater 
risk if TB is not suspected and diagnosis is delayed. This is well illustrated 
by the transmission of M. tuberculosis from one index case to three HCWs, 
two other hospitalised patients and one visitor. 
Early recognition of TB and adequate isolation of cases remain the 
most important interventions to prevent transmission (2, 8, 22, 23). In 
the current study, diagnostic delay was the main cause of patient-to-HCW 
transmission in 50% of the cases, often in an elderly Dutch patient with 
comorbidity. The association between initially missed diagnosis and older 
age has been described by others (23). Greater experience in TB manage-
ment, with increased TB suspicion and compliance with diagnostic 
algorithms, has the potential to reduce diagnostic delay and nosocomial 
transmission (23). In some cases in the present study, failure to apply 
with infection-control procedures, such as the use of appropriate masks, 
contributed to infection. Hospital infection-control measures are relevant 
to prevent transmission of TB to healthcare workers (18, 23, 24). 
Although the study design did not allow for a standardised assessment of 
ventilation during the study period, the relevance of airflow is also well 
known (21). Four cases in the current study were infected during high-risk 
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procedures, i.e. two HCWs while assisting with bronchoscopies, one 
laboratory attendant due to a needle stick injury and one HCW during 
irrigation of a TB abscess (syringing). The occupational risk of these 
procedures, as well as autopsies, has previously been described in case 
reports and reviews (2, 8, 23, 25-27). Adequate personal protection 
measures should be taken during these procedures. 
In spite of adequate infection-control measures, transmission of TB 
might still occur in healthcare institutions, and early diagnosis of latent TB 
infection or active TB in HCWs is needed in high-risk settings. In the 
present study, 70% of cases (16 out of 23) had been examined at least 
once because of high-risk activities or unprotected exposure to a patient 
at work. The reasons for not detecting and/or effectively treating LTBI 
were related to the inability of screening procedures to identify infections, 
the limitations of the TST and failure of (unsupervised) preventive 
treatment. However, the current study focused on a relatively limited 
number of HCWs in which infection-control measures failed. It needs to be 
emphasised that a much greater number of infected HCWs have benefited 
from screening and preventive treatment. 
In conclusion, DNA fingerprint surveillance can be used to confirm 
expected and reveal unexpected cases of nosocomial transmission, thus 
providing the necessary evidence for policy makers and professionals to 
take appropriate action. High suspicion of tuberculosis by the clinician, 
adequate infection-control measures by the hospital authorities and early 
identification of latent tuberculosis infection in healthcare workers by 
occupational specialists form the essential components of a 
comprehensive package to prevent tuberculosis in healthcare workers. 
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General discussion 
 
 
Chapter 8 
This chapter provides answers to the three research questions posed in 
this thesis (section 8.1), discusses implications for future TB control in the 
Netherlands (section 8.2), and lists the main conclusions and 
recommendations (section 8.3). 
 
 
8.1 Answer the research questions 
 
8.1.1 Question 1: What has been the added value of DNA 
fingerprinting for TB control in a metropolitan area? 
 
DNA fingerprinting confirmed outbreaks in the Rotterdam metropolitan 
area and was indispensable to develop and evaluate interventions for 
high-risk groups. Genotyping also supported decisions for extending 
contact investigations in circumstances with confirmed transmission, and 
contributed to surveillance of tuberculosis in the metropolitan area. 
 
DNA fingerprinting and contact investigation. In our cluster analysis study 
(Ch.3), several transmission sites, such as a pub, a vocational training 
school and a children’s ward of a hospital, were identified by genotyping. 
Matching DNA fingerprints of epidemiologically linked cases revealed or 
confirmed transmission at those places and as a consequence, contact 
investigations were extended to large numbers of contacts yielding 
secondary TB and LTBI cases. Thus, genotyping helped to decide upon 
and justify large scale contact investigations. The majority of the clustered 
TB cases in this study however were not identified through contact 
tracing. Other studies in low-incidence areas also reported that only 5-
10% of clustered cases were identified by conventional contact investi-
gation and called for improved strategies of active case finding targeted to 
specific populations (1-6). The difficulties to conduct contact tracing in 
pubs and treat latently infected contacts are discussed below.  
 In our study of a contact investigation around a homeless, drug-
addicted man (Ch.5) all six secondary TB cases were not molecularly 
linked to the index case and thus genotyping confirmed that illicit drug 
users and homeless persons in the Rotterdam metropolitan area were at 
high risk for TB. Other molecular epidemiological studies also showed that 
sometimes cases identified by contact investigation have unrelated strains 
(7-10). In one large study 29% of TB cases discovered by contact 
investigation had non-matching fingerprints (11). 
TB cases represent only the tip of the iceberg of transmission, since 
most M. tuberculosis infected cases never develop TB. The true amount of 
transmission can only be shown if culture negative TB and LTBI cases are 
included in research as we described in the cluster analysis study (Ch.3). 
Studies using only genotyping data exclude such cases and may thus 
underestimate the true extent of an outbreak and the value of active case 
finding. Thus, the effectiveness of contact tracing can only be established 
by combining conventional epidemiological investigation and molecular 
typing, including all TB and LTBI cases identified by contact investigation. 
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DNA fingerprinting and outbreak management. Outbreak management 
starts if a large number of cases are involved in recent chains of 
transmission or when disease is concentrated in certain risk groups. 
Typically, TB outbreaks have cases with identical M. tuberculosis isolates. 
Thus, cluster growth and cluster size are important indicators to monitor 
the occurrence and development of outbreaks. We described a cluster of 
150 national cases (Ch.6) with more than 80% residing in our study area 
and with a high proportion of cases using illicit drugs or being homeless. 
Knowledge of transmission within these communities was indispensable 
for successfully applying for funds to reinstitute a TB screening pro-
gramme among these risk group. Cluster investigations revealed intensive 
TB transmission in pubs in a number of our studies (Ch. 3 and Ch. 6), but 
interventions to control transmission and investigate contacts were very 
disappointing, as observed by others (12-14). 
TB epidemics can also consist of different M. tuberculosis strains 
among risk groups as we described among illicit drug users and homeless 
persons (Ch.5). In a 13-year observation period, 55 different fingerprints 
were recovered from isolates of cases of these risk groups in Rotterdam, 
with four dominant strains (Ch.6). Thus, DNA fingerprinting highlighted 
the potential threat of new outbreaks, because new strains were 
introduced and circulated among these risk groups regularly and 
supported our conclusion that screening should be continued also in non-
outbreak conditions. 
 
DNA fingerprinting and surveillance. A standardised way of classifying TB 
into recently, remotely and foreign-acquired disease provides indicators 
for surveillance and programme performance that can be used to prioritise 
interventions and allocate resources (Ch.2). TB control programmes with 
predominately recent transmission may focus on a package of targeted 
active case finding activities, while those with a high proportion of 
imported strains should consider screening activities for TB and LTBI in 
immigrants, and those with mainly reactivated cases can monitor the 
gradual decline of TB or step-up interventions to eliminate TB.  
DNA fingerprinting can help to estimate the number and timing of 
future cases in a cluster and also in a given area (1, 2, 15). In our cluster 
analysis study (Ch.3), we showed that TB developed within one year of 
infection in about 50% of cases and between one to five years in the other 
50%, which agrees with previous estimates of disease development (16). 
Although more research is needed into the prediction of future cases, it is 
clear that the chance that related cases develop depends on the number 
and time interval of secondary cases with a pulmonary source case.  
 
DNA fingerprinting and evaluation of programmes. In our health care 
worker (HCW) study (Ch.7), we looked at the role of active case finding to 
identify cases. We observed few missed opportunities to diagnose LTBI 
and TB in Dutch HCWs. Delayed diagnosis of the index cases, especially in 
the elderly patient, was the main cause of patient-to-HCW transmission. 
In some circumstances, inadequate infection-control measures contributed 
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to transmission and subsequently disease development. The majority of 
TB cases (70%) had been examined at least once because of high-risk 
activities or unprotected exposure to a patient and TB was actually 
diagnosed in half of these cases. Screening procedures and efficacy of 
preventive treatment limited case finding in some other cases.  
We used molecular typing to assess the impact of a screening 
programme on TB transmission among illicit drug users and homeless 
persons (Ch.6). The study showed that screening with mobile radiographic 
X-ray units decreased the annual number of notified TB cases following an 
outbreak. Screening reduced transmission because the proportion of cases 
with prevalent strains declined significantly from 82% to 45% in four 
years. Few studies have used genotyping as an evaluation instrument, 
probably because it requires universal genotyping for a prolonged period 
of time. 
 
 
8.1.2 Question 2: What are the causes of the high TB incidence in 
a metropolitan area, as revealed by DNA fingerprinting? 
 
DNA fingerprinting showed that the high TB incidence in the Rotterdam 
metropolitan area was related to the high proportion of immigrants, and 
was caused by recent transmission in both the immigrant and 
nonimmigrant population. Illicit drug users and homeless persons were 
particularly at risk of recently acquired TB. 
 
In the metropolitan study (Ch.4), the TB case rate in three highly 
urbanised municipalities (Rotterdam, Schiedam and Vlaardingen) was 3.8 
times higher than in surrounding municipalities. The rate ratios were lower 
after stratification for country of birth, i.e. 1.7 for immigrants and 2.8 for 
nonimmigrants. The reason for these lower incidences is the higher 
proportion of immigrants in highly urbanised areas; immigrants formed 
23% of the population in the three urban municipalities and 8% in the 
surrounding areas. These immigrants are mainly from high-endemic 
countries and more frequently latently infected, that may reactivate many 
years after entering the Netherlands (17). 
Recent transmission caused 40% of the case rate in the urban and 
28% in surrounding municipalities, translating into a 5.5 times higher 
recent transmission case rate in the urban population. Illicit drug users 
and homeless persons were particularly affected by recent transmission, 
and in fact a number of strains caused the outbreak among these risk 
groups in Rotterdam, as described in Ch.5 and 6. Recent transmission was 
also more common among the urban immigrant and nonimmigrant 
population not using illicit drugs or being homeless. Thus, ongoing 
transmission contributed substantially to the high TB incidence in the 
urban municipalities. 
In the metropolitan study, we also noticed a higher TB rate of 
foreign-acquired disease among the nonimmigrant urban population. 
Different risk and behavioural patterns such as frequent visits of second 
134
General Discussion 
generation immigrants to their parents’ native countries and international 
travel of young urban persons may explain this unexpected finding. The 
contribution of foreign-acquired disease among nonimmigrants to the 
overall caseload in urban municipalities was however small. 
In our studies, we identified a number of relevant locations for TB 
transmission in urban areas. First of all, transmission in homeless shelters 
and safe drug consumption rooms probably caused the high TB incidence 
among illicit drug users and homeless persons. Secondly, a number of our 
studies pointed at pubs as sites of TB transmission; several of the 
molecular clusters expanded due to pub-related outbreaks (18). 
Furthermore, the identification, investigation and treatment of infected 
contacts were limited. The social and behavioural problems in large cities 
in well-developed countries are very similar, as is the picture of these 
cities’ epidemiological features of TB as shown by DNA fingerprinting. 
 
 
8.1.3 Question 3: What do our studies add to the knowledge of TB 
transmission? 
 
A standardised use of both molecular and conventional epidemiological 
information improves place and time determination of transmission and 
the identification of persons and people at risk for tuberculosis.  
 
Place and time. We developed and applied a transmission classification 
model to determine whether TB cases were infected in a foreign country, 
or recently (≤ 2 years) or remotely (> 2 years) infected in the 
Netherlands. Molecular typing studies rarely distinguished foreign-
acquired disease from TB resulting from transmission within the country of 
residence (19, 20). In our transmission classification study (Ch.2), one-
third (38%) of all cases acquired infection in a foreign country. For 
immigrant TB cases in urban and suburban municipalities (Ch.4), these 
proportions were respectively 47% and 62%. Thus, transmission in a 
foreign country accounted for a substantial proportion of TB in our study 
area, which is beyond direct control of a local TB programme. 
Our studies highlighted that homeless shelters, safe drug 
consumption rooms and bars were places for TB transmission in the 
Netherlands, as has been reported by others (13, 21-25). The poor 
ventilation of these settings, the crowding of people and delayed diagnosis 
of infectious cases facilitate the spread of M. tuberculosis bacteria in these 
institutions.  
Genotyping more accurately ascertained time of infection for 
epidemiologically linked TB cases. In fact, for some of the HCWs (Ch.7) 
the actual date of nosocomial transmission could be determined because 
they had contact with their source case only once, e.g. during 
bronchoscopy. In the HCWs study, 71% of cases developed disease within 
one year. Another estimate of timing of infection was obtained in our 
transmission classification study (Ch.2), in which 76% of epidemiologically 
linked clustered cases developed disease within two years of infection. In 
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both studies however, cases with a remote infection probably have less 
chance to be epidemiologically linked due to patient recall bias. In the 
HCWs study earlier identification of disease may also limit generalisation 
of results. The best estimate of disease development was obtained in our 
cluster analysis study (Ch.3) which allowed us to draw a curve of 
secondary cases. In this study, TB developed within one year of infection 
in 52%, within two years in 71%, and between two to five years in 29% of 
patients, which more or less agreed with a previous estimate that 60% of 
infected cases developed disease within one year, 85% within two years, 
and 15% within two to five years (16). 
 
Person (risk factors and risk groups). In the metropolitan study (Ch.4), 
immigrants were identified at high risk for TB both due to reactivation of 
foreign-acquired infection and recent transmission in the Netherlands. 
Urban immigrants had a 2.6 times higher recent transmission case rate 
than suburban immigrants, and 6.1 times higher than urban nonimmi-
grants. Possible explanations are the higher risk of exposure to infectious 
TB in urban areas, limitations of contact tracing procedures, poor housing 
conditions and delays in diagnosis. DNA fingerprinting and epidemiological 
investigation of an illustrative cluster (Ch.3) proved that these foreign-
born clustered cases were infected in the Netherlands and not in their 
native countries, as might have been assumed. Cluster analysis showed 
that one single infectious TB case, a foreigner visiting the Netherlands, 
caused an extensive outbreak. Patient delay seeking medical attention and 
delay by the health system to diagnose infectious TB facilitated trans-
mission and resulted in several secondary cases. The effective spread of 
M. tuberculosis by a single infectious case, so-called supertransmitters or 
superspreaders, was reported elsewhere (3, 8, 26-29).  
Some of our studies drew attention to other well-known risk factors 
for TB, such as homeless persons, illicit drug users and alcoholics (3, 13, 
21, 30, 31). DNA fingerprinting showed that several M. tuberculosis 
strains were circulating among illicit drug users and homeless persons and 
were responsible for the high TB caseload among persons of these risk 
groups. Extensive pub-related transmission contributed to the growth of 
nearly all large clusters in our study area (Ch.3) (18). Recently, we 
described another TB outbreak in urban pubs that caused unprecedented 
high case rates among a specific ethnic population (26).  
Molecular typing has been used to determine whether recurrent TB 
was caused by a new strain (reinfection) or by the same strain (relapse) 
(32-36). In one of our studies we analysed a subset of 18 recurrent cases 
with two culture-confirmed episodes (Ch.2). Five cases (28%) had two 
different fingerprints and eleven (72%) identical fingerprints. Six recurrent 
cases with identical fingerprint shared epidemiological characteristics with 
one or more pulmonary TB cases that were added to the cluster since the 
first episode. This study suggested that reinfection with the same strain 
(ping-pong transmission) should be considered in recurrent cases if they 
are at high-risk for TB. 
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HIV-infected persons are at increased risk for TB. In Rotterdam, 
illicit drug users and homeless persons with TB were more often 
coinfected with HIV (15%) than cases without these risk factors (4%) 
(Ch.4). Genotyping results of the M. tuberculosis isolates were not 
assessed in this study, but clustering rates were higher in HIV-infected 
cases with the risk profile (62%; 18 of 29) than for HIV-infected cases 
without the risk profile (38%; 25 of 65). These differences were 
statistically significant (p=0.03) and further support the finding that 
ongoing transmission contributed to the high TB incidence among illicit 
drug users and homeless persons. 
Drug resistance is an emerging public health threat in the world. In 
our studies, transmission of drug resistant strains was not a subject of 
research, although an outbreak of MDR cases occurred during the study 
period (37). The clustering rate of resistant strains in the transmission 
classification study (50%; 66 of 131 cases) was lower than that of fully 
sensitive strains (55%; 1042 of 1895). Although the difference did not 
reach statistical significance (p=0.3), it is in concordance with the 
observation of Van Soolingen et al. that drug resistant strains generate 
less secondary cases than fully sensitive strains (31).  
In infectious disease outbreak management, it is relevant to know 
which secondary cases are caused by an index patient and present this 
graphically in a time line to detect epidemics, plan interventions and 
evaluate these efforts. Universal genotyping offers opportunities to 
visualise cases in a cluster diagram, which helps to find transmission 
locations and similarities and links between patients. It also assists 
monitoring an outbreak and estimating the number and timing of future 
cases. 
 
 
8.2 Implications for future TB control in the Netherlands 
 
DNA fingerprinting has tremendously improved our understanding of TB 
transmission (38), but as for any new technical achievement translation 
into real improvements remains a major challenge (39). Campbell et al. 
described the process and elements of using data for decision-making in 
health (40, 41). Some of the critical components are a sense of ownership 
and tools for self-assessment that help to identify achievements, 
constraints and possible actions. The tools and capacity to optimise the 
use of DNA fingerprinting for TB control in the Netherlands are not yet 
fully developed, especially not at local level, and need attention. Based on 
our experience and research, and in accordance with the guide on the 
application of genotyping issued by the the Center of Disease Control and 
Prevention in the United States (42), I suggest to prioritise cluster 
investigations, i.e. an investigation to identify epidemiological links 
between TB patients with matching fingerprints, as outlined in Table 8.1 
(18).  
137
Chapter 8 
 Table 8.1. Prioritising cluster investigation (11, 18, 42). 
 
High priority:  
• clusters with high-risk patients with a possible epidemiological link, e.g. 
institutionalised patients (prisons, asylum seekers centres, homeless 
shelters, hospitals), immunocompromised patients ( HIV-coinfection), 
or patients with (multi)drugresistant strains. 
• Fast-growing clusters, e.g. with three or more patients in a year. 
• Large clusters, e.g. with more than 10 patients, that continue to 
expand. 
 
Low priority: 
• last preceding pulmonary TB occurred more than two years previously. 
• patient did not reside in the Netherlands with another pulmonary TB 
case in the cluster. 
• fingerprint confirmed an expected epidemiological link. 
 
 
In the Netherlands, results from DNA fingerprinting and cluster 
investigation are best discussed in the recently developed TB control 
regions. TB specialists in these areas are knowledgeable of cases, risk 
groups and the epidemiological situation. They also know the local political 
situation and managerial possibilities. The studies in this thesis 
demonstrate such use of data for planning local TB control activities. 
Areas with high numbers and a high proportion of recent transmission 
benefit particularly from genotyping, and these are usually found in urban 
areas. We concur with Diel et al. that DNA fingerprinting should become 
an integral component of surveillance strategies aimed at TB control in 
metropolitan areas (1). 
Metropolitan TB control should focus on a package of interventions 
addressing the different causes of the high TB incidence in large cities 
(43). In our metropolitan study we distinguished two main pathways, i.e. 
reactivation of foreign-acquired infections, predominantly among 
immigrants, and ongoing transmission among risk groups and the general 
urban population. Entry screening of immigrants for TB and LTBI are 
important interventions to identify disease early and prevent transmission 
in a country. In principal these interventions do not differ in urban and 
non-urban areas, although the number of immigrants varies. 
Interventions aimed at reducing ongoing transmission are more complex 
and should be tailored e.g. to the metropolitan setting. Radiographic 
screening can be very useful to identify asymptomatic cases in hard-to-
reach, marginalised urban risk groups, such as illicit drug users and 
homeless persons. Case holding activities are key in TB control, and 
directly observed therapy is elementary to complete treatment in groups 
of TB patients that are more prevalent in urban areas. Treatment 
supervision is also necessary to prevent development of resistant strains. 
Contact tracing efforts in urban areas will benefit from interferon-gamma 
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release assays to correctly identify latent infections among BCG-
vaccinated contacts and offer opportunities for preventive treatment. 
Education targeted at health care providers in cities, and social workers 
involved with urban risk groups may reduce diagnostic delay and diminish 
transmission. Low-threshold services, such as public health TB clinics, are 
needed for marginalized and often uninsured persons. Lastly, genotyping 
can contribute to identify high-risk areas within metropolitan areas and 
offer opportunities for location-based TB screening (44). 
The Netherlands has no system for the systematic exchange of data 
and sharing experience between TB control departments. Some 
developing countries have excellent examples of the use of health 
management information systems (40, 41) that can be beneficial for TB 
control. Data of DNA fingerprinting and its use for action planning provide 
a good opportunity to conduct for instance routine peer performance 
meetings of the seven regions in the Netherlands or among Western 
European cities. 
Another challenge is to use DNA fingerprinting for predicting future 
cases in an area (15). As a rule of thumb I applied the principle that – 
without ongoing transmission – a cluster will grow in the second year by 
50%, in the third year by 25%, in the fourth year by 12.5% and in the 
fifth year by 6.3% of cases diagnosed in the first year (18). This is an area 
for further research that can help programme development in the 
elimination phase of TB. 
Our metropolitan study showed that even among the urban 
population the majority of TB cases were infected in a foreign, often high-
endemic country. Although screening can identify TB and LTBI cases early, 
the long term perspective should emphasise controlling TB in these high-
endemic countries. This has become even more urgent with the event of 
MDR-TB and XDR-TB. 
139
Chapter 8 
8.3 Conclusions and recommendations 
 
Conclusions 
• The added value of DNA fingerprinting for TB control in the Rotterdam 
metropolitan area has been its use for identifying and confirming 
outbreaks, and developing and evaluating interventions for high-risk 
groups.  
• DNA fingerprinting also supported decisions for extending contact 
investigations in circumstances with confirmed transmission, and 
contributed to surveillance of tuberculosis in the metropolitan area.  
• The high TB incidence in the Rotterdam metropolitan area was related 
to the high proportion of immigrants, and was caused by recent 
transmission. Illicit drug users and homeless persons were particularly 
at risk. 
• DNA fingerprinting confirmed reduced TB transmission among illicit 
drug users and homeless persons after four years of screening. 
• A standardised use of both molecular and conventional epidemiological 
information improves place and time determination of transmission and 
the identification of groups of persons at risk for tuberculosis.  
• DNA fingerprinting enables the classification of cases as recently or 
remotely infected within a country, or infected in a foreign country. The 
number and distribution of these classified cases is relevant for 
programme performance and planning action.  
• DNA fingerprinting assists to monitor an outbreak and estimate the 
number and timing of future cases, in particular in high-transmission 
settings such as metropolitan areas. 
 
Recommendations 
• Metropolitan TB control should include a package of targeted 
interventions of active case finding and case holding activities,  focused 
on immigrants and hard-to-reach, marginalised urban risk groups, such 
as illicit drug users and homeless persons. 
• Universal genotyping in the Netherlands should be continued to support 
TB outbreak investigation, surveillance and programme evaluation. 
• Cluster investigation should be prioritised to cases with unknown 
epidemiological links and to possible recently infected cases.  
• The tools and capacity to optimise the use of DNA fingerprinting for 
local and regional TB control in the Netherlands needs to be further 
developed and strengthened. 
• Regional performance meetings should be conducted to share data and 
exchange experience to further enhance the use of DNA fingerprinting 
for TB control in the Netherlands.  
• A European network should be established to facilitate the exchange of 
experience between metropolitan TB control programmes. 
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Summary 
Summary 
 
This thesis addresses the question what has been the use of DNA 
fingerprinting for tuberculosis control in a metropolitan area.  
 
Chapter 1 contains an outline of tuberculosis (TB), DNA fingerprinting 
methods and the molecular epidemiology of TB. Although TB is still highly 
endemic in many less-developed countries, incidence declined in the 
Netherlands to the lowest ever recorded in 2006 with 6.2 cases per 
100,000 population. Urban case rates however are several times higher 
than the national average, not only in the Netherlands but also in other 
low-endemic countries. DNA fingerprinting has been very useful for a 
better understanding of TB transmission. Molecular studies have con-
firmed outbreaks, identified risk factors for recent transmission, revealed 
the importance of reinfection in recurrent TB and pointed at the occur-
rence of laboratory cross contamination. In the Netherlands, DNA 
fingerprinting methods have been used since 1993 to distinguish 
Mycobacterium tuberculosis strains. This chapter ends with the three 
research questions posed in this thesis: 1) What has been the added value 
of DNA fingerprinting for TB control in a metropolitan area; 2) What are 
the causes of the high TB incidence as shown by DNA fingerprinting in a 
metropolitan area, and 3) What do our studies add to the knowledge of TB 
transmission? 
Chapter 2 describes a transmission classification model to 
determine place and time of infection of all culture-positive and culture-
negative TB cases in the Rotterdam metropolitan area. Cases were divided 
into those with a unique mycobacterial DNA fingerprint, a clustering 
fingerprint and with an unknown fingerprint. Classification trees for each 
category determined whether cases were infected in a foreign country, or 
recently (≤ 2 years) or remotely (> 2 years) infected in the Netherlands. 
During the 12-year study period, 38% of all TB cases were infected in a 
foreign country, 36% resulted from recent transmission in the Netherlands 
and 18% from remote infections in the Netherlands, while for the 
remaining cases (9%) either time or place of infection could not be 
determined. Conventional epidemiological data suggested that at least 
29% of clustered cases were not part of recent chains of transmission. 
Our findings highlighted that genotyping should be combined with 
conventional epidemiological investigation to establish place and time of 
infection of TB cases as accurately as possible.  
Chapter 3 presents an illustrative cluster demonstrating the use of 
genotyping in metropolitan TB control. Of 21 secondary cases related to 
the index case, 52% developed TB within one year, 19% within one to two 
years and 29% within two to five years. Cluster analysis underscored 
relevant issues for TB control in a metropolitan setting, such as the early 
recognition of an outbreak, the importance of reinfections, the 
consequences of delayed diagnosis, the contribution of pub-related trans-
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mission and the value of DNA fingerprinting for decisions upon extension 
of contact investigations. Visualising cases in a cluster diagram was 
particularly useful in finding transmission locations and the similarities and 
links between patients. 
Chapter 4 addresses the high TB case rate in the Rotterdam 
metropolitan area. Characteristics of patients and mycobacteria in three 
highly urbanised municipalities were compared with those of surrounding 
less-urbanised municipalities. The TB case rate in the highly urbanised 
municipalities was 3.8 times higher than in the surrounding municipalities. 
After stratification for country of birth, case rates were 1.7 times higher 
for immigrants and 2.8 times higher for nonimmigrants. Recent trans-
mission caused 40% of the total urban TB case rate and was 5.5 times 
higher than the rate in surrounding municipalities. Illicit drug users and 
homeless persons accounted for 10.3% of all urban TB cases. We 
concluded that the high urban TB case rate was related to the high 
proportion of immigrants in these cities, as well as recent transmission 
among urban immigrants and nonimmigrants. Illicit drug users and 
homeless persons in urban municipalities were particularly at risk for TB 
due to recent infection. 
Chapter 5 describes an extensive contact investigation among illicit 
drug users and homeless persons in Rotterdam. None of the six secondary 
TB cases in this investigation were molecularly linked to the index case. 
Genotyping revealed intense transmission by multiple sources. As a 
consequence, a mobile radiographic TB screening programme among illicit 
drug users and homeless persons was reintroduced. Chapter 6 evaluates 
the impact of the screening programme using DNA fingerprinting. In four 
years, the annual number of TB cases with these risk profiles decreased 
from 24 to 11 cases and the proportion of disease due to prevalent M. 
tuberculosis strains fell from more than 80% to 45%. We concluded that 
radiographic screening reduced transmission among illicit drug users and 
homeless persons. 
Chapter 7 describes the use of DNA fingerprinting to determine 
whether health care workers (HCWs) with TB were infected during their 
work in the Netherlands. In 67 (66%) out of 101 HCWs with TB, the place 
of infection could be determined. Among them, 42% was infected during 
work in the Netherlands, 28% had a community-acquired infection and 
30% was infected abroad. Delayed diagnosis, especially in the elderly 
patient, was the main cause of patient-to-HCW transmission. Inadequate 
control measures contributed in a number of circumstances to TB trans-
mission. We concluded that a high suspicion of TB by the clinician, 
adequate infection-control measures by hospital authorities and early 
identification of latent TB infection by occupational health specialists are 
essential to prevent TB among HCWs. 
The general discussion in Chapter 8 answers the research questions 
and describes the findings of the studies in this thesis. This chapter also 
describes the implications for future TB control in the Netherlands. Finally, 
the conclusions and recommendations that follow from the research in this 
thesis are formulated, and are described below. 
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Conclusions 
• The added value of DNA fingerprinting for TB control in the Rotterdam 
metropolitan area has been its use for identifying and confirming 
outbreaks, and developing and evaluating interventions for high-risk 
groups.  
• DNA fingerprinting also supported decisions for extending contact 
investigations in circumstances with confirmed transmission, and 
contributed to surveillance of tuberculosis in the metropolitan area.  
• The high TB incidence in the Rotterdam metropolitan area was related 
to the high proportion of immigrants, and was caused by recent 
transmission. Illicit drug users and homeless persons were particularly 
at risk. 
• DNA fingerprinting confirmed reduced TB transmission among illicit 
drug users and homeless persons after four years of screening. 
• A standardised use of both molecular and conventional epidemiological 
information improves place and time determination of transmission and 
the identification of groups of persons at risk for tuberculosis.  
• DNA fingerprinting enables the classification of cases as recently or 
remotely infected within a country, or infected in a foreign country. The 
number and distribution of these classified cases is relevant for 
programme performance and planning action.  
• DNA fingerprinting assists to monitor an outbreak and estimate the 
number and timing of future cases, in particular in high-transmission 
settings such as metropolitan areas. 
 
Recommendations 
• Metropolitan TB control should include a package of targeted 
interventions of active case finding and case holding activities,  focused 
on immigrants and hard-to-reach, marginalised urban risk groups, such 
as illicit drug users and homeless persons. 
• Universal genotyping in the Netherlands should be continued to support 
TB outbreak investigation, surveillance and programme evaluation. 
• Cluster investigation should be prioritised to cases with unknown 
epidemiological links and to possible recently infected cases.  
• The tools and capacity to optimise the use of DNA fingerprinting for 
local and regional TB control in the Netherlands needs to be further 
developed and strengthened. 
• Regional performance meetings should be conducted to share data and 
exchange experience to further enhance the use of DNA fingerprinting 
for TB control in the Netherlands.  
• A European network should be established to facilitate the exchange of 
experience between metropolitan TB control programmes. 
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Dit proefschrift richt zich op de vraag wat de rol van DNA fingerprinting is 
geweest voor de tuberculosebestrijding in een grootstedelijk gebied. 
 
Hoofdstuk 1 bevat een overzicht van de ziekte tuberculose, DNA 
fingerprinting methodes en de moleculaire epidemiologie van tuberculose. 
Hoewel tuberculose nog steeds hoogendemisch is in veel ontwikkelings-
landen, is de incidentie in Nederland in 2006 gedaald tot de laagste ooit 
geregistreerd met 6,2 gevallen per 100.000 inwoners. De stedelijke 
tuberculose-incidentie is echter vele malen hoger dan het landelijk 
gemiddelde, niet alleen in Nederland maar ook in andere laagendemische 
landen. DNA fingerprinting is zeer bruikbaar geweest om de transmissie 
van tuberculose beter te begrijpen. Moleculaire studies hebben 
tuberculose-uitbraken bevestigd, risicofactoren voor recente transmissie 
geïdentificeerd, het belang van re-infectie bij recidief tuberculose 
aangetoond en gewezen op het voorkomen van laboratorium kruis-
contaminatie. Sinds 1993 wordt in Nederland DNA fingerprinting 
toegepast om Mycobacterium tuberculosis stammen te onderscheiden. Dit 
hoofdstuk eindigt met de drie onderzoeksvragen die onderwerp zijn van 
het proefschrift: 1) Wat is de toegevoegde waarde geweest van DNA 
fingerprinting voor de tuberculosebestrijding in een grootstedelijk gebied; 
2) Wat laat DNA fingerprinting zien als de oorzaken van de hoge 
tuberculose-incidentie in een grootstedelijk gebied, en 3) Wat voegen 
onze onderzoeken toe aan de kennis van de transmissie van tuberculose. 
Hoofdstuk 2 beschrijft een transmissie-classificatie model voor de 
bepaling van plaats en tijdstip van infectie van alle kweekpositieve en 
kweeknegatieve tuberculosepatiënten in het grootstedelijk gebied rondom 
Rotterdam. Patiënten werden onderverdeeld in diegenen met een unieke 
mycobacteriële DNA fingerprint, een clusterende fingerprint en met een 
onbekende fingerprint. Voor elke categorie bepaalde een beslisboom of 
patiënten in het buitenland geïnfecteerd waren of recent (≤2 jaar) of lang 
geleden (>2 jaar) in Nederland waren geïnfecteerd. Tijdens een studie-
periode van 12 jaar was 38% van alle tuberculosepatiënten in het buiten-
land geïnfecteerd, 36% het gevolg van recente transmissie in Nederland 
en 18% lang geleden in Nederland geïnfecteerd, terwijl van de overige 
patiënten (9%) plaats of tijdstip van infectie niet bepaald kon worden. 
Traditionele epidemiologische gegevens suggereerde dat 29% van de 
clusterende patiënten niet recent geïnfecteerd was. Onze bevindingen 
benadrukken dat genotypering gecombineerd moet worden met conven-
tioneel epidemiologisch onderzoek om plaats en tijdstip van infectie van 
tuberculosepatiënten zo nauwkeurig mogelijk te bepalen. 
Hoofdstuk 3 beschrijft een cluster die het gebruik van genotypering 
in een grootstedelijk gebied illustreert. Van 21 secundaire tuberculose-
patiënten gerelateerd aan een index patiënt, ontwikkelde 52% de ziekte 
binnen een jaar, 19% tussen een en twee jaar en 29% tussen twee en vijf 
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jaar. Clusteranalyse onderstreepte relevante aandachtspunten voor de 
tuberculosebestrijding in een grootstedelijk gebied, zoals het tijdig 
onderkennen van een uitbraak, het belang van re-infecties, de gevolgen 
van vertraagde diagnostiek, de bijdrage van transmissie in cafés en de 
waarde van DNA fingerprinting voor de besluitvorming om contact-
onderzoeken uit te breiden. Visualisering met behulp van een cluster 
diagram was vooral nuttig voor het vinden van transmissielocaties en de 
overeenkomsten en verbanden tussen patiënten. 
Hoofdstuk 4 bespreekt de hoge tuberculose-incidentie in de 
Rotterdamse regio. Kenmerken van tuberculosepatiënten en myco-
bacteriën in drie grootstedelijke gemeenten werden vergeleken met die 
van omliggende minder-verstedelijkte gemeenten. De tuberculose-
incidentie in de grootstedelijke gemeenten was 3,8 keer hoger dan in de 
omliggende gemeenten. Na stratificatie voor geboorteland was de 
tuberculose-incidentie in de grootstedelijke gemeenten 1,7 keer hoger 
voor immigranten en 2,8 keer hoger voor niet-immigranten. Recente 
transmissie veroorzaakte 40% van de totale tuberculose-incidentie in de 
grootstedelijke gemeenten en was 5,5 keer hoger dan in de omliggende 
gemeenten. Harddruggebruikers en daklozen vertegenwoordigden 10,3% 
van alle grootstedelijke tuberculosepatiënten. Wij concludeerden dat de 
hoge tuberculose-incidentie in de grootstedelijke gemeenten gerelateerd 
was aan het hoge percentage immigranten in deze steden, alsmede aan 
recente transmissie zowel onder immigranten als niet-immigranten. In het 
bijzonder hadden harddruggebruikers en daklozen in de grootstedelijke 
gemeenten een verhoogd risico voor tuberculose als gevolg van recente 
transmissie. 
Hoofdstuk 5 beschrijft een uitgebreid contactonderzoek onder 
harddruggebruikers en daklozen in Rotterdam. Geen van de zes secun-
daire gevallen in dit contactonderzoek had een moleculaire link met de 
bronpatiënt. Genotypering liet intense transmissie door meerdere bronnen 
zien. Deze bevinding was onder andere aanleiding om een mobiel 
röntgenologisch tuberculose-screeningsprogramma voor harddrug-
gebruikers en daklozen opnieuw te introduceren. Hoofdstuk 6 evalueert 
dit screeningsprogramma met behulp van DNA fingerprinting. In 4 jaar 
daalde het aantal tuberculosepatiënten met dit risicoprofiel van 24 tot 11 
gevallen per jaar en verminderde het percentage patiënten met 
tuberculose veroorzaakt door een prevalente M. tuberculosis bacterie van 
80% naar 45%. We concludeerden dat röntgenologische screening de 
transmissie onder harddruggebruikers en daklozen verminderde.  
Hoofdstuk 7 beschrijft het gebruik van DNA fingerprinting om te 
bepalen of gezondheidswerkers met tuberculose tijdens hun werk in 
Nederland geïnfecteerd waren. Bij 67 van 101 (66%) gezondheidswerkers 
met tuberculose kon de plaats van infectie worden vastgesteld. Van deze 
was 42% geïnfecteerd tijdens werk in Nederland, 28% buiten het werk om 
geïnfecteerd en 30% in het buitenland. Vertraagde diagnostiek, vooral bij 
de oudere tuberculosepatiënt, was de belangrijkste oorzaak van 
transmissie van patiënt naar gezondheidswerker. Inadequate infectie-
preventiemaatregelen droeg in een aantal omstandigheden bij aan de 
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tuberculose transmissie. Wij concludeerden dat een sterke verdenking op 
tuberculose door de clinicus, adequate infectiepreventiemaatregelen door 
ziekenhuisautoriteiten en vroege opsporing van latente tuberculose-
infectie door ARBO-diensten nodig zijn om tuberculose bij gezond-
heidswerkers te voorkomen. 
De algemene discussie in Hoofdstuk 8 beantwoordt de 
onderzoeksvragen en beschrijft de bevindingen van de onderzoeken. Dit 
hoofdstuk beschrijft tevens mogelijkheden van gebruik van DNA 
fingerprinting voor de toekomstige tuberculosebestrijding in Nederland. 
Tot slot worden de conclusies en aanbevelingen voortkomend uit het 
onderzoek voor dit proefschrift geformuleerd, zoals hieronder nogmaals 
beschreven. 
 
 
Conclusies 
• DNA fingerprinting voor de tuberculosebestrijding in het grootstedelijk 
gebied van Rotterdam is van waarde geweest voor het herkennen en 
bevestigen van uitbraken en het ontwikkelen en evalueren van 
interventies voor risicogroepen. 
• DNA fingerprinting ondersteunde de besluitvorming om 
contactonderzoeken uit te breiden doordat  het transmissie bevestigde, 
en droeg verder bij aan de surveillance van tuberculose in het 
grootstedelijk gebied. 
• De hoge tuberculose-incidentie in Rotterdam was gerelateerd aan het 
hoge percentage immigranten, en werd tevens veroorzaakt door 
recente transmissie. Harddruggebruikers en daklozen hadden in het 
bijzonder een verhoogd risico. 
• DNA fingerprinting bevestigde een verminderde tuberculose transmissie 
onder harddruggebruikers en daklozen na vier jaar screening. 
• Gestandaardiseerd gebruik van zowel moleculaire en conventionele 
epidemiologisch informatie helpt bij de vaststelling van plaats en 
tijdstip van transmissie en bij de bepaling van groepen van personen 
die risico lopen op tuberculose. 
• DNA fingerprinting helpt bij de classificatie van patiënten die recent of 
lang geleden in Nederland of in het buitenland geïnfecteerd zijn. Het 
aantal en distributie van deze patiënten is van belang om 
bestrijdingsprogramma’s te evalueren en beleid te bepalen. 
• DNA fingerprinting helpt bij het monitoren van een uitbraak en kan 
bijdragen aan de voorspelling van aantal en tijdstip van toekomstige 
gevallen, in het bijzonder in settings met veel transmissie zoals in 
grootstedelijke gebieden. 
 
Aanbevelingen 
• De tuberculosebestrijding in grote steden dient een pakket van 
interventies te omvatten die bedoeld zijn om patiënten actief op te 
sporen en eenmaal vastgestelde patiënten adequaat uit te behandelen, 
en moet gericht zijn op immigranten en moeilijk-bereikbare, 
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gemarginaliseerde stedelijke risicogroepen, zoals harddruggebruikers 
en daklozen. 
• Universele genotypering in Nederland dient voortgezet te worden ter 
ondersteuning van tuberculose-uitbraakonderzoek, surveillance en 
programma-evaluatie. 
• Clusteronderzoek moet zich vooral richten op patiënten met nog 
onbekende epidemiologische verbanden en patiënten bij wie recente 
transmissie een mogelijkheid is.  
• De instrumenten en capaciteit om DNA fingerprinting optimaal te 
gebruiken voor de lokale en regionale tuberculosebestrijding in 
Nederland moet verder ontwikkeld en versterkt worden. 
• Regionale bijeenkomsten dienen georganiseerd te worden om data te 
vergelijken en ervaringen uit te wisselen waarbij de toepassing van 
DNA fingerprinting voor de tuberculosebestrijding in Nederland 
toeneemt. 
• Een Europees netwerk moet worden opgericht om de uitwisseling van 
ervaringen van grootstedelijke tuberculosebestrijdingprogramma’s te 
faciliteren. 
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Mijn interesse voor tuberculose dateert al uit mijn studietijd. Hoewel ik me 
niet kan herinneren een tuberculosepatiënt tegengekomen te zijn tijdens 
mijn coschappen, zag ik bestrijding van deze ziekte in de Nederlandse 
setting wel als een logisch vervolg op een tropencarrière. In de tropen 
groeide mijn overtuiging dat sommige ziekten, vaak met fatale gevolgen, 
simpel te voorkomen zijn waardoor mijn aandacht naar de preventieve 
aspecten van de gezondheidszorg verschoof. Daarbij had ik ook geleerd 
dat organisatie van een ziekenhuis, district of een programma van cruciaal 
belang is voor goede zorg. Tijdens het werk in de Rotterdamse GGD kwam 
daar geleidelijk het belang van onderzoek bij. In juni 2004, tijdens een 
werkbezoek aan de tuberculosebestrijders in St. Petersburg spoorde 
collega Rob van Hest mij aan om te gaan promoveren. Tijdens een 
vakantie aan de Corsicaanse kust heb ik daarover zitten brainstormen en 
ben de uitdaging met mezelf aangegaan. Het resultaat heeft zijn weerslag 
in dit proefschrift. In dit nawoord wil ik graag een aantal mensen 
bedanken die een belangrijke rol hebben gespeeld in mijn loopbaan en in 
het bijzonder tijdens mijn promotie. 
 Dik Habbema, mijn promotor, bedank ik voor de mogelijkheid om 
onder zijn supervisie dit promotieonderzoek te doen. Dik, ik herinner me 
ons eerste contact toen je me kritisch vroeg of een promotieonderzoek 
wel zou passen naast een fulltime baan als tuberculosearts en hoofd van 
een afdeling. Nou, dat leek mij niet zo’n probleem, want ik had natuurlijk 
ook nog vrije tijd en barstte van de energie. Er lag bovendien genoeg om 
uit te zoeken en op te schrijven. Dik, ik wil je graag bedanken voor de 
plezierige gesprekken en je waardevolle commentaar, de aanvullingen op 
de onderzoeksvragen en de structurering van het proefschrift. In het 
bijzonder mijn dank voor de laatste maanden toen je me keer op keer 
verzekerde dat de deadline van juli 2008 gehaald zou worden. Je had 
gelijk. 
 Jan Hendrik Richardus, mijn copromotor, bedank ik voor de 
intensieve en zeer prettige begeleiding. Jan Hendrik, jij hebt me bij mijn 
nekvel gepakt toen ik met de gedachte rondliep om te promoveren. Je 
vertelde me dat er maar één instituut was waar ik dat het beste kon doen 
en dat was bij de afdeling Maatschappelijke Gezondheidszorg van het 
Erasmus MC. En jij werd mijn copromotor. Tijdens onze constructieve 
gesprekken legde jij de lat elke keer wat hoger wat soms tot gepuf van 
mijn kant leidde, maar uiteindelijk steeds weer een beter resultaat 
opleverde. Het is volgens mij waar het om een promotiebegeleiding om 
gaat. Ik wil je ook graag bedanken voor de aandacht die jij gaf aan allerlei 
zaken die niet direct met mijn promotieonderzoek te maken hadden. 
Soms waren de gesprekken van coachende aard, waarbij ik je heb leren 
kennen als een zeer integer persoon. Je hebt me ook geïnspireerd om 
mijn oude foto’s van een lepra survey in Ghana weer eens uit de kast te 
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halen, waarbij onze gemeenschappelijke passie voor de bestrijding van 
mycobacteriële ziekten naar voren kwam.  
 Er zijn verschillende personen die mij op het tuberculose- en public 
health pad hebben gezet of daarop hebben gehouden. Ger Steenbergen, 
destijds verantwoordelijk voor het nationale tuberculose- en 
leprabestrijdingsprogramma in Zambia, inspireerde me tijdens de 
jaarlijkse ‘witte ronde’ op de tuberculoseafdeling van het missieziekenhuis 
waar ik toen werkzaam was. Dr. E.K. Sory, regionaal medisch directeur in 
Cape Coast, Ghana en Rien Gotink, medisch adviseur van UNICEF in 
Accra, Ghana waren van grote waarde voor mijn definitieve keuze voor de 
public health. Daniel Chandramohan, mijn mentor tijdens de MSc 
opleiding in Londen bestendigde deze keus voor de volksgezondheid. Toen 
ik eenmaal gekozen had voor een carrière in de Nederlandse 
tuberculosebestrijding was Sytze Keizer, tuberculosearts van de GGD 
Amsterdam mijn opleider. Sytze, ik heb je persoonlijke betrokkenheid bij 
mijn opleiding en loopbaan altijd heel erg gewaardeerd. Jaap Klein, 
longarts Medisch Spectrum Twente, Enschede was mijn opleider tijdens de 
klinische stage. Jaap, van jou mocht ik leren hoe je ook met patiënten en 
collega’s communiceert. 
 I like to thank the TB patients in Zambia, Ghana and the 
Netherlands for accepting me as their doctor and getting the opportunity 
to learn so many clinical and social aspects of the disease. Furthermore, I 
thank the staff of the two mission hospitals for their support during the 
years I worked in Africa.  
Tuberculosis physicians in the world form a pleasant international 
family. During my training, I had the opportunity to travel to Denver, USA 
and to be trained by Prof. Michael Iseman and his team. Mike, I still have 
the signed copy of your book, which is really the guide for tuberculosis 
doctors. I also had the opportunity to visit Departments of Tuberculosis 
Control in St. Petersburg, San Francisco, Shanghai and Cape town. It is 
great to share knowledge and experience and learn from each other. 
Masae Kawamura thanks for the opportunity to visit you during my 
holidays and for the genotyping guide which you took from your cupboard 
and gave it to me. Our discussions on urban tuberculosis control were 
very inspiring and one of your quotes is included in my thesis. 
Dick van Soolingen en de medewerkers van het Nationale 
Mycobacteriën Referentie Laboratorium van het Rijksinstituut voor Volks-
gezondheid en Milieu bedank ik de jarenlange prettige samenwerking, 
voor het controleren en corrigeren van de moleculaire data van de 
Rotterdamse patiënten en de mogelijkheden om fingerprinting in de 
praktijk te zien. Martien Borgdorff en medewerkers van KNCV Tuber-
culosefonds bedank ik voor de samenwerking op verschillende terreinen. 
In het bijzonder is mijn dank voor de financiële ondersteuning van het 
onderzoek naar transmissiepatronen in onze regio. De GGD’en Hollands 
Midden, Zuidhollandse Eilanden en Zuid-Holland Zuid bedank ik voor de 
steeds intensievere samenwerking en het beschikbaar stellen van de data 
voor een aantal onderzoeken die in dit proefschrift beschreven zijn. 
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 Ik ben de GGD Rotterdam-Rijnmond erkentelijk voor de gelegenheid 
om dit promotietraject te doorlopen. Marianne Donker, algemeen 
directeur, bedankt voor de steun die jij de afgelopen jaren aan de afdeling 
gegeven hebt. In de tijd dat tuberculose in de regio jaarlijks toenam, 
hebben wij van het Rotterdamse college van Burgemeester en 
Wethouders de opdracht gekregen om de stijgende trend nader te 
analyseren. Marianne, jij typeerde eens dat ik die opdracht wel heel 
gedegen aanpakte met een wetenschappelijke beantwoording middels een 
proefschrift. Het antwoord is met dit proefschrift gegeven en de 
beschreven interventies hebben de trend succesvol omgebogen naar een 
neerwaartse! Onno de Zwart, clustermanager infectieziektebestrijding, 
bedank ik voor de vele jaren samenwerking, eerst als collega-
afdelingshoofd en de laatste jaren als mijn leidinggevende. Onno, je hebt 
op vele manieren gezorgd dat de randvoorwaarden goed waren voor een 
succesvolle promotie. Het laatste jaar had ik één dag vrijstelling om de 
klus te klaren en ik heb dat als zeer belangrijk ervaren. Ik had daardoor 
extra energie voor de eindspurt. Ook wil ik je bedanken voor de sabbatical 
van twee maanden waarin ik binnenkort een nieuwe uitdaging met mezelf 
aan zal gaan. 
Een onderzoek opzetten, uitvoeren en publiceren is teamwerk. Ik wil 
alle coauteurs bedanken voor de succesvolle samenwerking. In het 
bijzonder wil ik hier Hennie Baars’ betrokkenheid benoemen aan het 
onderzoek naar transmissiepatronen in de regio. Hennie, alleen door jouw 
monnikenwerk hebben wij een uniek patiëntenbestand in de regio kunnen 
maken, waaruit ook in de toekomst nog veel gepubliceerd gaat worden. 
Met Rob van Hest vormde ik al sinds 1997 een schrijversduo toen wij het 
lustrumboek samenstelden voor de Nederlandse Vereniging voor 
Tropische Geneeskunde. Rob, ik typeerde dat toen dat jij teveel schreef en 
ik schrapte. De afgelopen jaren ben ik veel meer gaan schrijven en heb jij 
ook regelmatig geschrapt in mijn teksten. Ik ben je veel dank 
verschuldigd voor jouw tomeloze inzet in het meeschrijven met mijn 
artikelen voor dit proefschrift.  
 De collega’s van de afdeling tuberculosebestrijding van de GGD 
Rotterdam-Rijnmond ben ik bijzonder veel dank verschuldigd. Het 
proefschrift laat de inspanningen zien die jullie elke dag leveren om 
tuberculose succesvol te bestrijden in onze regio. Dankzij het zorgvuldig 
invoeren van gegevens in het elektronisch patiëntendossier, de diag-
nostiek, behandeling en begeleiding van patiënten uit te voeren en het 
correct melden van nieuwe patiënten, kon dit alles onderzocht worden. De 
ondersteuning die ik tijdens mijn promotie en mijn werk in Rotterdam 
ervaren heb, is altijd zeer hartverwarmend en stimulerend geweest. 
 Veel collega’s in de Rotterdamse en Nederlandse tuberculose-
bestrijding hebben mij op enig moment geholpen tijdens mijn loopbaan en 
met dit proefschrift. Ik kan ze hier niet allemaal noemen. Het zou echter 
niet passen als ik drie personen niet in het bijzonder bedank. Met Richard 
van Altena, longarts van het tuberculosecentrum Beatrixoord, Haren (Gr.), 
Marleen Bakker, longarts van het Erasmus MC in Rotterdam en Conny 
Burdo, sociaal-verpleegkundige van de afdeling tuberculosebestrijding van 
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de GGD Rotterdam-Rijnmond, heb ik afgelopen jaren een bijzondere band 
ontwikkeld. Richard, jij was altijd online als ik ’s avonds aan mijn 
onderzoek werkte, hoewel het me vaak niet duidelijk was of je in de 
kliniek, thuis of in Spanje of elders in de wereld was. Ik ben je erg 
dankbaar voor je toewijding en betrokkenheid bij onze patiënten. Marleen, 
je komst naar Rotterdam was een versterking voor de Rotterdamse tuber-
culosebestrijding. Je consulentschap bij de GGD en de reizen naar Zuid-
Afrika versterkten de samenwerking tussen public health en kliniek; je 
enthousiasme voor de ziekte stimuleerde me in brede zin. Conny, jij hebt 
vele jaren meegeholpen en me gesteund in het management van de 
afdeling. Jouw vragen hebben mij bovendien geprikkeld om meer 
aandacht te besteden aan andere zaken in het leven. Richard, Marleen en 
Conny, dank voor jullie steun en vriendschap. 
 De twee paranimfen, Roelof de Vries en Rob van Hest, wil ik 
bedanken dat zij mij in de laatste fase van de promotie en tijdens de 
feestelijkheden zullen bij staan. Roelof, jij was er samen met Marga voor 
mij en Florence tijdens heel bijzondere periodes in ons leven. Zo waren 
jullie de producent van ons eerste boekje met rondzendbrieven uit 
Zambia: een kostbaar bezit en zeer exclusief met een oplage van drie 
exemplaren. Roelof, dat jij als paranimf mij bijstaat voelt als 
vanzelfsprekend. Bedankt dat ik in jullie nieuwe huis in Colmenar in 
Spanje de rust en diepte mocht vinden om het proefschrift zo goed als af 
te schrijven. En Rob, het is natuurlijk ook vanzelfsprekend dat jij bij mijn 
promotie paranimf bent, want jij was de aanstichter van deze onder-
neming. 
 Lieve Florence, Douwe en Koen. Mijn grootste dank is aan jullie, 
voor jullie steun en liefde. Florence, jij bent al meer dan de helft van mijn 
leven mijn maatje en hebt me altijd gesteund in de dingen die ik doe. Dat 
geldt ook voor deze uitdaging. Douwe en Koen, jullie humor en 
relativering brachten me weer met beide benen op de grond. Aan jullie 
drieën is dit proefschrift opgedragen. 
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Gerard de Vries is geboren op 1 juni 1959 te Grootegast (Gr.). Hij volgt 
zijn middelbare schoolopleiding aan het College Groevenbeek te Ermelo en 
behaalt in 1977 het Atheneumdiploma. In datzelfde jaar start hij met de 
studie Geneeskunde aan de Vrije Universiteit te Amsterdam en behaalt in 
1986 het artsdiploma. Hij werkt tussen 1986 en 1988 als arts-assistent 
Chirurgie en Verloskunde & Gynaecologie in het ziekenhuis Zonnegloren te 
Soest, een voormalig tuberculosesanatorium. In 1988 volgt hij de 
Nationale Tropencursus voor Artsen aan het Koninklijk Instituut voor de 
Tropen in Amsterdam. Van 1989 tot 1992 werkt hij via Memisa als 
tropenarts en als medical superintendent in het Our Lady’s Hospital 
Chilonga in Mpika, Zambia. In Nederland werkt hij vervolgens als basisarts 
in twee asielzoekerscentra en volgt de International Course on District 
Health Care aan het Koninklijk Instituut voor de Tropen in Amsterdam. 
Van 1993 tot 1996 gaat hij via Memisa naar Ghana om als tropenarts in 
het St. Francis Xavier Hospital in Assin Foso en als District Director of 
Health Services van het Assin District te werken. Van 1996 tot 1997 
studeert hij aan de London School of Hygiene and Tropical Medicine in 
London, Engeland en behaalt de Master of Science graad in Public Health 
in Developing Countries. Hij werkt voor de Wereldgezondheidsorganisatie 
als consulent van het Polio Eradicatie Programma in Zambia en als 
cursuscoördinator van de Nederlandse Tropencursus aan de Netherlands 
School of Public Health in Utrecht, alvorens hij in september 1999 bij zijn 
huidige werkgever, de Gemeentelijke Gezondheidsdienst (GGD) 
Rotterdam-Rijnmond, in dienst treedt. Hij volgt de opleiding Sociale 
Geneeskunde (bijzondere tak tuberculosebestrijding) aan de Netherlands 
School of Public Health in Utrecht en verkrijgt in 2001 zijn registratie als 
sociaal-geneeskundige. Tussen 2001 en 2008 is hij hoofd van de afdeling 
tuberculosebestrijding van de GGD Rotterdam-Rijnmond en werkt tevens 
als tuberculosearts voor de GGD Hollands Midden in Gouda. In 2004 start 
hij zijn proefschrift in samenwerking met de afdeling Maatschappelijke 
Gezondheidszorg Erasmus MC van het Universitair Medisch Centrum in 
Rotterdam. Onlangs is hij benoemd als hoofd van de Unit Nationaal van 
het KNCV Tuberculosefonds te Den Haag en blijft parttime werkzaam bij 
de afdeling tuberculosebestrijding van de GGD Rotterdam-Rijnmond. Hij is 
geregistreerd als epidemioloog-A en als praktijkopleider voor artsen 
maatschappij en gezondheid, en heeft deelgenomen aan verschillende 
samenwerkingsactiviteiten met andere tuberculoseafdelingen in de wereld. 
Naast dit proefschrift publiceerde hij diverse artikelen over verschillende 
aspecten van tuberculose en tuberculosebestrijding in internationale en 
Nederlandse tijdschriften. Gerard is getrouwd met Florence van 
Wijngaarden en zij hebben twee zoons: Douwe en Koen. 
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Gerard de Vries was born on June 1, 1959 in Grootegast (Gr.), the 
Netherlands. He completed his secondary school at College Groevenbeek 
in Ermelo in 1977. He started his medical studies in Amsterdam at the 
Free University and obtained his medical degree in 1986. His medical 
career started with a housemanship in Surgery and Obstetrics & 
Gynaecology at the Zonnegloren Hospital in Soest, a former tuberculosis 
sanatorium in the Netherlands. In 1988, he participated in the Dutch 
Course for Tropical Medicine for Doctors at the Royal Tropical Institute in 
Amsterdam. From 1989 to 1992 he worked via Memisa as medical officer 
and as medical superintendent at Our Lady’s Hospital Chilonga in Mpika, 
Zambia. In the Netherlands, subsequently he worked as medical doctor in 
two asylum seeker centres and participated in the International Course on 
District Health Care at the Royal Tropical Institute in Amsterdam. From 
1993 to 1996 he worked again via Memisa as medical officer at St. Francis 
Xavier Hospital in Assin Foso and as District Director of Health Services of 
the Assin District, Ghana. From 1996 to 1997 he studied at the London 
School of Hygiene and Tropical Medicine, London, United Kingdom and 
obtained a Master of Science degree in Public Health in Developing 
Countries. He worked for the World Health Organisation as a consultant 
for the Polio Eradication Programme in Zambia and as a course 
coordinator for the Netherlands Tropical Course at the Netherlands School 
of Public Health in Utrecht, the Netherlands, before he joined his present 
employer, the Municipal Public Health Service Rotterdam-Rijnmond, in 
September 1999. He started the training for public health physician 
(tuberculosis control) at the Netherlands School of Public Health in Utrecht 
and obtained his registration as public health physician in 2001. Between 
2001 and 2008 he was head of the Department of Tuberculosis Control of 
the Municipal Public Health Service Rotterdam-Rijnmond and at the same 
time worked as tuberculosis public health physician at the Municipal 
Health Service Hollands Midden in Gouda. In 2004 he started his PhD in 
collaboration with the Department of Public Health of the Erasmus MC, 
University Medical Center Rotterdam. Recently, he was appointed as head 
of the National Unit of KNCV Tuberculosis Foundation in The Hague and 
will continue to work part-time with the Department of Tuberculosis 
Control of the Municipal Public Health Service in Rotterdam. He is 
registered as epidemiologist and as trainer for public health physicians, 
and has participated in various collaborative activities with other 
Departments of Tuberculosis Control in the world. Apart from this thesis, 
he has published several articles on different aspects of tuberculosis 
control in international and Dutch medical journals. Gerard is married with 
Florence van Wijngaarden and they have two sons: Douwe and Koen.
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PhD Portfolio Summary 
Summary of PhD training and teaching activities 
Name PhD student: Gerard de Vries 
Erasmus MC Department: Dept of Public Health 
Research School: 
PhD period: 2004-2008 
Promotor(s): Prof.dr. J.D.F. Habbema 
Supervisor: Dr. J.H. Richardus 
1. PhD training 
Year Workload 
(Hours/ECTS) 
General academic skills  
-  
  
Research skills 
-  
  
In-depth courses (e.g. Research school, Medical Training) 
-  
  
Presentations 
- De toepassing van DNA fingerprinting voor de lokale 
tuberculosebestrijding. Laboratorium voor Infectieziekten en 
Screening, Rijksinstituut voor Volksgezondheid en Milieu, 
Bilthoven 
- Specific strategies in metropoles: the experience of 
Rotterdam. Colloque européen sur la tuberculose. La 
tuberculose dans les mégapoles européennes, Paris, France. 
- Molecular epidemiology: a tool for public health. Using DNA 
fingerprinting for outbreak management in tuberculosis 
control. European Congress of Clinical Microbiology and 
Infectious Diseases. Nice, France. 
- Using DNA fingerprinting for outbreak management in 
tuberculosis control, Wetenschappelijke congres van de 
Nederlandse Vereniging voor Medische Microbiologie, 
Papendal 
- Tuberculosis: ancient disease, modern tools and targeted 
interventions. Experience from Rotterdam. Health Protection 
Agency national congress, Warwick, United Kingdom. 
- Molecular epidemiology: a tool for public health. Experience 
from Rotterdam. The Vilnius Tuberculosis Meetings, EuroTB / 
Wolfheze Workshop, Vilnius, Lithuania. 
- The epidemiology of tuberculosis in the Netherlands, Clinical 
Tuberculosis Course, Cape Town, South Africa. 
2005 
2005 
2006 
2006 
2006 
2006 
2008 
20 
20 
20 
10 
20 
10
20 
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hours
hours
hours
hours
hours
hours
hours
 
 
 
PhD Portfolio Summary 
(continued) 
International conferences 
- 3rd Congress of International Union against Tuberculosis and 
Lung Disease (IUATLD), European Region. Moscow, Russia 
(including poster presentation). 
- Rethinking the Epidemiology of Tuberculosis Infection: The 
First Global Symposium on Interferon-gamma Assays. 
Vancouver, Canada  (including poster presentation). 
- Powering Up Political Will for TB Control. 11th Annual 
Conference of the International Union against Tuberculosis 
and Lung Disease (IUATLD), North American Region. 
Vancouver, Canada. 
2004 
2007 
2007 
40 
40 
12 
Seminars and workshops 
- Clinical Tuberculosis Course, Cape town, South Africa 2006 20 
Didactic skills 
-  
  
Other 
-  
  
2. Teaching activities 
Year Workload 
(Hours/ECTS) 
Lecturing 
- Module ‘Infection disease hygiene’ for pulmonologists and TB 
physicians, Dutch Thoracic Society, Utrecht. 
- Module ‘Tuberculosis Control’ for medical students Erasmus 
MC (Social Medicine), Rotterdam 
2005-2008 
2005 
24 
6 
Supervising practicals and excursions 
- Registered trainer for public health medicine, Netherlands 
School of Public and Occupational Health, Amsterdam 
2006-2008 
Supervising Master’s theses 
-  
  
Other 
-  
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